TW202323498A - Heterocyclic compound, organic light emitting device comprising same, and composition for organic material layer of organic light emitting device - Google Patents

Heterocyclic compound, organic light emitting device comprising same, and composition for organic material layer of organic light emitting device Download PDF

Info

Publication number
TW202323498A
TW202323498A TW111134757A TW111134757A TW202323498A TW 202323498 A TW202323498 A TW 202323498A TW 111134757 A TW111134757 A TW 111134757A TW 111134757 A TW111134757 A TW 111134757A TW 202323498 A TW202323498 A TW 202323498A
Authority
TW
Taiwan
Prior art keywords
substituted
unsubstituted
chemical formula
deuterium
heterocyclic compound
Prior art date
Application number
TW111134757A
Other languages
Chinese (zh)
Inventor
盧永錫
朴建裕
金東駿
Original Assignee
南韓商Lt素材股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 南韓商Lt素材股份有限公司 filed Critical 南韓商Lt素材股份有限公司
Publication of TW202323498A publication Critical patent/TW202323498A/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • C07D491/153Ortho-condensed systems the condensed system containing two rings with oxygen as ring hetero atom and one ring with nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Abstract

The present specification relates to a heterocyclic compound represented by Chemical Formula 1, an organic light emitting device comprising the same, and a composition for an organic material layer of the organic light emitting device.

Description

雜環化合物、包括其之有機發光元件以及有機發光元件的有機材料層之組成物Heterocyclic compound, organic light-emitting device including same, and composition of organic material layer of organic light-emitting device

本申請案主張基於在2021年9月14日向韓國智慧財產局提出申請的韓國專利申請案第10-2021-0122791號的優先權權益,所述韓國專利申請案的全部內容作為本說明書的一部分併入本案。This application claims priority based on Korean Patent Application No. 10-2021-0122791 filed with the Korea Intellectual Property Office on September 14, 2021, the entire contents of which are incorporated as part of this specification into this case.

本揭露是有關於一種雜環化合物、包括其之有機發光元件以及有機發光元件的有機材料層之組成物。The disclosure relates to a heterocyclic compound, an organic light-emitting element including the heterocyclic compound, and a composition of an organic material layer of the organic light-emitting element.

有機發光元件是一種自發射型顯示元件,且其優點在於不僅具有寬視角及極佳的對比度,而且具有快的響應速度。The organic light-emitting element is a self-emissive display element, and has the advantages of not only having a wide viewing angle and excellent contrast, but also having a fast response speed.

有機發光元件具有在兩個電極之間設置有機薄膜的結構。當向具有此種結構的有機發光元件施加電壓時,自所述兩個電極注入的電子及電洞在有機薄膜中組合以形成對,且然後當該些電子及電洞消失時發光。有機薄膜可根據需要由單層或多層構成。An organic light emitting element has a structure in which an organic thin film is provided between two electrodes. When a voltage is applied to the organic light emitting element having such a structure, electrons and holes injected from the two electrodes combine to form pairs in the organic thin film, and then emit light when the electrons and holes disappear. The organic thin film may consist of a single layer or a multilayer as required.

有機薄膜的材料可根據需要具有發光功能。舉例而言,作為有機薄膜的材料,可使用能夠自身單獨形成發光層的化合物,或者亦可使用能夠發揮基於主體-摻雜劑的發光層的主體或摻雜劑作用的化合物。除此之外,能夠發揮電洞注入、電洞傳輸、電子阻擋、電洞阻擋、電子傳輸、電子注入及類似作用等作用的化合物亦可用作有機薄膜的材料。The material of the organic thin film may have a light emitting function as required. For example, as a material of the organic thin film, a compound capable of forming a light-emitting layer by itself, or a compound capable of functioning as a host or a dopant of a light-emitting layer based on a host-dopant may be used. In addition, compounds capable of performing functions such as hole injection, hole transport, electron blocking, hole blocking, electron transport, electron injection, and the like can also be used as materials for organic thin films.

為了提高有機發光元件的效能、壽命或效率,一直持續地需要開發有機薄膜材料。 先前技術文件 專利文件 (專利文件1)美國專利第4,356,429號 In order to improve the efficacy, lifetime or efficiency of organic light-emitting devices, there is a continuous need to develop organic thin film materials. Prior Technical Documents patent documents (Patent Document 1) US Patent No. 4,356,429

[技術問題][technical problem]

本揭露的目的是提供一種雜環化合物、包括其之有機發光元件以及有機發光元件的有機材料層之組成物。 [技術解決方案] The purpose of the present disclosure is to provide a composition of a heterocyclic compound, an organic light-emitting device including the same, and an organic material layer of the organic light-emitting device. [Technical solution]

本揭露提供一種由以下化學式1表示的雜環化合物: [化學式1]

Figure 02_image001
在化學式1中, R1至R12彼此相同或不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C60烷基;經取代或未經取代的C2至C60烯基;經取代或未經取代的C2至C60炔基;經取代或未經取代的C1至C60烷氧基;經取代或未經取代的C3至C60環烷基;經取代或未經取代的C2至C60雜環烷基;經取代或未經取代的C6至C60芳基;以及經取代或未經取代的C2至C60雜芳基,且R1至R12中的至少一者為氘, X1、X2及X3彼此相同或不同,且各自獨立地為NAr1、O、S或CR13R14,且X1、X2及X3中的至少一者為NAr1, Ar1為由以下化學式1-1表示的基團, [化學式1-1]
Figure 02_image003
在化學式1-1中, L1與L2彼此相同或不同,且各自獨立地為單鍵;經取代或未經取代的C6至C60伸芳基;或者經取代或未經取代的C2至C60伸雜芳基, Ar2與Ar3彼此相同或不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C60烷基;經取代或未經取代的C2至C60烯基;經取代或未經取代的C2至C60炔基;經取代或未經取代的C1至C60烷氧基;經取代或未經取代的C3至C60環烷基;經取代或未經取代的C2至C60雜環烷基;經取代或未經取代的C6至C60芳基;以及經取代或未經取代的C2至C60雜芳基, a與b彼此相同或不同,且各自獨立地為0至3的整數,且 R13與R14彼此相同或不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C60烷基;經取代或未經取代的C2至C60烯基;經取代或未經取代的C2至C60炔基;經取代或未經取代的C1至C60烷氧基;經取代或未經取代的C3至C60環烷基;經取代或未經取代的C2至C60雜環烷基;經取代或未經取代的C6至C60芳基;以及經取代或未經取代的C2至C60雜芳基。 The present disclosure provides a heterocyclic compound represented by the following Chemical Formula 1: [Chemical Formula 1]
Figure 02_image001
In Chemical Formula 1, R1 to R12 are the same or different from each other, and are each independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C60 alkyl; substituted or Unsubstituted C2 to C60 alkenyl; substituted or unsubstituted C2 to C60 alkynyl; substituted or unsubstituted C1 to C60 alkoxy; substituted or unsubstituted C3 to C60 cycloalkyl ; substituted or unsubstituted C2 to C60 heterocycloalkyl; substituted or unsubstituted C6 to C60 aryl; and substituted or unsubstituted C2 to C60 heteroaryl, and in R1 to R12 At least one is deuterium, X1, X2 and X3 are the same or different from each other, and each independently is NAr1, O, S or CR13R14, and at least one of X1, X2 and X3 is NAr1, and Ar1 is represented by the following chemical formula 1- The group represented by 1, [chemical formula 1-1]
Figure 02_image003
In Chemical Formula 1-1, L1 and L2 are the same or different from each other, and each is independently a single bond; a substituted or unsubstituted C6 to C60 aryl; or a substituted or unsubstituted C2 to C60 hetero Aryl, Ar2 and Ar3 are the same or different from each other, and are each independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C60 alkyl; substituted or unsubstituted Substituted C2 to C60 alkenyl; substituted or unsubstituted C2 to C60 alkynyl; substituted or unsubstituted C1 to C60 alkoxy; substituted or unsubstituted C3 to C60 cycloalkyl; Substituted or unsubstituted C2 to C60 heterocycloalkyl; substituted or unsubstituted C6 to C60 aryl; and substituted or unsubstituted C2 to C60 heteroaryl, a and b are the same or different from each other, And each independently is an integer of 0 to 3, and R13 and R14 are the same or different from each other, and are each independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C60 alkyl; substituted or unsubstituted C2 to C60 alkenyl; substituted or unsubstituted C2 to C60 alkynyl; substituted or unsubstituted C1 to C60 alkoxy; substituted or unsubstituted C3 to C60 cycloalkyl; substituted or unsubstituted C2 to C60 heterocycloalkyl; substituted or unsubstituted C6 to C60 aryl; and substituted or unsubstituted C2 to C60 heteroaryl .

此外,本揭露提供一種有機發光元件,所述有機發光元件包括:第一電極;第二電極,被設置成面對第一電極;以及一或多個有機材料層,設置於第一電極與第二電極之間,其中有機材料層的一或多個層包含由以上化學式1表示的雜環化合物。In addition, the present disclosure provides an organic light-emitting device, the organic light-emitting device includes: a first electrode; a second electrode disposed to face the first electrode; and one or more organic material layers disposed between the first electrode and the second electrode. Between the two electrodes, one or more layers of the organic material layer includes the heterocyclic compound represented by the above Chemical Formula 1.

此外,本揭露提供一種有機發光元件,其中有機材料層更包含由以下化學式2表示的雜環化合物: [化學式2]

Figure 02_image005
在化學式2中, R21至R34彼此相同或不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C60烷基;經取代或未經取代的C2至C60烯基;經取代或未經取代的C2至C60炔基;經取代或未經取代的C1至C60烷氧基;經取代或未經取代的C3至C60環烷基;經取代或未經取代的C2至C60雜環烷基;經取代或未經取代的C6至C60芳基;以及經取代或未經取代的C2至C60雜芳基, L3與L4彼此相同或不同,且各自獨立地為單鍵;經取代或未經取代的C6至C60伸芳基;或者經取代或未經取代的C2至C60伸雜芳基, Ar11與Ar12彼此相同或不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C60烷基;經取代或未經取代的C2至C60烯基;經取代或未經取代的C2至C60炔基;經取代或未經取代的C1至C60烷氧基;經取代或未經取代的C3至C60環烷基;經取代或未經取代的C2至C60雜環烷基;經取代或未經取代的C6至C60芳基;經取代或未經取代的C2至C60雜芳基;-P(=O)R101R102;以及–SiR101R102R103,且R101、R102及R103彼此相同或不同,且各自獨立地為經取代或未經取代的C1至C60烷基;經取代或未經取代的C6至C60芳基;或者經取代或未經取代的C2至C60雜芳基,且 m與n彼此相同或不同,且各自獨立地為0至3的整數。 In addition, the present disclosure provides an organic light-emitting device, wherein the organic material layer further includes a heterocyclic compound represented by the following chemical formula 2: [chemical formula 2]
Figure 02_image005
In Chemical Formula 2, R21 to R34 are the same or different from each other, and are each independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C60 alkyl; substituted or Unsubstituted C2 to C60 alkenyl; substituted or unsubstituted C2 to C60 alkynyl; substituted or unsubstituted C1 to C60 alkoxy; substituted or unsubstituted C3 to C60 cycloalkyl ; substituted or unsubstituted C2 to C60 heterocycloalkyl; substituted or unsubstituted C6 to C60 aryl; and substituted or unsubstituted C2 to C60 heteroaryl, L3 and L4 are identical to each other or Different, and each independently is a single bond; substituted or unsubstituted C6 to C60 aryl; or substituted or unsubstituted C2 to C60 heteroaryl, Ar11 and Ar12 are the same or different from each other, and each independently selected from the group consisting of: hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C60 alkyl; substituted or unsubstituted C2 to C60 alkenyl; substituted or unsubstituted Substituted C2 to C60 alkynyl; substituted or unsubstituted C1 to C60 alkoxy; substituted or unsubstituted C3 to C60 cycloalkyl; substituted or unsubstituted C2 to C60 heterocycloalkyl ; substituted or unsubstituted C6 to C60 aryl; substituted or unsubstituted C2 to C60 heteroaryl; -P(=O)R101R102; and -SiR101R102R103, and R101, R102 and R103 are the same or different , and are each independently substituted or unsubstituted C1 to C60 alkyl; substituted or unsubstituted C6 to C60 aryl; or substituted or unsubstituted C2 to C60 heteroaryl, and m and n are the same or different from each other, and each independently represents an integer of 0 to 3.

此外,本揭露提供一種有機發光元件的有機材料層之組成物,所述組成物包含由以上化學式1表示的雜環化合物及由以上化學式2表示的雜環化合物。 [有益效果] In addition, the present disclosure provides a composition of an organic material layer of an organic light-emitting device, the composition including the heterocyclic compound represented by the above Chemical Formula 1 and the heterocyclic compound represented by the above Chemical Formula 2. [beneficial effect]

根據一個實施例的雜環化合物可用作有機發光元件的有機材料層的材料。所述化合物可用作有機發光元件中的電洞注入層材料、電子阻擋層材料、電洞傳輸層材料、發光層材料、電子傳輸層材料、電洞阻擋層材料、電子注入層材料及類似材料。具體而言,所述化合物可用作有機發光元件的發光層材料。The heterocyclic compound according to one embodiment may be used as a material of an organic material layer of an organic light emitting element. The compound can be used as hole injection layer material, electron blocking layer material, hole transport layer material, light emitting layer material, electron transport layer material, hole blocking layer material, electron injection layer material and similar materials in organic light emitting elements . Specifically, the compound can be used as a light-emitting layer material of an organic light-emitting element.

具體而言,所述雜環化合物可單獨用作發光材料或與P型主體混合用作發光材料,且可用作發光層的主體材料或摻雜劑材料。當在有機材料層中使用由以上化學式1表示的化合物時,其可降低有機發光元件的驅動電壓,提高發光效率,並且提高壽命性質。Specifically, the heterocyclic compound can be used alone or mixed with a P-type host as a light-emitting material, and can be used as a host material or a dopant material of a light-emitting layer. When the compound represented by the above Chemical Formula 1 is used in the organic material layer, it may reduce the driving voltage of the organic light emitting element, improve luminous efficiency, and improve lifetime properties.

更具體而言,當根據一個實施例的雜環化合物用作發光層時,其可增強電洞傳輸性質及電子傳輸性質,藉由調節帶間隙(band gap)及三重態能階(triplet energy level)(T 1能階)值來提高電洞傳輸能力,降低有機發光元件的驅動電壓並藉由提高分子的穩定性來提高光效率,並且藉由所述化合物的被提高的熱穩定性來提高有機發光元件的壽命性質。 More specifically, when the heterocyclic compound according to one embodiment is used as a light-emitting layer, it can enhance hole transport properties and electron transport properties by adjusting band gap and triplet energy level ) (T 1 energy level) value to improve the hole transport ability, reduce the driving voltage of the organic light-emitting device and improve the light efficiency by improving the stability of the molecule, and improve the thermal stability of the compound by improving Lifetime Properties of Organic Light Emitting Elements.

在下文中,將更詳細地闡述本揭露。Hereinafter, the present disclosure will be explained in more detail.

在本說明書中,用語「取代(substitution)」意指鍵合至化合物的碳原子的氫原子變為另一取代基,且被取代的位置不受限制,只要其為氫原子被取代的位置(亦即,取代基能夠進行取代的位置)即可,且當二或更多個取代基進行取代時,所述二或更多個取代基可彼此相同或不同。In this specification, the term "substitution" means that a hydrogen atom bonded to a carbon atom of a compound becomes another substituent, and the substituted position is not limited as long as it is a position where a hydrogen atom is substituted ( That is, the position where the substituent can be substituted) is sufficient, and when two or more substituents are substituted, the two or more substituents may be the same as or different from each other.

在本說明書中,用語「經取代或未經取代的」意指經選自由氘、鹵素、氰基、C1至C60直鏈或支鏈烷基、C2至C60直鏈或支鏈烯基、C2至C60直鏈或支鏈炔基、C3至C60單環或多環環烷基、C2至C60單環或多環雜環烷基、C6至C60單環或多環芳基、C2至C60單環或多環雜芳基、-SiRR'R''、-P(=O)RR'、C1至C20烷基胺基、C6至C60單環或多環芳基胺基及C2至C60單環或多環雜芳基胺基組成的群組的一或多個取代基取代或未經取代,或者經對選自以上所示取代基的二或更多個取代基進行連結的取代基取代或未經取代。In this specification, the term "substituted or unsubstituted" means a group selected from deuterium, halogen, cyano, C1 to C60 straight or branched chain alkyl, C2 to C60 straight or branched chain alkenyl, C2 to C60 straight chain or branched chain alkynyl, C3 to C60 monocyclic or polycyclic cycloalkyl, C2 to C60 monocyclic or polycyclic heterocycloalkyl, C6 to C60 monocyclic or polycyclic aryl, C2 to C60 monocyclic Cyclic or polycyclic heteroaryl, -SiRR'R'', -P(=O)RR', C1 to C20 alkylamine, C6 to C60 monocyclic or polycyclic arylamine and C2 to C60 monocyclic or one or more substituents of the group consisting of polycyclic heteroarylamine groups may be substituted or unsubstituted, or substituted by a substituent that connects two or more substituents selected from the substituents shown above, or Not replaced.

在本說明書中,鹵素可為氟、氯、溴或碘。In this specification, halogen may be fluorine, chlorine, bromine or iodine.

在本說明書中,烷基可包括具有1至60個碳原子的直鏈或支鏈,且可進一步被其他取代基取代。烷基的碳原子數可為1至60,具體而言為1至40,且更具體而言為1至20。烷基的具體實例可包括甲基、乙基、丙基、正丙基、異丙基、丁基、正丁基、異丁基、第三丁基、第二丁基、1-甲基-丁基、1-乙基-丁基、戊基、正戊基、異戊基、新戊基、第三戊基、己基、正己基、1-甲基戊基、2-甲基戊基、4-甲基-2-戊基、3,3-二甲基丁基、2-乙基丁基、庚基、正庚基、1-甲基己基、環戊基甲基、環己基甲基、辛基、正辛基、第三辛基、1-甲基庚基、2-乙基己基、2-丙基戊基、正壬基、2,2-二甲基庚基、1-乙基-丙基、1,1-二甲基-丙基、異己基、4-甲基己基、5-甲基己基及類似基團,但不限於此。In the present specification, the alkyl group may include straight or branched chains having 1 to 60 carbon atoms, and may be further substituted with other substituents. The number of carbon atoms of the alkyl group may be 1 to 60, specifically 1 to 40, and more specifically 1 to 20. Specific examples of the alkyl group may include methyl, ethyl, propyl, n-propyl, isopropyl, butyl, n-butyl, isobutyl, tert-butyl, second-butyl, 1-methyl- Butyl, 1-ethyl-butyl, pentyl, n-pentyl, isopentyl, neopentyl, tertiary pentyl, hexyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 4-methyl-2-pentyl, 3,3-dimethylbutyl, 2-ethylbutyl, heptyl, n-heptyl, 1-methylhexyl, cyclopentylmethyl, cyclohexylmethyl , octyl, n-octyl, third octyl, 1-methylheptyl, 2-ethylhexyl, 2-propylpentyl, n-nonyl, 2,2-dimethylheptyl, 1-ethyl propyl-propyl, 1,1-dimethyl-propyl, isohexyl, 4-methylhexyl, 5-methylhexyl and the like, but not limited thereto.

在本說明書中,烯基可包括具有2至60個碳原子的直鏈或支鏈,且可進一步被其他取代基取代。烯基的碳原子數可為2至60,具體而言為2至40,且更具體而言為2至20。烯基的具體實例可包括乙烯基、1-丙稀基、異丙稀基、1-丁烯基、2-丁烯基、3-丁烯基、1-戊烯基、2-戊烯基、3-戊烯基、3-甲基-1-丁烯基、1,3-丁二烯基、烯丙基、1-苯基乙烯基-1-基、2-苯基乙烯基-1-基、2,2-二苯基乙烯基-1-基、2-苯基-2-(萘基-1-基)乙烯基-1-基、2,2-雙(二苯基-1-基)乙烯基-1-基、二苯乙烯基(stilbenyl group)、苯乙烯基及類似基團,但不限於此。In the present specification, the alkenyl group may include straight or branched chains having 2 to 60 carbon atoms, and may be further substituted with other substituents. The number of carbon atoms of the alkenyl group may be 2 to 60, specifically 2 to 40, and more specifically 2 to 20. Specific examples of alkenyl may include vinyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl , 3-pentenyl, 3-methyl-1-butenyl, 1,3-butadienyl, allyl, 1-phenylethenyl-1-yl, 2-phenylethenyl-1 -yl, 2,2-diphenylethenyl-1-yl, 2-phenyl-2-(naphthyl-1-yl)ethenyl-1-yl, 2,2-bis(diphenyl-1 -yl) vinyl-1-yl, stilbenyl (stilbenyl group), styryl and the like, but not limited thereto.

在本說明書中,炔基可包括具有2至60個碳原子的直鏈或支鏈,且可進一步被其他取代基取代。炔基的碳原子數可為2至60、具體而言為2至40且更具體而言為2至20。In the present specification, the alkynyl group may include straight or branched chains having 2 to 60 carbon atoms, and may be further substituted with other substituents. The number of carbon atoms of the alkynyl group may be 2 to 60, specifically 2 to 40, and more specifically 2 to 20.

在本說明書中,烷氧基可為直鏈、支鏈或環狀鏈。烷氧基的碳原子數並無特別限制,但較佳為1至20。烷氧基的具體實例可包括甲氧基、乙氧基、正丙氧基、異丙氧基、正丁氧基、異丁氧基、第三丁氧基、第二丁氧基、正戊氧基、新戊氧基、異戊氧基、正己氧基、3,3-二甲基丁氧基、2-乙基丁氧基、正辛氧基、正壬氧基、正癸氧基、苄氧基、對甲基苄氧基及類似基團,但不限於此。In this specification, an alkoxy group may be a linear, branched or cyclic chain. The number of carbon atoms in the alkoxy group is not particularly limited, but is preferably 1-20. Specific examples of alkoxy may include methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy, sec-butoxy, n-pentoxy Oxygen, neopentyloxy, isopentyloxy, n-hexyloxy, 3,3-dimethylbutoxy, 2-ethylbutoxy, n-octyloxy, n-nonyloxy, n-decyloxy , benzyloxy, p-methylbenzyloxy and similar groups, but not limited thereto.

在本說明書中,環烷基可包括具有3至60個碳原子的單環或多環,且可進一步被其他取代基取代。在本文中,多環指代其中環烷基與其他環狀基直接連結或縮合的基團。在本文中,所述其他環狀基可為環烷基,但亦可為不同類型的環狀基,例如雜環烷基、芳基、雜芳基及類似基團。環烷基的碳原子數可為3至60,具體而言為3至40,且更具體而言為5至20。環烷基的具體實例可包括環丙基、環丁基、環戊基、3-甲基環戊基、2,3-二甲基環戊基、環己基、3-甲基環己基、4-甲基環己基、2,3-二甲基環己基、3,4,5-三甲基環己基、4-第三丁基環己基、環庚基、環辛基及類似基團,但不限於此。In the present specification, the cycloalkyl group may include a monocyclic or polycyclic ring having 3 to 60 carbon atoms, and may be further substituted with other substituents. Herein, a polycyclic ring refers to a group in which a cycloalkyl group is directly linked or condensed with other cyclic groups. Herein, the other cyclic group may be a cycloalkyl group, but may also be a different type of cyclic group, such as a heterocycloalkyl group, an aryl group, a heteroaryl group, and the like. The number of carbon atoms of the cycloalkyl group may be 3 to 60, specifically 3 to 40, and more specifically 5 to 20. Specific examples of cycloalkyl may include cyclopropyl, cyclobutyl, cyclopentyl, 3-methylcyclopentyl, 2,3-dimethylcyclopentyl, cyclohexyl, 3-methylcyclohexyl, 4 - methylcyclohexyl, 2,3-dimethylcyclohexyl, 3,4,5-trimethylcyclohexyl, 4-tert-butylcyclohexyl, cycloheptyl, cyclooctyl and similar groups, but Not limited to this.

在本說明書中,雜環烷基可包含O、S、Se、N或Si作為雜原子,可包括具有2至60個碳原子的單環或多環,且可進一步被其他取代基取代。在本文中,多環指代其中雜環烷基與其他環狀基直接連結或縮合的基團。在本文中,所述其他環狀基可為雜環烷基,但亦可為不同類型的環狀基,例如環烷基、芳基、雜芳基及類似基團。雜環烷基的碳原子數可為2至60,具體而言為2至40,且更具體而言為3至20。In the present specification, the heterocycloalkyl group may contain O, S, Se, N or Si as a heteroatom, may include a monocyclic or polycyclic ring having 2 to 60 carbon atoms, and may be further substituted with other substituents. Herein, a polycyclic ring refers to a group in which a heterocycloalkyl group is directly linked or condensed with other cyclic groups. Herein, the other cyclic group may be a heterocycloalkyl group, but may also be a different type of cyclic group, such as cycloalkyl, aryl, heteroaryl and the like. The number of carbon atoms of the heterocycloalkyl group may be 2 to 60, specifically 2 to 40, and more specifically 3 to 20.

在本說明書中,芳基可包括具有6至60個碳原子的單環或多環,且可進一步被其他取代基取代。在本文中,多環意指其中芳基與其他環狀基直接連結或縮合的基團。在本文中,所述其他環狀基可為芳基,但亦可為不同類型的環狀基,例如環烷基、雜環烷基、雜芳基及類似基團。芳基包括螺環基。芳基的碳原子數可為6至60,具體而言為6至40,且更具體而言為6至25。芳基的具體實例可包括苯基、聯苯基、三苯基、萘基、蒽基、䓛基、菲基、苝基、螢蒽基、聯三伸苯基、萉基、芘基、稠四苯基、稠五苯基、芴基、茚基、苊基、苯並芴基、螺環二芴基、2,3-二氫-1H-茚基、其縮環基及類似基團,但不限於此。In the present specification, the aryl group may include a monocyclic or polycyclic ring having 6 to 60 carbon atoms, and may be further substituted with other substituents. Herein, polycyclic means a group in which an aryl group is directly linked or condensed with other cyclic groups. Herein, the other cyclic group may be an aryl group, but may also be a different type of cyclic group, such as cycloalkyl, heterocycloalkyl, heteroaryl and the like. Aryl includes spirocyclyl. The number of carbon atoms of the aryl group may be 6 to 60, specifically 6 to 40, and more specifically 6 to 25. Specific examples of aryl may include phenyl, biphenyl, triphenyl, naphthyl, anthracenyl, phenanthryl, phenanthrenyl, perylenyl, fluoranthracenyl, biterphenylenyl, phenanthryl, pyrenyl, fused Tetraphenyl, fused pentaphenyl, fluorenyl, indenyl, acenaphthyl, benzofluorenyl, spirobifluorenyl, 2,3-dihydro-1H-indenyl, their ring-condensing groups and similar groups, But not limited to this.

在本說明書中,芴基可被取代,且相鄰的取代基可彼此鍵合以形成環。In this specification, the fluorenyl group may be substituted, and adjacent substituents may be bonded to each other to form a ring.

當芴基被取代時,經取代的芴基可變成

Figure 02_image007
Figure 02_image009
Figure 02_image011
Figure 02_image013
Figure 02_image015
Figure 02_image017
或類似基團,但不限於此。 When fluorenyl is substituted, the substituted fluorenyl can become
Figure 02_image007
,
Figure 02_image009
,
Figure 02_image011
,
Figure 02_image013
,
Figure 02_image015
,
Figure 02_image017
or similar groups, but not limited thereto.

在本說明書中,雜芳基可包含S、O、Se、N或Si作為雜原子,可包括具有2至60個碳原子的單環或多環,且可進一步被其他取代基取代。在本文中,多環指代其中雜芳基與其他環狀基直接連結或縮合的基團。在本文中,其他環狀基可為雜芳基,但亦可為不同類型的環狀基,例如環烷基、雜環烷基、芳基及類似基團。雜芳基的碳原子數可為2至60,具體而言為2至40,且更具體而言為3至25。雜芳基的具體實例可包括吡啶基、吡咯基、嘧啶基、噠嗪基、呋喃基、噻吩基、咪唑基、吡唑基、噁唑基、異噁唑基、噻唑基、異噻唑基、三唑基、呋呫基、噁二唑基、噻二唑基、二噻唑基、四唑基、吡喃基、噻喃基、二嗪基、噁嗪基、噻嗪基、二噁英基(dioxinyl group)、三嗪基、四嗪基、喹啉基、異喹啉基、喹唑啉基(quinazolinyl group)、異喹唑啉基、喹噁啉基(quinozolilyl group)、萘啶基、吖啶基、菲啶基(phenanthridinyl group)、咪唑並吡啶基、二氮雜萘基、三氮雜茚基、吲哚基、中氮茚基、苯並噻唑基、苯並噁唑基、苯並咪唑基、苯並噻吩基、苯並呋喃基、二苯並噻吩基、二苯並呋喃基、咔唑基、苯並咔唑基、二苯並咔唑基、啡嗪基、二苯並矽雜環戊二烯基(dibenzosilole group)、螺環二(二苯並矽雜環戊二烯)基、二氫啡嗪基、啡噁嗪基、菲啶基(phenanthridyl group)、噻吩基、吲哚並[2,3-a]咔唑基、吲哚並[2,3-b]咔唑基、二氫吲哚基、10,11-二氫-二苯並[b,f]氮呯基、9,10-二氫吖啶基、啡嗪基、啡噻嗪基(phenothiazinyl group)、酞嗪基、萘啶基、菲咯啉基、苯並[c][1,2,5]噻二唑基、5,10-二氫二苯並[b,e][1,4]氮雜矽啉基、吡唑並[1,5-c]喹唑啉基、吡啶並[1,2-b]吲唑基、吡啶並[1,2-a]咪唑並[1,2-e]二氫吲哚基、5,11-二氫茚並[1,2-b]咔唑基及類似基團,但不限於此。In the present specification, the heteroaryl group may contain S, O, Se, N or Si as a heteroatom, may include a monocyclic or polycyclic ring having 2 to 60 carbon atoms, and may be further substituted with other substituents. Herein, polycyclic refers to a group in which a heteroaryl group is directly linked or condensed with other cyclic groups. Herein, other cyclic groups may be heteroaryl groups, but may also be different types of cyclic groups, such as cycloalkyl, heterocycloalkyl, aryl and the like. The number of carbon atoms of the heteroaryl group may be 2 to 60, specifically 2 to 40, and more specifically 3 to 25. Specific examples of heteroaryl may include pyridyl, pyrrolyl, pyrimidinyl, pyridazinyl, furyl, thienyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, Triazolyl, furanyl, oxadiazolyl, thiadiazolyl, bithiazolyl, tetrazolyl, pyryl, thiopyranyl, diazinyl, oxazinyl, thiazinyl, dioxinyl ( dioxinyl group), triazine, tetrazine, quinolinyl, isoquinolinyl, quinazolinyl group, isoquinazolinyl, quinozolilyl group, naphthyridinyl, acridine Pyridyl, phenanthridinyl (phenanthridinyl group), imidazopyridyl, naphthyl, triazindenyl, indolyl, indolizyl, benzothiazolyl, benzoxazolyl, benzo Imidazolyl, benzothienyl, benzofuryl, dibenzothienyl, dibenzofuryl, carbazolyl, benzocarbazolyl, dibenzocarbazolyl, phenazinyl, dibenzosilyl Heterocyclopentadienyl (dibenzosilole group), spirobis (dibenzosilyl) base, dihydrophenanthazinyl, phenanthoxazinyl, phenanthridyl group (phenanthridyl group), thienyl, indyl Indolo[2,3-a]carbazolyl, Indolo[2,3-b]carbazolyl, Indolinyl, 10,11-dihydro-dibenzo[b,f]nitrogen 9,10-dihydroacridinyl, phenthiazinyl, phenothiazinyl group, phthalazinyl, naphthyridinyl, phenanthrolinyl, benzo[c][1,2,5] Thiadiazolyl, 5,10-dihydrodibenzo[b,e][1,4]azasilinyl, pyrazolo[1,5-c]quinazolinyl, pyrido[1, 2-b]indazolyl, pyrido[1,2-a]imidazo[1,2-e]indolinyl, 5,11-dihydroindeno[1,2-b]carbazolyl and similar groups, but not limited thereto.

在本說明書中,胺基可選自由以下組成的群組:單烷基胺基;單芳基胺基;單雜芳基胺基;-NH 2;二烷基胺基;二芳基胺基;二雜芳基胺基;烷基芳基胺基;烷基雜芳基胺基;以及芳基雜芳基胺基,且胺基的碳原子數並無特別限制,但較佳為1至30。胺基的具體實例可包括甲基胺基、二甲基胺基、乙基胺基、二乙基胺基、苯基胺基、萘基胺基、聯苯基胺基、二聯苯基胺基、蒽基胺基、9-甲基-蒽基胺基、二苯基胺基、苯基萘基胺基、二甲苯基胺基、苯基甲苯基胺基、三苯基胺基、聯苯基萘基胺基、苯基聯苯基胺基、聯苯基芴基胺基、苯基聯三伸苯基胺基、聯苯基聯三伸苯基胺基及類似基團,但不限於此。 In this specification, the amine group can be selected from the group consisting of: monoalkylamine group; monoarylamine group; monoheteroarylamine group; -NH 2 ; ; diheteroarylamine group; alkylarylamine group; alkylheteroarylamine group; 30. Specific examples of the amine group may include methylamine, dimethylamine, ethylamine, diethylamine, phenylamine, naphthylamine, biphenylamine, biphenylamine Base, anthracenylamine, 9-methyl-anthrylamine, diphenylamine, phenylnaphthylamine, xylylamine, phenylcresylamine, triphenylamine, biphenyl Phenylnaphthylamino, phenylbiphenylylamino, biphenylfluorenylamino, phenylbisphenylylamino, biphenylbiphenylylamino and similar groups, but not limited to this.

在本說明書中,伸芳基意指在芳基中具有兩個鍵合位置的基團,即二價基團。除了該些基團中的每一者為二價基團以外,可應用上述芳基的說明。此外,伸雜芳基意指在雜芳基中具有兩個鍵合位置的基團,即二價基團。除了該些基團中的每一者為二價基團以外,可應用上述雜芳基的說明。In this specification, the aryl group means a group having two bonding positions in the aryl group, that is, a divalent group. Except that each of these groups is a divalent group, the description of the aryl group above applies. In addition, the heteroaryl group means a group having two bonding positions in the heteroaryl group, that is, a divalent group. Except that each of these groups is a divalent group, the above description of heteroaryl applies.

在本說明書中,「相鄰」基團可意指在與對應取代基被取代的原子直接連結的原子上進行取代的取代基、在空間上位置最接近對應取代基的取代基、或在對應取代基被取代的原子上進行取代的另一取代基。舉例而言,在苯環中鄰位處進行取代的兩個取代基以及在脂族環中相同碳處進行取代的兩個取代基可被解釋為彼此「相鄰」的基團。In this specification, an "adjacent" group may mean a substituent that is substituted on an atom that is directly attached to the atom to which the corresponding substituent is substituted, a substituent that is spatially closest to the corresponding substituent, or a substituent that is at the corresponding Substituent Another substituent that is substituted on the atom being substituted. For example, two substituents substituted at ortho positions in a benzene ring and two substituents substituted at the same carbon in an aliphatic ring may be construed as being "adjacent" to each other.

在本揭露中,「化學式或化合物結構中未指明取代基的情形」意味著氫原子鍵合至碳原子。然而,由於氘( 2H)是氫的同位素,因此一些氫原子可為氘。 In the present disclosure, "the case where no substituent is specified in the chemical formula or compound structure" means that a hydrogen atom is bonded to a carbon atom. However, since deuterium ( 2 H) is an isotope of hydrogen, some hydrogen atoms may be deuterium.

在本揭露的一個實施例中,「化學式或化合物結構中未指明取代基的情形」可意味著可作為取代基的位置皆為氫或氘。換言之,由於氘是氫的同位素,因此一些氫原子可為作為同位素的氘,且此時氘含量可為0%至100%。In one embodiment of the present disclosure, "the case where no substituent is specified in the chemical formula or compound structure" may mean that the positions that can be used as substituents are all hydrogen or deuterium. In other words, since deuterium is an isotope of hydrogen, some hydrogen atoms may be deuterium as an isotope, and the deuterium content may be 0% to 100% at this time.

在本揭露的一個實施例中,在「在化學式或化合物結構中未指明取代基的情形」中,當未明確排除氘(例如,「氘含量為0%」、「氫含量為100%」或「取代基皆為氫」)時,氫與氘可在化合物中混合並使用。In one embodiment of the present disclosure, in "the situation where no substituent is specified in the chemical formula or compound structure", when deuterium is not explicitly excluded (for example, "the deuterium content is 0%", "the hydrogen content is 100%" or "The substituents are all hydrogen"), hydrogen and deuterium can be mixed and used in the compound.

在本揭露的一個實施例中,氘是氫的同位素中的一者,是具有由一個質子及一個中子組成的氘核作為核的元素,且可被表達為氫-2,且元素符號亦可被寫為D或 2H。 In one embodiment of the present disclosure, deuterium is one of the isotopes of hydrogen, an element having a deuteron composed of one proton and one neutron as a nucleus, and can be expressed as hydrogen-2, and the element symbol is also Can be written as D or 2 H.

在本揭露的一個實施例中,同位素意指具有相同原子數(Z)但具有不同質量數(A)的原子,且亦可被解釋為具有相同質子數但具有不同中子數的元素。In one embodiment of the present disclosure, isotopes refer to atoms with the same atomic number (Z) but different mass numbers (A), and can also be interpreted as elements with the same number of protons but different numbers of neutrons.

在本揭露的一個實施例中,當基礎化合物可具有的取代基的總數被定義為T1,且該些取代基之中的特定取代基的數目被定義為T2時,特定取代基的含量T%的含義可被定義為T2/T1×100=T%。In one embodiment of the present disclosure, when the total number of substituents that the base compound may have is defined as T1, and the number of specific substituents among these substituents is defined as T2, the content of the specific substituent T% The meaning of can be defined as T2/T1×100=T%.

換言之,在一個實例中,在由

Figure 02_image019
表示的苯基中具有20%的氘含量可意指苯基可具有的取代基的總數是5(方程式中的T1)且所述取代基之中氘的數目是1(方程式中的T2)的情形。換言之,在苯基中具有20%的氘含量可由以下結構式表示。
Figure 02_image021
In other words, in one instance, after the
Figure 02_image019
A deuterium content of 20% in the indicated phenyl group may mean that the total number of substituents that the phenyl group may have is 5 (T1 in the equation) and the number of deuterium in said substituents is 1 (T2 in the equation) situation. In other words, having a deuterium content of 20% in the phenyl group can be represented by the following structural formula.
Figure 02_image021

此外,在本揭露的一個實施例中,「具有0%的氘含量的苯基」可意指不包含氘原子的苯基,即具有5個氫原子的苯基。In addition, in one embodiment of the present disclosure, "phenyl with 0% deuterium content" may mean a phenyl group without deuterium atoms, ie, a phenyl group with 5 hydrogen atoms.

在本揭露中,C6至C60芳族烴環意指包含由C6至C60碳及氫組成的芳族環的化合物。C6至C60芳族烴環的實例可包括苯基、聯苯基、三聯苯基、聯三伸苯、萘、蒽、萉、菲、芴、芘、䓛、苝、薁及類似化合物,但不限於此,且包括此項技術中已知的滿足上述碳原子數的所有芳族烴環化合物。In the present disclosure, a C6 to C60 aromatic hydrocarbon ring means a compound including an aromatic ring composed of C6 to C60 carbons and hydrogen. Examples of the C6 to C60 aromatic hydrocarbon ring may include phenyl, biphenyl, terphenyl, biterphenyl, naphthalene, anthracene, anthracene, phenanthrene, fluorene, pyrene, perylene, perylene, azulene and similar compounds, but not It is limited thereto, and includes all aromatic hydrocarbon ring compounds known in the art that satisfy the above-mentioned number of carbon atoms.

本揭露提供一種由以下化學式1表示的雜環化合物: [化學式1]

Figure 02_image023
在化學式1中, R1至R12彼此相同或不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C60烷基;經取代或未經取代的C2至C60烯基;經取代或未經取代的C2至C60炔基;經取代或未經取代的C1至C60烷氧基;經取代或未經取代的C3至C60環烷基;經取代或未經取代的C2至C60雜環烷基;經取代或未經取代的C6至C60芳基;以及經取代或未經取代的C2至C60雜芳基,且R1至R12中的至少一者為氘, X1、X2及X3彼此相同或不同,且各自獨立地為NAr1、O、S或CR13R14,且X1、X2及X3中的至少一者為NAr1, Ar1為由以下化學式1-1表示的基團, [化學式1-1]
Figure 02_image025
在化學式1-1中, L1與L2彼此相同或不同,且各自獨立地為單鍵;經取代或未經取代的C6至C60伸芳基;或者經取代或未經取代的C2至C60伸雜芳基, Ar2與Ar3彼此相同或不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C60烷基;經取代或未經取代的C2至C60烯基;經取代或未經取代的C2至C60炔基;經取代或未經取代的C1至C60烷氧基;經取代或未經取代的C3至C60環烷基;經取代或未經取代的C2至C60雜環烷基;經取代或未經取代的C6至C60芳基;以及經取代或未經取代的C2至C60雜芳基, a與b彼此相同或不同,且各自獨立地為0至3的整數,且 R13與R14彼此相同或不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C60烷基;經取代或未經取代的C2至C60烯基;經取代或未經取代的C2至C60炔基;經取代或未經取代的C1至C60烷氧基;經取代或未經取代的C3至C60環烷基;經取代或未經取代的C2至C60雜環烷基;經取代或未經取代的C6至C60芳基;以及經取代或未經取代的C2至C60雜芳基。 The present disclosure provides a heterocyclic compound represented by the following Chemical Formula 1: [Chemical Formula 1]
Figure 02_image023
In Chemical Formula 1, R1 to R12 are the same or different from each other, and are each independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C60 alkyl; substituted or Unsubstituted C2 to C60 alkenyl; substituted or unsubstituted C2 to C60 alkynyl; substituted or unsubstituted C1 to C60 alkoxy; substituted or unsubstituted C3 to C60 cycloalkyl ; substituted or unsubstituted C2 to C60 heterocycloalkyl; substituted or unsubstituted C6 to C60 aryl; and substituted or unsubstituted C2 to C60 heteroaryl, and in R1 to R12 At least one is deuterium, X1, X2 and X3 are the same or different from each other, and each independently is NAr1, O, S or CR13R14, and at least one of X1, X2 and X3 is NAr1, and Ar1 is represented by the following chemical formula 1- The group represented by 1, [chemical formula 1-1]
Figure 02_image025
In Chemical Formula 1-1, L1 and L2 are the same or different from each other, and each is independently a single bond; a substituted or unsubstituted C6 to C60 aryl; or a substituted or unsubstituted C2 to C60 hetero Aryl, Ar2 and Ar3 are the same or different from each other, and are each independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C60 alkyl; substituted or unsubstituted Substituted C2 to C60 alkenyl; substituted or unsubstituted C2 to C60 alkynyl; substituted or unsubstituted C1 to C60 alkoxy; substituted or unsubstituted C3 to C60 cycloalkyl; Substituted or unsubstituted C2 to C60 heterocycloalkyl; substituted or unsubstituted C6 to C60 aryl; and substituted or unsubstituted C2 to C60 heteroaryl, a and b are the same or different from each other, And each independently is an integer of 0 to 3, and R13 and R14 are the same or different from each other, and are each independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C60 alkyl; substituted or unsubstituted C2 to C60 alkenyl; substituted or unsubstituted C2 to C60 alkynyl; substituted or unsubstituted C1 to C60 alkoxy; substituted or unsubstituted C3 to C60 cycloalkyl; substituted or unsubstituted C2 to C60 heterocycloalkyl; substituted or unsubstituted C6 to C60 aryl; and substituted or unsubstituted C2 to C60 heteroaryl .

在本揭露的一個實施例中,X1可為NAr1,且X2與X3可彼此相同或不同,且各自獨立地為O、S或CR13R14。In an embodiment of the present disclosure, X1 may be NAr1, and X2 and X3 may be the same or different from each other, and each independently is O, S or CR13R14.

在本揭露的另一實施例中,X2可為NAr1,且X1及X3可彼此相同或不同,且各自獨立地為O、S或CR13R14。In another embodiment of the present disclosure, X2 can be NAr1, and X1 and X3 can be the same or different from each other, and each independently is O, S or CR13R14.

在本揭露的另一實施例中,X3可為NAr1,且X1及X2可彼此相同或不同,且各自獨立地為O、S或CR13R14。In another embodiment of the present disclosure, X3 may be NAr1, and X1 and X2 may be the same or different from each other, and each independently is O, S or CR13R14.

在本揭露的一個實施例中,由化學式1表示的雜環化合物可為以下化學式1-a至化學式1-f中的任一者,但不限於該些實例: [化學式1-a]

Figure 02_image027
在化學式1-a中, X3是O、S或CR13R14,且 R1至R14及Ar1如以上化學式1及化學式1-1中所定義, [化學式1-b]
Figure 02_image029
在化學式1-b中, X3是O、S或CR13R14,且 R1至R14及Ar1如以上化學式1及以上化學式1-1中所定義, [化學式1-c]
Figure 02_image031
在化學式1-c中, X3是O、S或CR13R14,且 R1至R14及Ar1如以上化學式1及以上化學式1-1中所定義, [化學式1-d]
Figure 02_image033
在化學式1-d中, X3是O、S或CR13R14,且 R1至R14及Ar1如以上化學式1及以上化學式1-1中所定義, [化學式1-e]
Figure 02_image035
在化學式1-e中, X3是O、S或CR13R14,且 R1至R14及Ar1如以上化學式1及以上化學式1-1中所定義, [化學式1-f]
Figure 02_image037
在化學式1-f中, X3是O、S或CR13R14,且 R1至R14及Ar1如以上化學式1及以上化學式1-1中所定義。 In one embodiment of the present disclosure, the heterocyclic compound represented by Chemical Formula 1 may be any one of the following Chemical Formula 1-a to Chemical Formula 1-f, but not limited to these examples: [Chemical Formula 1-a]
Figure 02_image027
In Chemical Formula 1-a, X3 is O, S or CR13R14, and R1 to R14 and Ar1 are as defined above in Chemical Formula 1 and Chemical Formula 1-1, [Chemical Formula 1-b]
Figure 02_image029
In Chemical Formula 1-b, X3 is O, S or CR13R14, and R1 to R14 and Ar1 are as defined in the above Chemical Formula 1 and the above Chemical Formula 1-1, [Chemical Formula 1-c]
Figure 02_image031
In Chemical Formula 1-c, X3 is O, S or CR13R14, and R1 to R14 and Ar1 are as defined in the above Chemical Formula 1 and the above Chemical Formula 1-1, [Chemical Formula 1-d]
Figure 02_image033
In Chemical Formula 1-d, X3 is O, S or CR13R14, and R1 to R14 and Ar1 are as defined in the above Chemical Formula 1 and the above Chemical Formula 1-1, [Chemical Formula 1-e]
Figure 02_image035
In Chemical Formula 1-e, X3 is O, S or CR13R14, and R1 to R14 and Ar1 are as defined in the above Chemical Formula 1 and the above Chemical Formula 1-1, [Chemical Formula 1-f]
Figure 02_image037
In Chemical Formula 1-f, X3 is O, S or CR13R14, and R1 to R14 and Ar1 are as defined in the above Chemical Formula 1 and the above Chemical Formula 1-1.

在本揭露的一個實施例中,R1至R12可彼此相同或不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C30烷基;經取代或未經取代的C2至C30烯基;經取代或未經取代的C2至C30炔基;經取代或未經取代的C1至C30烷氧基;經取代或未經取代的C3至C30環烷基;經取代或未經取代的C2至C30雜環烷基;經取代或未經取代的C6至C30芳基;以及經取代或未經取代的C2至C30雜芳基,且R1至R12中的至少一者可為氘,In one embodiment of the present disclosure, R1 to R12 may be the same or different from each other, and are each independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C30 alkane substituted or unsubstituted C2 to C30 alkenyl; substituted or unsubstituted C2 to C30 alkynyl; substituted or unsubstituted C1 to C30 alkoxy; substituted or unsubstituted C3 to C30 cycloalkyl; substituted or unsubstituted C2 to C30 heterocycloalkyl; substituted or unsubstituted C6 to C30 aryl; and substituted or unsubstituted C2 to C30 heteroaryl, and At least one of R1 to R12 may be deuterium,

在本揭露的另一實施例中,R1至R12可彼此相同或不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C20烷基;經取代或未經取代的C2至C20烯基;經取代或未經取代的C2至C20炔基;經取代或未經取代的C1至C20烷氧基;經取代或未經取代的C3至C20環烷基;經取代或未經取代的C2至C20雜環烷基;經取代或未經取代的C6至C20芳基;以及經取代或未經取代的C2至C20雜芳基,且R1至R12中的至少一者可為氘,In another embodiment of the present disclosure, R1 to R12 may be the same or different from each other, and are each independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C20 Alkyl; substituted or unsubstituted C2 to C20 alkenyl; substituted or unsubstituted C2 to C20 alkynyl; substituted or unsubstituted C1 to C20 alkoxy; substituted or unsubstituted C3 to C20 cycloalkyl; substituted or unsubstituted C2 to C20 heterocycloalkyl; substituted or unsubstituted C6 to C20 aryl; and substituted or unsubstituted C2 to C20 heteroaryl, And at least one of R1 to R12 can be deuterium,

在本揭露的另一實施例中,R1至R12可為氫或氘,且R1至R12中的至少一者可為氘。In another embodiment of the present disclosure, R1 to R12 may be hydrogen or deuterium, and at least one of R1 to R12 may be deuterium.

在本揭露的另一實施例中,R1至R12可為氘。In another embodiment of the present disclosure, R1 to R12 may be deuterium.

在本揭露的一個實施例中,化學式1-1中的L1與L2可彼此相同或不同,且各自獨立地為單鍵;經取代或未經取代的C6至C30伸芳基;或者經取代或未經取代的C2至C30伸雜芳基,且a與b可彼此相同或不同,且可各自獨立地為0至3的整數。In one embodiment of the present disclosure, L1 and L2 in Chemical Formula 1-1 may be the same or different from each other, and each independently is a single bond; a substituted or unsubstituted C6 to C30 aryl group; or a substituted or An unsubstituted C2 to C30 heteroaryl group, and a and b may be the same or different from each other, and each independently may be an integer of 0 to 3.

在本揭露的另一實施例中,化學式1-1中的L1與L2可彼此相同或不同,且各自獨立地為單鍵;經取代或未經取代的C6至C20伸芳基;或者經取代或未經取代的C2至C20伸雜芳基,且a與b可彼此相同或不同,且可各自獨立地為0至3的整數。In another embodiment of the present disclosure, L1 and L2 in Chemical Formula 1-1 may be the same or different from each other, and each is independently a single bond; a substituted or unsubstituted C6 to C20 aryl group; or a substituted or an unsubstituted C2 to C20 heteroaryl group, and a and b may be the same or different from each other, and may each independently be an integer of 0 to 3.

在本揭露的另一實施例中,化學式1-1中的L1與L2可彼此相同或不同,且可各自獨立地為以下結構,但不限於該些實例:

Figure 02_image039
Figure 02_image041
Figure 02_image043
。 In another embodiment of the present disclosure, L1 and L2 in Chemical Formula 1-1 may be the same or different from each other, and may each independently be the following structures, but are not limited to these examples:
Figure 02_image039
,
Figure 02_image041
,
Figure 02_image043
.

在本揭露的一個實施例中,化學式1-1中的Ar2與Ar3可彼此相同或不同,且可各自獨立地為經取代或未經取代的C6至C60芳基;或者經取代或未經取代的C2至C60雜芳基。In one embodiment of the present disclosure, Ar2 and Ar3 in Chemical Formula 1-1 may be the same or different from each other, and may each be independently substituted or unsubstituted C6 to C60 aryl; or substituted or unsubstituted C2 to C60 heteroaryl.

在本揭露的另一實施例中,化學式1-1中的Ar2與Ar3可彼此相同或不同,且可各自獨立地為經取代或未經取代的C6至C30芳基;或者經取代或未經取代的C2至C30雜芳基。In another embodiment of the present disclosure, Ar2 and Ar3 in Chemical Formula 1-1 may be the same or different from each other, and may each be independently substituted or unsubstituted C6 to C30 aryl; or substituted or unsubstituted Substituted C2 to C30 heteroaryl.

在本揭露的另一實施例中,化學式1-1中的Ar2與Ar3可彼此相同或不同,且可各自獨立地為經取代或未經取代的C6至C20芳基;或者經取代或未經取代的C2至C20雜芳基。In another embodiment of the present disclosure, Ar2 and Ar3 in Chemical Formula 1-1 may be the same or different from each other, and may each be independently substituted or unsubstituted C6 to C20 aryl; or substituted or unsubstituted Substituted C2 to C20 heteroaryl.

在本揭露的另一實施例中,化學式1-1中的Ar2與Ar3可彼此相同或不同,且可各自獨立地為以下結構,但不限於該些實例:

Figure 02_image045
Figure 02_image047
Figure 02_image049
Figure 02_image051
Figure 02_image053
Figure 02_image055
Figure 02_image057
Figure 02_image059
。 In another embodiment of the present disclosure, Ar2 and Ar3 in Chemical Formula 1-1 may be the same or different from each other, and may each independently have the following structures, but are not limited to these examples:
Figure 02_image045
,
Figure 02_image047
,
Figure 02_image049
,
Figure 02_image051
,
Figure 02_image053
,
Figure 02_image055
,
Figure 02_image057
,
Figure 02_image059
.

在本揭露的一個實施例中,R13與R14可彼此相同或不同,且可各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C20烷基;經取代或未經取代的C2至C20烯基;經取代或未經取代的C2至C20炔基;經取代或未經取代的C1至C20烷氧基;經取代或未經取代的C3至C20環烷基;經取代或未經取代的C2至C20雜環烷基;經取代或未經取代的C6至C20芳基;以及經取代或未經取代的C2至C20雜芳基。In one embodiment of the present disclosure, R13 and R14 may be the same or different from each other, and may be independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C20 Alkyl; substituted or unsubstituted C2 to C20 alkenyl; substituted or unsubstituted C2 to C20 alkynyl; substituted or unsubstituted C1 to C20 alkoxy; substituted or unsubstituted C3 to C20 cycloalkyl; substituted or unsubstituted C2 to C20 heterocycloalkyl; substituted or unsubstituted C6 to C20 aryl; and substituted or unsubstituted C2 to C20 heteroaryl.

在本揭露的另一實施例中,R13與R14可彼此相同或不同,且可各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C10烷基;經取代或未經取代的C2至C10烯基;經取代或未經取代的C2至C10炔基;以及經取代或未經取代的C1至C10烷氧基。In another embodiment of the present disclosure, R13 and R14 may be the same or different from each other, and may be independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C10 alkyl; substituted or unsubstituted C2 to C10 alkenyl; substituted or unsubstituted C2 to C10 alkynyl; and substituted or unsubstituted C1 to C10 alkoxy.

在本揭露的另一實施例中,R13與R14可彼此相同或不同,且可各自獨立地為甲基、乙基、丙基或類似基團。In another embodiment of the present disclosure, R13 and R14 may be the same or different from each other, and may be each independently methyl, ethyl, propyl or similar groups.

在本揭露的一個實施例中,由以上化學式1表示的雜環化合物可不包含氘作為取代基,或者以氫原子與氘原子的總數計,氘含量可為1%至100%。In one embodiment of the present disclosure, the heterocyclic compound represented by the above Chemical Formula 1 may not contain deuterium as a substituent, or the content of deuterium may be 1% to 100% based on the sum of hydrogen atoms and deuterium atoms.

在本揭露的另一實施例中,由以上化學式1表示的雜環化合物可不包含氘作為取代基,或者以氫原子與氘原子的總數計,氘含量可為5%至100%。In another embodiment of the present disclosure, the heterocyclic compound represented by the above Chemical Formula 1 may not contain deuterium as a substituent, or the content of deuterium may be 5% to 100% based on the sum of hydrogen atoms and deuterium atoms.

在本揭露的另一實施例中,由以上化學式1表示的雜環化合物可不包含氘作為取代基,或者以氫原子與氘原子的總數計,氘含量可為10%至100%。In another embodiment of the present disclosure, the heterocyclic compound represented by the above Chemical Formula 1 may not contain deuterium as a substituent, or the content of deuterium may be 10% to 100% based on the sum of hydrogen atoms and deuterium atoms.

在本揭露的另一實施例中,由以上化學式1表示的雜環化合物可不包含氘作為取代基,或者以氫原子與氘原子的總數計,氘含量可為20%至100%。In another embodiment of the present disclosure, the heterocyclic compound represented by the above Chemical Formula 1 may not contain deuterium as a substituent, or the deuterium content may be 20% to 100% based on the sum of hydrogen atoms and deuterium atoms.

舉例而言,由以上化學式1表示的雜環化合物可不包含氘作為取代基,或者以氫原子與氘原子的總數計,氘含量可大於0%,可為5%或大於5%、10%或大於10%、15%或大於15%、20%或大於20%、25%或大於25%、30%或大於30%、35%或大於35%、40%或大於40%、45%或大於45%或者50%或大於50%,且可為100%或小於100%、95%或小於95%、90%或小於90%、85%或小於85%、80%或小於80%、75%或小於75%、70%或小於70%、65%或小於65%或者60%或小於60%。For example, the heterocyclic compound represented by the above Chemical Formula 1 may not contain deuterium as a substituent, or the deuterium content may be more than 0%, may be 5% or more, 10% or more based on the total number of hydrogen atoms and deuterium atoms Greater than 10%, 15% or greater, 20% or greater, 25% or greater, 30% or greater, 35% or greater, 40% or greater, 45% or greater 45% or 50% or more than 50%, and can be 100% or less than 100%, 95% or less than 95%, 90% or less than 90%, 85% or less than 85%, 80% or less than 80%, 75% or less than 75%, 70% or less, 65% or less, or 60% or less.

在本揭露的一個實施例中,由以上化學式1表示的雜環化合物可不包含氘作為取代基,或者以氫原子與氘原子的總數計,R 1至R 12的氘含量可為1%至100%。 In one embodiment of the present disclosure, the heterocyclic compound represented by the above Chemical Formula 1 may not contain deuterium as a substituent, or the deuterium content of R1 to R12 may be 1% to 100% based on the total number of hydrogen atoms and deuterium atoms %.

在本揭露的另一實施例中,由以上化學式1表示的雜環化合物可不包含氘作為取代基,或者以氫原子與氘原子的總數計,R 1至R 12的氘含量可為5%至95%。 In another embodiment of the present disclosure, the heterocyclic compound represented by the above chemical formula 1 may not contain deuterium as a substituent, or the deuterium content of R 1 to R 12 may be 5% to 5% based on the total number of hydrogen atoms and deuterium atoms. 95%.

在本揭露的另一實施例中,由以上化學式1表示的雜環化合物可不包含氘作為取代基,或者以氫原子與氘原子的總數計,R 1至R 12的氘含量可為10%至90%。 In another embodiment of the present disclosure, the heterocyclic compound represented by the above Chemical Formula 1 may not contain deuterium as a substituent, or the deuterium content of R 1 to R 12 may be 10% to 10% based on the total number of hydrogen atoms and deuterium atoms. 90%.

舉例而言,由以上化學式1表示的雜環化合物可不包含氘作為取代基,或者以氫原子與氘原子的總數計,R 1至R 12的氘含量可大於0%,可為5%或大於5%、10%或大於10%、15%或大於15%、20%或大於20%、25%或大於25%、30%或大於30%、35%或大於35%、40%或大於40%、45%或大於45%或者50%或大於50%,且可為100%或小於100%、95%或小於95%、90%或小於90%、85%或小於85%、80%或小於80%、75%或小於75%、70%或小於70%、65%或小於65%或者60%或小於60%。 For example, the heterocyclic compound represented by the above Chemical Formula 1 may not contain deuterium as a substituent, or the deuterium content of R1 to R12 may be greater than 0%, may be 5% or greater, based on the total number of hydrogen atoms and deuterium atoms 5%, 10% or more than 10%, 15% or more than 15%, 20% or more than 20%, 25% or more than 25%, 30% or more than 30%, 35% or more than 35%, 40% or more than 40% %, 45% or more, or 50% or more, and may be 100% or less, 95% or less, 90% or less, 85% or less, 80% or Less than 80%, 75% or less, 70% or less, 65% or less, or 60% or less.

在本揭露的一個實施例中,以上化學式1-1中的Ar2及Ar3可為經氘取代的C6至C30芳基或者經氘取代的C2至C30雜芳基。在此情形中,以氫原子與氘原子的總數計,氘含量可為1%至100%。In one embodiment of the present disclosure, Ar2 and Ar3 in the above Chemical Formula 1-1 may be deuterium-substituted C6-C30 aryl or deuterium-substituted C2-C30 heteroaryl. In this case, the deuterium content may be 1% to 100% based on the sum of hydrogen atoms and deuterium atoms.

在本揭露的另一實施例中,以上化學式1-1中的Ar2及Ar3可為經氘取代的C6至C30芳基或者經氘取代的C2至C30雜芳基。在此情形中,以氫原子與氘原子的總數計,氘含量可為5%至95%。In another embodiment of the present disclosure, Ar2 and Ar3 in the above Chemical Formula 1-1 may be deuterium-substituted C6-C30 aryl or deuterium-substituted C2-C30 heteroaryl. In this case, the deuterium content may be 5% to 95% based on the sum of hydrogen atoms and deuterium atoms.

在本揭露的另一實施例中,以上化學式1-1中的Ar2及Ar3可為經氘取代的C6至C30芳基或者經氘取代的C2至C30雜芳基。在此情形中,以氫原子與氘原子的總數計,氘含量可為10%至90%。In another embodiment of the present disclosure, Ar2 and Ar3 in the above Chemical Formula 1-1 may be deuterium-substituted C6-C30 aryl or deuterium-substituted C2-C30 heteroaryl. In this case, the deuterium content may be 10% to 90% based on the sum of hydrogen atoms and deuterium atoms.

舉例而言,當以上化學式1-1中的Ar2及Ar3可為經氘取代的C6至C30芳基或者經氘取代的C2至C30雜芳基時,以氫原子與氘原子的總數計,取代基的氘含量可為0%或大於0%、5%或大於5%、10%或大於10%、15%或大於15%、20%或大於20%、25%或大於25%、30%或大於30%、35%或大於35%、40%或大於40%、45%或大於45%或者50%或大於50%,且可為100%或小於100%、95%或小於95%、90%或小於90%、85%或小於85%、80%或小於80%、75%或小於75%、70%或小於70%、65%或小於65%或者60%或小於60%。For example, when Ar2 and Ar3 in the above chemical formula 1-1 can be a C6 to C30 aryl group substituted by deuterium or a C2 to C30 heteroaryl group substituted by deuterium, based on the total number of hydrogen atoms and deuterium atoms, the substitution The deuterium content of the group can be 0% or greater, 5% or greater, 10% or greater, 15% or greater, 20% or greater, 25% or greater, 30% or greater than 30%, 35% or greater, 40% or greater, 45% or greater, or 50% or greater, and may be 100% or less, 95% or less, 90% or less, 85% or less, 85% or less, 80% or less, 75% or less, 70% or less, 65% or less, 65% or less, or 60% or less.

在本揭露的一個實施例中,由以上化學式1表示的雜環化合物可為選自由以下化合物組成的群組的任一者:

Figure 02_image061
Figure 02_image063
Figure 02_image065
Figure 02_image067
Figure 02_image069
Figure 02_image071
Figure 02_image073
Figure 02_image075
Figure 02_image077
Figure 02_image079
Figure 02_image081
Figure 02_image083
Figure 02_image085
Figure 02_image087
Figure 02_image089
Figure 02_image091
Figure 02_image093
Figure 02_image095
Figure 02_image097
Figure 02_image099
Figure 02_image101
Figure 02_image103
Figure 02_image105
Figure 02_image107
Figure 02_image109
。 In one embodiment of the present disclosure, the heterocyclic compound represented by the above Chemical Formula 1 may be any one selected from the group consisting of the following compounds:
Figure 02_image061
Figure 02_image063
Figure 02_image065
Figure 02_image067
Figure 02_image069
Figure 02_image071
Figure 02_image073
Figure 02_image075
Figure 02_image077
Figure 02_image079
Figure 02_image081
Figure 02_image083
Figure 02_image085
Figure 02_image087
Figure 02_image089
Figure 02_image091
Figure 02_image093
Figure 02_image095
Figure 02_image097
Figure 02_image099
Figure 02_image101
Figure 02_image103
Figure 02_image105
Figure 02_image107
Figure 02_image109
.

此外,藉由將各種取代基引入至以上化學式1的結構,可合成具有所引入取代基的獨特性質的化合物。舉例而言,藉由將主要用於在有機發光元件的製造期間使用的電洞注入層材料、電洞傳輸層材料、電子阻擋層材料、發光層材料、電子傳輸層材料、電洞阻擋層材料及電子注入層材料的取代基引入至核心結構,可合成滿足每一有機材料層中所需要的條件的材料。In addition, by introducing various substituents into the structure of the above Chemical Formula 1, compounds having unique properties of the introduced substituents can be synthesized. For example, by using hole injection layer materials, hole transport layer materials, electron blocking layer materials, light emitting layer materials, electron transport layer materials, hole blocking layer materials mainly used during the manufacture of organic light emitting elements And the substituents of the material of the electron injection layer are introduced into the core structure, and materials satisfying the conditions required in each organic material layer can be synthesized.

此外,各種取代基被引入至以上化學式1的結構,以使得能帶間隙可能夠被精細地控制,而可改善有機材料之間的介面中的性質,且材料的用途可變得多樣化。In addition, various substituents are introduced into the structure of the above Chemical Formula 1, so that the energy band gap can be finely controlled, so that the properties in the interface between organic materials can be improved, and the use of the material can be diversified.

此外,本揭露提供一種有機發光元件,所述有機發光元件包括:第一電極;第二電極,被設置成面對第一電極;以及一或多個有機材料層,設置於第一電極與第二電極之間,其中有機材料層中的一或多個層包含由化學式1表示的雜環化合物。In addition, the present disclosure provides an organic light-emitting device, the organic light-emitting device includes: a first electrode; a second electrode disposed to face the first electrode; and one or more organic material layers disposed between the first electrode and the second electrode. Between the two electrodes, one or more of the organic material layers includes the heterocyclic compound represented by Chemical Formula 1.

在本揭露的一個實施例中,第一電極可為正電極,且第二電極可為負電極。In one embodiment of the present disclosure, the first electrode may be a positive electrode, and the second electrode may be a negative electrode.

在本揭露的另一實施例中,第一電極可為負電極,且第二電極可為正電極。In another embodiment of the present disclosure, the first electrode may be a negative electrode, and the second electrode may be a positive electrode.

在本揭露的一個實施例中,有機發光元件可為紅色有機發光元件,且由以上化學式1表示的雜環化合物可用作紅色有機發光元件的材料。In one embodiment of the present disclosure, the organic light emitting device may be a red organic light emitting device, and the heterocyclic compound represented by the above Chemical Formula 1 may be used as a material of the red organic light emitting device.

在本揭露的另一實施例中,有機發光元件可為綠色有機發光元件,且由以上化學式1表示的雜環化合物可用作綠色有機發光元件的材料。In another embodiment of the present disclosure, the organic light emitting device may be a green organic light emitting device, and the heterocyclic compound represented by the above Chemical Formula 1 may be used as a material of the green organic light emitting device.

在本揭露的另一實施例中,有機發光元件可為藍色有機發光元件,且由以上化學式1表示的雜環化合物可用作藍色有機發光元件的材料。In another embodiment of the present disclosure, the organic light emitting device may be a blue organic light emitting device, and the heterocyclic compound represented by the above Chemical Formula 1 may be used as a material of the blue organic light emitting device.

由以上化學式1表示的雜環化合物的具體細節與上述細節相同。Specific details of the heterocyclic compound represented by the above Chemical Formula 1 are the same as those described above.

在本揭露的一個實施例中,有機發光元件可為紅色有機發光元件,且由以上化學式1表示的雜環化合物可用作紅色有機發光元件的發光層材料。In one embodiment of the present disclosure, the organic light emitting device may be a red organic light emitting device, and the heterocyclic compound represented by the above Chemical Formula 1 may be used as a light emitting layer material of the red organic light emitting device.

在本揭露的另一實施例中,有機發光元件可為綠色有機發光元件,且由以上化學式1表示的雜環化合物可用作綠色有機發光元件的發光層材料。In another embodiment of the present disclosure, the organic light emitting device may be a green organic light emitting device, and the heterocyclic compound represented by the above Chemical Formula 1 may be used as a material for the light emitting layer of the green organic light emitting device.

在本揭露的另一實施例中,有機發光元件可為藍色有機發光元件,且由以上化學式1表示的雜環化合物可用作藍色有機發光元件的發光層材料。In another embodiment of the present disclosure, the organic light emitting device may be a blue organic light emitting device, and the heterocyclic compound represented by the above Chemical Formula 1 may be used as a light emitting layer material of the blue organic light emitting device.

由以上化學式1表示的雜環化合物的具體細節與上述細節相同。Specific details of the heterocyclic compound represented by the above Chemical Formula 1 are the same as those described above.

除了使用上述雜環化合物形成一或多個有機材料層以外,可藉由用於製造有機發光元件的常規方法及材料來製造根據本揭露的有機發光元件。In addition to using the aforementioned heterocyclic compounds to form one or more organic material layers, the organic light emitting device according to the present disclosure can be manufactured by conventional methods and materials used for manufacturing organic light emitting devices.

當製造有機發光元件時,所述雜環化合物可藉由溶液塗佈方法以及真空沈積方法而形成有機材料層。在本文中,所述溶液塗佈方法指代旋轉塗佈(spin coating)、浸塗(dip coating)、噴墨印刷(inkjet printing)、網版印刷(screen printing)、噴霧方法(spray method)、輥塗(roll coating)或類似方法,但不限於此。When manufacturing an organic light-emitting device, the heterocyclic compound can form an organic material layer by a solution coating method and a vacuum deposition method. Herein, the solution coating method refers to spin coating, dip coating, inkjet printing, screen printing, spray method, Roll coating or the like, but not limited thereto.

根據本揭露的有機發光元件的有機材料層可被形成為單層結構,但亦可被形成為其中疊層有二或更多個有機材料層的多層結構。舉例而言,根據本揭露的有機發光元件可具有包括電洞注入層、電洞傳輸層、發光層、電子注入層、電子傳輸層、電子阻擋層、電洞阻擋層及類似層作為有機材料層的結構。然而,有機發光元件的結構不限於此,且可包括更小數目的有機材料層。The organic material layer of the organic light emitting device according to the present disclosure may be formed in a single layer structure, but may also be formed in a multilayer structure in which two or more organic material layers are stacked. For example, an organic light-emitting element according to the present disclosure may have a layer including a hole injection layer, a hole transport layer, a light-emitting layer, an electron injection layer, an electron transport layer, an electron blocking layer, a hole blocking layer, and the like as an organic material layer. Structure. However, the structure of the organic light emitting element is not limited thereto, and may include a smaller number of organic material layers.

在本揭露的一個實施例中,有機發光元件可更包括選自由發光層、電洞注入層、電洞傳輸層、電子注入層、電子傳輸層、電子阻擋層及電洞阻擋層組成的群組的一或多個層,且所述一或多個層可包含所述雜環化合物。In an embodiment of the present disclosure, the organic light-emitting device may further include a layer selected from the group consisting of a light-emitting layer, a hole injection layer, a hole transport layer, an electron injection layer, an electron transport layer, an electron blocking layer, and a hole blocking layer. One or more layers, and the one or more layers may include the heterocyclic compound.

在本揭露的一個實施例中,有機發光元件可包括一或多個有機材料層,所述有機材料層可包括發光層,且所述發光層可包含由以上化學式1表示的雜環化合物。In one embodiment of the present disclosure, the organic light emitting device may include one or more organic material layers, the organic material layer may include a light emitting layer, and the light emitting layer may include the heterocyclic compound represented by the above Chemical Formula 1.

在本揭露的另一實施例中,有機材料層可包括發光層,所述發光層可包含主體材料,且所述主體材料可包含所述雜環化合物。In another embodiment of the present disclosure, the organic material layer may include a light emitting layer, the light emitting layer may include a host material, and the host material may include the heterocyclic compound.

在本揭露的一個實施例中,有機發光元件可包含由以上化學式1表示的雜環化合物,且可更包含由以下化學式2表示的雜環化合物: [化學式2]

Figure 02_image111
在化學式2中, R21至R34彼此相同或不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C60烷基;經取代或未經取代的C2至C60烯基;經取代或未經取代的C2至C60炔基;經取代或未經取代的C1至C60烷氧基;經取代或未經取代的C3至C60環烷基;經取代或未經取代的C2至C60雜環烷基;經取代或未經取代的C6至C60芳基;以及經取代或未經取代的C2至C60雜芳基, L3與L4彼此相同或不同,且各自獨立地為單鍵;經取代或未經取代的C6至C60伸芳基;或者經取代或未經取代的C2至C60伸雜芳基, Ar11與Ar12彼此相同或不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C60烷基;經取代或未經取代的C2至C60烯基;經取代或未經取代的C2至C60炔基;經取代或未經取代的C1至C60烷氧基;經取代或未經取代的C3至C60環烷基;經取代或未經取代的C2至C60雜環烷基;經取代或未經取代的C6至C60芳基;經取代或未經取代的C2至C60雜芳基;-P(=O)R101R102;以及–SiR101R102R103,且R101、R102及R103彼此相同或不同,且各自獨立地為經取代或未經取代的C1至C60烷基;經取代或未經取代的C6至C60芳基;或者經取代或未經取代的C2至C60雜芳基,且 m與n彼此相同或不同,且各自獨立地為0至3的整數。 In one embodiment of the present disclosure, the organic light-emitting device may include a heterocyclic compound represented by the above Chemical Formula 1, and may further include a heterocyclic compound represented by the following Chemical Formula 2: [Chemical Formula 2]
Figure 02_image111
In Chemical Formula 2, R21 to R34 are the same or different from each other, and are each independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C60 alkyl; substituted or Unsubstituted C2 to C60 alkenyl; substituted or unsubstituted C2 to C60 alkynyl; substituted or unsubstituted C1 to C60 alkoxy; substituted or unsubstituted C3 to C60 cycloalkyl ; substituted or unsubstituted C2 to C60 heterocycloalkyl; substituted or unsubstituted C6 to C60 aryl; and substituted or unsubstituted C2 to C60 heteroaryl, L3 and L4 are identical to each other or Different, and each independently is a single bond; substituted or unsubstituted C6 to C60 aryl; or substituted or unsubstituted C2 to C60 heteroaryl, Ar11 and Ar12 are the same or different from each other, and each independently selected from the group consisting of: hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C60 alkyl; substituted or unsubstituted C2 to C60 alkenyl; substituted or unsubstituted Substituted C2 to C60 alkynyl; substituted or unsubstituted C1 to C60 alkoxy; substituted or unsubstituted C3 to C60 cycloalkyl; substituted or unsubstituted C2 to C60 heterocycloalkyl ; substituted or unsubstituted C6 to C60 aryl; substituted or unsubstituted C2 to C60 heteroaryl; -P(=O)R101R102; and -SiR101R102R103, and R101, R102 and R103 are the same or different , and are each independently substituted or unsubstituted C1 to C60 alkyl; substituted or unsubstituted C6 to C60 aryl; or substituted or unsubstituted C2 to C60 heteroaryl, and m and n are the same or different from each other, and each independently represents an integer of 0 to 3.

在本揭露的另一實施例中,化學式2中的R 21至R 34可彼此相同或不同,且可各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C30烷基;經取代或未經取代的C2至C30烯基;經取代或未經取代的C2至C30炔基;以及經取代或未經取代的C1至C30烷氧基。 In another embodiment of the present disclosure, R 21 to R 34 in Chemical Formula 2 may be the same or different from each other, and may each be independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or Unsubstituted C1 to C30 alkyl; substituted or unsubstituted C2 to C30 alkenyl; substituted or unsubstituted C2 to C30 alkynyl; and substituted or unsubstituted C1 to C30 alkoxy .

在本揭露的另一實施例中,化學式2中的R 21至R 34可彼此相同或不同,且可各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C10烷基;經取代或未經取代的C2至C10烯基;經取代或未經取代的C2至C10炔基;以及經取代或未經取代的C1至C10烷氧基。 In another embodiment of the present disclosure, R 21 to R 34 in Chemical Formula 2 may be the same or different from each other, and may each be independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or Unsubstituted C1 to C10 alkyl; substituted or unsubstituted C2 to C10 alkenyl; substituted or unsubstituted C2 to C10 alkynyl; and substituted or unsubstituted C1 to C10 alkoxy .

在本揭露的另一實施例中,化學式2中的R 21至R 34可彼此相同或不同,且可各自獨立地選自由以下組成的群組:氫;氘;鹵素;以及氰基。 In another embodiment of the present disclosure, R 21 to R 34 in Chemical Formula 2 may be the same or different from each other, and may be each independently selected from the group consisting of hydrogen; deuterium; halogen; and cyano.

在本揭露的另一實施例中,化學式2中的R 21至R 34可彼此相同或不同,且可各自獨立地為氫或氘。 In another embodiment of the present disclosure, R 21 to R 34 in Chemical Formula 2 may be the same or different from each other, and may each independently be hydrogen or deuterium.

在本揭露的另一實施例中,化學式2中的L3與L4可彼此相同或不同,且可各自獨立地為單鍵;經取代或未經取代的C6至C30伸芳基;或者經取代或未經取代的C2至C30伸雜芳基,且m與n可彼此相同或不同,且可各自獨立地為0至3的整數。In another embodiment of the present disclosure, L3 and L4 in Chemical Formula 2 may be the same or different from each other, and each independently may be a single bond; a substituted or unsubstituted C6 to C30 aryl; or a substituted or An unsubstituted C2 to C30 heteroaryl group, and m and n may be the same or different from each other, and each independently may be an integer of 0 to 3.

在本揭露的另一實施例中,化學式2中的L3與L4可彼此相同或不同,且可各自獨立地為單鍵;經取代或未經取代的C6至C20伸芳基;或者經取代或未經取代的C2至C20伸雜芳基,且m與n可彼此相同或不同,且可各自獨立地為0至3的整數。In another embodiment of the present disclosure, L3 and L4 in Chemical Formula 2 may be the same or different from each other, and each independently may be a single bond; a substituted or unsubstituted C6 to C20 aryl group; or a substituted or An unsubstituted C2 to C20 heteroaryl group, and m and n may be the same or different from each other, and may each independently be an integer of 0 to 3.

在本揭露的另一實施例中,化學式2中的Ar11與Ar12可彼此相同或不同,且可各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C30烷基;經取代或未經取代的C2至C30烯基;經取代或未經取代的C2至C30炔基;經取代或未經取代的C1至C30烷氧基;經取代或未經取代的C3至C30環烷基;經取代或未經取代的C2至C30雜環烷基;經取代或未經取代的C6至C30芳基;經取代或未經取代的C2至C30雜芳基;-P(=O)R101R102;以及-SiR101R102R103,且R101、R102及R103可彼此相同或不同,且可各自獨立地為經取代或未經取代的C1至C30烷基;經取代或未經取代的C6至C30芳基;或者經取代或未經取代的C2至C30雜芳基。In another embodiment of the present disclosure, Ar11 and Ar12 in Chemical Formula 2 may be the same or different from each other, and may be independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted Substituted C1 to C30 alkyl; substituted or unsubstituted C2 to C30 alkenyl; substituted or unsubstituted C2 to C30 alkynyl; substituted or unsubstituted C1 to C30 alkoxy; substituted or unsubstituted C3 to C30 cycloalkyl; substituted or unsubstituted C2 to C30 heterocycloalkyl; substituted or unsubstituted C6 to C30 aryl; substituted or unsubstituted C2 to C30 Heteroaryl; -P(=O)R101R102; and -SiR101R102R103, and R101, R102 and R103 may be the same or different from each other, and may each be independently substituted or unsubstituted C1 to C30 alkyl; substituted or unsubstituted C6 to C30 aryl; or substituted or unsubstituted C2 to C30 heteroaryl.

在本揭露的另一實施例中,化學式2中的Ar 11與Ar 12可彼此相同或不同,且可各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C6至C20芳基;經取代或未經取代的C2至C20雜芳基;-P(=O)R101R102;以及-SiR101R102R103,且R101、R102及R103可彼此相同或不同,且可各自獨立地為經取代或未經取代的C6至C10芳基;或者經取代或未經取代的C2至C10雜芳基。 In another embodiment of the present disclosure, Ar 11 and Ar 12 in Chemical Formula 2 may be the same or different from each other, and may each be independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or Unsubstituted C6 to C20 aryl; substituted or unsubstituted C2 to C20 heteroaryl; -P(=O)R101R102; and -SiR101R102R103, and R101, R102 and R103 may be the same or different from each other, and may Each is independently a substituted or unsubstituted C6 to C10 aryl group; or a substituted or unsubstituted C2 to C10 heteroaryl group.

在本揭露的一個實施例中,由以上化學式2表示的雜環化合物可不包含氘作為取代基,或者以氫原子與氘原子的總數計,氘含量可為0%至100%。In an embodiment of the present disclosure, the heterocyclic compound represented by the above Chemical Formula 2 may not contain deuterium as a substituent, or the deuterium content may be 0% to 100% based on the total number of hydrogen atoms and deuterium atoms.

在本揭露的另一實施例中,由以上化學式2表示的雜環化合物可不包含氘作為取代基,或者以氫原子與氘原子的總數計,氘含量可為10%至100%。In another embodiment of the present disclosure, the heterocyclic compound represented by the above chemical formula 2 may not contain deuterium as a substituent, or the deuterium content may be 10% to 100% based on the total of hydrogen atoms and deuterium atoms.

在本揭露的另一實施例中,由以上化學式2表示的雜環化合物可不包含氘作為取代基,或者以氫原子與氘原子的總數計,氘含量可為20%至90%。In another embodiment of the present disclosure, the heterocyclic compound represented by the above chemical formula 2 may not contain deuterium as a substituent, or the deuterium content may be 20% to 90% based on the total number of hydrogen atoms and deuterium atoms.

在本揭露的另一實施例中,由以上化學式2表示的雜環化合物可不包含氘作為取代基,或者以氫原子與氘原子的總數計,氘含量可為30%至80%。In another embodiment of the present disclosure, the heterocyclic compound represented by the above chemical formula 2 may not contain deuterium as a substituent, or the deuterium content may be 30% to 80% based on the total of hydrogen atoms and deuterium atoms.

舉例而言,由以上化學式2表示的雜環化合物可不包含氘作為取代基,或者以氫原子與氘原子的總數計,氘含量可大於0%,可為10%或大於10%、20%或大於20%、30%或大於30%、40%或大於40%或者50%或大於50%,且可為100%或小於100%、90%或小於90%、80%或小於80%、70%或小於70%或者60%或小於60%。For example, the heterocyclic compound represented by the above Chemical Formula 2 may not contain deuterium as a substituent, or the deuterium content may be more than 0%, may be 10% or more, 20% or more based on the total number of hydrogen atoms and deuterium atoms Greater than 20%, 30% or greater, 40% or greater than 40%, or 50% or greater than 50%, and may be 100% or less, 90% or less, 80% or less, 70% % or less than 70% or 60% or less than 60%.

在本揭露的一個實施例中,由以上化學式2表示的雜環化合物可為選自由以下化合物組成的群組的任一者:

Figure 02_image113
Figure 02_image115
Figure 02_image117
Figure 02_image119
Figure 02_image121
Figure 02_image123
Figure 02_image125
Figure 02_image127
。 In one embodiment of the present disclosure, the heterocyclic compound represented by the above Chemical Formula 2 may be any one selected from the group consisting of the following compounds:
Figure 02_image113
Figure 02_image115
Figure 02_image117
Figure 02_image119
Figure 02_image121
Figure 02_image123
Figure 02_image125
Figure 02_image127
.

在製造根據本揭露的有機發光元件時,其可包含由以上化學式1表示的雜環化合物及由以上化學式2表示的雜環化合物。When manufacturing the organic light emitting device according to the present disclosure, it may include the heterocyclic compound represented by the above Chemical Formula 1 and the heterocyclic compound represented by the above Chemical Formula 2.

在製造根據本揭露的有機發光元件時,當混合並包含由以上化學式1表示的雜環化合物與由以上化學式2表示的雜環化合物時,可提高有機發光元件的極佳驅動電壓、發光效率及壽命。由此可預期,當同時混合並包含所述兩種雜環化合物時,會發生激發錯合體現象(exciplex phenomenon)。When the organic light-emitting element according to the present disclosure is manufactured, when the heterocyclic compound represented by the above Chemical Formula 1 and the heterocyclic compound represented by the above Chemical Formula 2 are mixed and contained, the excellent driving voltage, luminous efficiency, and life. From this, it can be expected that when the two heterocyclic compounds are mixed and contained at the same time, an exciplex phenomenon will occur.

激發錯合體現象為藉由兩個分子之間的電子交換而發射施體(donor)(p-主體)最高佔用分子軌域(highest occupied molecular orbital,HOMO)能階與受體(acceptor)(n-主體)最低未佔用分子軌域(lowest unoccupied molecular orbital,LUMO)能階之間的能量差的現象。當兩個分子之間發生激發錯合體現象時,會發生反向系統間交叉(reverse intersystem crossing,RISC),且因此,螢光的內部量子效率(internal quantum efficiency)可提高至100%。當具有良好電洞傳輸能力的施體(p-主體)及具有良好電子傳輸能力的受體(n-主體)被用作發光層的主體時,由於電洞被注入至p-主體中且電子被注入至n-主體中,因此驅動電壓可降低,藉此有助於提高壽命。亦即,當由以上化學式1表示的化合物用作受體且由以上化學式2表示的化合物用作施體時,表現出有機發光元件的極佳性質。The excited complex phenomenon is the emission of the donor (donor) (p-subject) highest occupied molecular orbital (highest occupied molecular orbital, HOMO) energy level and the acceptor (acceptor) (n -Main) The phenomenon of the energy difference between the lowest unoccupied molecular orbital (LUMO) energy levels. When excitation complexes occur between two molecules, reverse intersystem crossing (RISC) occurs, and thus, the internal quantum efficiency of fluorescence can be increased to 100%. When a donor (p-host) with good hole transport capability and an acceptor (n-host) with good electron transport capability are used as the host of the light-emitting layer, since holes are injected into the p-host and electrons Implanted into the n-body, so the driving voltage can be reduced, thereby helping to improve lifetime. That is, when the compound represented by the above Chemical Formula 1 is used as an acceptor and the compound represented by the above Chemical Formula 2 is used as a donor, excellent properties of the organic light emitting element are exhibited.

在本揭露的一個實施例中,當有機發光元件包含由以上化學式1表示的雜環化合物與由以上化學式2表示的雜環化合物的混合物時,雜環化合物中的至少一者可具有大於0%且為100%或小於100%的氘含量。In one embodiment of the present disclosure, when the organic light-emitting element includes a mixture of a heterocyclic compound represented by the above Chemical Formula 1 and a heterocyclic compound represented by the above Chemical Formula 2, at least one of the heterocyclic compounds may have more than 0% and a deuterium content of 100% or less.

在本揭露的另一實施例中,當有機發光元件包含由以上化學式1表示的雜環化合物與由以上化學式2表示的雜環化合物的混合物時,雜環化合物中的至少一者可具有為10%至100%的氘含量。In another embodiment of the present disclosure, when the organic light-emitting element includes a mixture of a heterocyclic compound represented by the above Chemical Formula 1 and a heterocyclic compound represented by the above Chemical Formula 2, at least one of the heterocyclic compounds may have a value of 10 % to 100% deuterium content.

在本揭露的另一實施例中,當有機發光元件包含由以上化學式1表示的雜環化合物與由以上化學式2表示的雜環化合物的混合物時,雜環化合物中的至少一者可具有為15%至95%的氘含量。In another embodiment of the present disclosure, when the organic light-emitting element includes a mixture of a heterocyclic compound represented by the above Chemical Formula 1 and a heterocyclic compound represented by the above Chemical Formula 2, at least one of the heterocyclic compounds may have 15 % to 95% deuterium content.

在本揭露的另一實施例中,當有機發光元件包含由以上化學式1表示的雜環化合物與由以上化學式2表示的雜環化合物的混合物時,雜環化合物中的至少一者可具有為20%至80%的氘含量。In another embodiment of the present disclosure, when the organic light-emitting element includes a mixture of a heterocyclic compound represented by the above Chemical Formula 1 and a heterocyclic compound represented by the above Chemical Formula 2, at least one of the heterocyclic compounds may have a value of 20 % to 80% deuterium content.

舉例而言,當有機發光元件包含由以上化學式1表示的雜環化合物與由以上化學式2表示的雜環化合物的混合物時,雜環化合物中的至少一者可具有為0%或大於0%、5%或大於5%、10%或大於10%、15%或大於15%、20%或大於20%、25%或大於25%、30%或大於30%、35%或大於35%、40%或大於40%、45%或大於45%或者50%或大於50%的氘含量,且可為100%或小於100%、95%或小於95%、90%或小於90%、85%或小於85%、80%或小於80%、75%或小於75%、70%或小於70%、65%或小於65%或者60%或小於60%。For example, when the organic light-emitting element includes a mixture of a heterocyclic compound represented by the above Chemical Formula 1 and a heterocyclic compound represented by the above Chemical Formula 2, at least one of the heterocyclic compounds may have 0% or more, 5% or more, 10% or more than 10%, 15% or more than 15%, 20% or more than 20%, 25% or more than 25%, 30% or more than 30%, 35% or more than 35%, 40% % or greater than 40%, 45% or greater than 45%, or 50% or greater than 50% deuterium content, and may be 100% or less, 95% or less, 90% or less, 85% or Less than 85%, 80% or less, 75% or less, 70% or less, 65% or less, or 60% or less.

此外,本揭露的一個實施例提供一種有機發光元件的有機材料層之組成物,所述組成物包含由以上化學式1表示的雜環化合物及由以上化學式2表示的雜環化合物。In addition, an embodiment of the present disclosure provides a composition of an organic material layer of an organic light-emitting device, the composition including the heterocyclic compound represented by the above Chemical Formula 1 and the heterocyclic compound represented by the above Chemical Formula 2.

由以上化學式1表示的雜環化合物及由以上化學式2表示的雜環化合物的具體細節與上述細節相同。Specific details of the heterocyclic compound represented by the above Chemical Formula 1 and the heterocyclic compound represented by the above Chemical Formula 2 are the same as those described above.

在本揭露的一個實施例中,在所述有機發光元件的有機材料層之組成物中,由以上化學式1表示的雜環化合物與由以上化學式2表示的雜環化合物可具有1:10至10:1、1:8至8:1、1:6至6:1、1:4至4:1、1:3至3:1或1:2至2:1的重量比,但不限於此。In an embodiment of the present disclosure, in the composition of the organic material layer of the organic light-emitting device, the heterocyclic compound represented by the above chemical formula 1 and the heterocyclic compound represented by the above chemical formula 2 may have a ratio of 1:10 to 10 :1, 1:8 to 8:1, 1:6 to 6:1, 1:4 to 4:1, 1:3 to 3:1 or 1:2 to 2:1 weight ratios, but not limited to .

當形成有機發光元件的有機材料層時,可使用所述有機發光元件的有機材料層之組成物,且具體而言,當形成發光層的主體時,可更佳地使用所述組成物。The composition of the organic material layer of an organic light emitting element may be used when forming the organic material layer of the organic light emitting element, and specifically, the composition may be more preferably used when forming the main body of the light emitting layer.

在本揭露的一個實施例中,有機材料層可包含由以上化學式1表示的雜環化合物及由以上化學式2表示的雜環化合物,且可與磷光摻雜劑一起使用。In one embodiment of the present disclosure, the organic material layer may include the heterocyclic compound represented by the above Chemical Formula 1 and the heterocyclic compound represented by the above Chemical Formula 2, and may be used together with a phosphorescent dopant.

作為用於磷光摻雜劑的材料,可使用此項技術中已知的材料。舉例而言,可使用由LL'MX'、LL'L''M、LMX'X''、L 2MX'及L 3M表示的磷光摻雜劑材料,但本揭露的範圍不限於該些實例。 As a material for the phosphorescent dopant, materials known in the art can be used. For example, phosphorescent dopant materials represented by LL'MX', LL'L''M, LMX'X'', L2MX ', and L3M can be used, but the scope of the present disclosure is not limited to these instance.

M可為銥、鉑、鋨或類似材料。M can be iridium, platinum, osmium or similar material.

L可為藉由sp2碳及雜原子與M配位的陰離子雙牙配位子,且X可起到陷獲電子或電洞的作用。L、L'及L''的非限制性實例包括2-(1-萘基)苯並噁唑、2-苯基苯並噁唑、2-苯基苯並噻唑、7,8-苯並喹啉、苯基吡啶、苯並噻吩基吡啶、3-甲氧基-2-苯基吡啶、噻吩基吡啶、甲苯基吡啶及類似材料。X'及X''的非限制性實例包括乙醯丙酮化物(acetylacetonate,acac)、六氟乙醯丙酮化物、亞柳基(salicylidene)、吡啶甲酸酯(picolinate)、8-羥基喹啉酸鹽及類似材料。L can be an anionic bidentate ligand coordinated to M through sp2 carbon and heteroatoms, and X can play the role of trapping electrons or holes. Non-limiting examples of L, L' and L'' include 2-(1-naphthyl)benzoxazole, 2-phenylbenzoxazole, 2-phenylbenzothiazole, 7,8-benzo Quinoline, phenylpyridine, benzothienylpyridine, 3-methoxy-2-phenylpyridine, thienylpyridine, tolylpyridine, and similar materials. Non-limiting examples of X' and X'' include acetylacetonate (acac), hexafluoroacetylacetonate, salicylidene, picolinate, 8-hydroxyquinolinic acid Salt and similar materials.

磷光摻雜劑的具體實例如下所示,但不限於該些實例。

Figure 02_image129
Figure 02_image131
。 Specific examples of phosphorescent dopants are shown below, but are not limited to these examples.
Figure 02_image129
Figure 02_image131
.

在本揭露的一個實施例中,有機材料層可包含由以上化學式1表示的雜環化合物及由以上化學式2表示的雜環化合物,且可與銥系摻雜劑一起使用。In one embodiment of the present disclosure, the organic material layer may include the heterocyclic compound represented by the above Chemical Formula 1 and the heterocyclic compound represented by the above Chemical Formula 2, and may be used together with an iridium-based dopant.

在本揭露的一個實施例中,作為綠色磷光摻雜劑的Ir(ppy) 3可用作銥系摻雜劑。 In one embodiment of the present disclosure, Ir(ppy) 3 , which is a green phosphorescent dopant, can be used as an iridium-based dopant.

在本揭露的一個實施例中,以總發光層重量計,摻雜劑可具有為1%至15%、較佳為2%至10%且更佳為3%至7%的含量。In an embodiment of the present disclosure, the dopant may have a content of 1% to 15%, preferably 2% to 10%, and more preferably 3% to 7%, based on the weight of the total light emitting layer.

在根據本揭露的一個實施例的有機發光元件中,有機材料層可包括電子注入層或電子傳輸層,且所述電子注入層或所述電子傳輸層可包含由以上化學式1表示的雜環化合物。In the organic light emitting element according to one embodiment of the present disclosure, the organic material layer may include an electron injection layer or an electron transport layer, and the electron injection layer or the electron transport layer may include a heterocyclic compound represented by the above Chemical Formula 1 .

在根據本揭露的另一實施例的有機發光元件中,有機材料層可包括電子阻擋層或電洞阻擋層,且所述電子阻擋層或所述電洞阻擋層可包含由以上化學式1表示的雜環化合物。In an organic light emitting element according to another embodiment of the present disclosure, the organic material layer may include an electron blocking layer or a hole blocking layer, and the electron blocking layer or the hole blocking layer may include Heterocyclic compounds.

在根據本揭露的另一實施例的有機發光元件中,有機材料層可包括電子傳輸層、發光層或電洞阻擋層,且所述電子傳輸層、所述發光層或所述電洞阻擋層可包含由以上化學式1表示的雜環化合物。In the organic light emitting device according to another embodiment of the present disclosure, the organic material layer may include an electron transport layer, a light emitting layer or a hole blocking layer, and the electron transport layer, the light emitting layer or the hole blocking layer A heterocyclic compound represented by the above Chemical Formula 1 may be included.

在根據本揭露的另一實施例的有機發光元件中,有機材料層可包括發光層,且所述發光層可包含由以上化學式1表示的雜環化合物。In an organic light emitting device according to another embodiment of the present disclosure, the organic material layer may include a light emitting layer, and the light emitting layer may include the heterocyclic compound represented by Chemical Formula 1 above.

在根據本揭露的另一實施例的有機發光元件中,有機材料層可包括發光層,所述發光層可包含主體材料,且所述主體材料可包含由以上化學式1表示的雜環化合物。In an organic light emitting device according to another embodiment of the present disclosure, the organic material layer may include a light emitting layer, the light emitting layer may include a host material, and the host material may include the heterocyclic compound represented by Chemical Formula 1 above.

根據本揭露的一個實施例的有機發光元件可更包括選自由發光層、電洞注入層、電洞傳輸層、電子注入層、電子阻擋層及電洞阻擋層組成的群組的一或多個層。An organic light-emitting device according to an embodiment of the present disclosure may further include one or more materials selected from the group consisting of a light-emitting layer, a hole injection layer, a hole transport layer, an electron injection layer, an electron blocking layer, and a hole blocking layer. layer.

圖1至圖3例示根據本揭露一個實施例的有機發光元件的電極及有機材料層的疊層次序。然而,其並不旨在使本申請案的範圍受限於該些圖式,且此項技術中已知的有機發光元件的結構亦可應用於本申請案。1 to 3 illustrate the stacking sequence of electrodes and organic material layers of an organic light emitting device according to an embodiment of the present disclosure. However, it is not intended to limit the scope of the present application to these drawings, and structures of organic light-emitting devices known in the art can also be applied to the present application.

根據圖1,示出其中正電極200、有機材料層300及負電極400依序疊層於基板100上的有機發光元件。然而,其並不僅限於此種結構,且如圖2中所示,亦可實施其中負電極、有機材料層及正電極依序疊層於基板上的有機發光元件。According to FIG. 1 , an organic light emitting element in which a positive electrode 200 , an organic material layer 300 and a negative electrode 400 are sequentially stacked on a substrate 100 is shown. However, it is not limited to this structure, and as shown in FIG. 2 , an organic light emitting element in which a negative electrode, an organic material layer, and a positive electrode are sequentially stacked on a substrate may also be implemented.

圖3例示其中有機材料層是多層的情形。根據圖3的有機發光元件包括電洞注入層301、電洞傳輸層302、發光層303、電洞阻擋層304、電子傳輸層305及電子注入層306。然而,本申請案的範圍不受限於此種疊層結構,且若有必要,則可省略除了發光層以外的其餘層,且可進一步添加其他必要的功能層。FIG. 3 illustrates a case where the organic material layer is a multilayer. The organic light emitting device according to FIG. 3 includes a hole injection layer 301 , a hole transport layer 302 , a light emitting layer 303 , a hole blocking layer 304 , an electron transport layer 305 and an electron injection layer 306 . However, the scope of the present application is not limited to such a laminated structure, and if necessary, layers other than the light emitting layer may be omitted, and other necessary functional layers may be further added.

在本揭露的一個實施例中,提供一種用於製造有機發光元件的方法,所述方法包括以下步驟:製備基板;在基板上形成第一電極;在第一電極上形成一或多個有機材料層;以及在有機材料層上形成第二電極,其中形成有機材料層的步驟包括使用根據本揭露的一個實施例的有機材料層組成物形成一或多個有機材料層的步驟。In one embodiment of the present disclosure, a method for manufacturing an organic light-emitting element is provided, the method including the following steps: preparing a substrate; forming a first electrode on the substrate; forming one or more organic materials on the first electrode layer; and forming a second electrode on the organic material layer, wherein the step of forming the organic material layer includes the step of forming one or more organic material layers using the organic material layer composition according to an embodiment of the present disclosure.

在本揭露的一個實施例中,形成有機材料層的步驟可為將由以上化學式1表示的雜環化合物與由以上化學式2表示的雜環化合物預混合,並使用熱真空沈積方法形成有機材料層。In one embodiment of the present disclosure, the step of forming the organic material layer may be to premix the heterocyclic compound represented by the above Chemical Formula 1 with the heterocyclic compound represented by the above Chemical Formula 2, and form the organic material layer using a thermal vacuum deposition method.

預混合是指在將材料預混合之後在源中混合經預混合材料,並在將由以上化學式1表示的雜環化合物及由以上化學式2表示的雜環化合物沈積於有機材料層上之前將經預混合材料放入至一個源中。Premixing refers to mixing the premixed material in the source after premixing the materials, and mixing the premixed material before depositing the heterocyclic compound represented by the above Chemical Formula 1 and the heterocyclic compound represented by the above Chemical Formula 2 on the organic material layer. Mixed materials are put into one source.

根據本申請案的一個實施例,經預混合材料可被稱為有機材料層組成物。According to one embodiment of the present application, the premixed material may be referred to as an organic material layer composition.

包含由以上化學式1表示的雜環化合物的有機材料層可根據需要更包含其他材料。The organic material layer including the heterocyclic compound represented by the above Chemical Formula 1 may further include other materials as needed.

根據需要,同時包含由以上化學式1表示的雜環化合物與由以上化學式2表示的雜環化合物的有機材料層可更包含其他材料。The organic material layer including both the heterocyclic compound represented by the above Chemical Formula 1 and the heterocyclic compound represented by the above Chemical Formula 2 may further contain other materials as needed.

在根據本揭露的一個實施例的有機發光元件中,在下面例示除了由以上化學式1表示的雜環化合物或由以上化學式2表示的雜環化合物以外的材料,但該些僅用於例示,且並非用於限制本申請案的範圍,且可由此項技術中已知的材料來代替。In the organic light-emitting element according to one embodiment of the present disclosure, materials other than the heterocyclic compound represented by the above Chemical Formula 1 or the heterocyclic compound represented by the above Chemical Formula 2 are exemplified below, but these are only for illustration, and It is not intended to limit the scope of the application, and materials known in the art may be substituted.

作為正電極材料,可使用具有相對大的功函數的材料,且可使用透明導電氧化物、金屬、導電聚合物或類似材料。正電極材料的具體實例包括:金屬,例如釩、鉻、銅、鋅及金,或其合金;金屬氧化物,例如氧化鋅、氧化銦、氧化銦錫(indium tin oxide,ITO)及氧化銦鋅(indium zinc oxide,IZO);ZnO:Al或SnO 2:金屬(例如Sb)與氧化物的組合;導電聚合物(conductive polymer),例如聚(3-甲基噻吩)、聚[3,4-(乙烯-1,2-二氧)噻吩](poly[3,4-(ethylene-1,2-dioxy)thiophene],PEDOT)、聚吡咯及聚苯胺;以及類似材料,但不限於此。 As the positive electrode material, a material having a relatively large work function may be used, and a transparent conductive oxide, metal, conductive polymer, or the like may be used. Specific examples of positive electrode materials include: metals such as vanadium, chromium, copper, zinc, and gold, or alloys thereof; metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO) and indium zinc oxide (indium zinc oxide, IZO); ZnO: Al or SnO 2 : combination of metal (such as Sb) and oxide; conductive polymer (conductive polymer), such as poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy)thiophene] (poly[3,4-(ethylene-1,2-dioxy)thiophene], PEDOT), polypyrrole, and polyaniline; and similar materials, but not limited thereto.

作為負電極材料,可使用具有相對低的功函數的材料,且可使用金屬、金屬氧化物、導電聚合物或類似材料。負電極材料的具體實例包括:金屬,例如鎂、鈣、鈉、鉀、鈦、銦、釔、鋰、釓、鋁、銀、錫及鉛,或其合金;多層式材料,例如LiF/Al或LiO 2/Al;以及類似材料,但不限於此。 As the negative electrode material, a material having a relatively low work function can be used, and a metal, a metal oxide, a conductive polymer, or the like can be used. Specific examples of negative electrode materials include: metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, and lead, or alloys thereof; multilayer materials such as LiF/Al or LiO 2 /Al; and similar materials, but not limited thereto.

作為電洞注入層材料,亦可使用已知的電洞注入層材料,且舉例而言,可使用酞菁化合物,例如美國專利第4,356,429號中揭露的銅酞菁及類似材料;或文獻[高級材料(Advanced Material),6,第677頁(1994)]中所述的星形猝發型胺衍生物,例如三(4-咔唑基-9-基苯基)胺(tris(4-carbazoyl-9-ylphenyl)amine,TCTA)、4,4',4''-三[苯基(間甲苯基)胺基]三苯基胺(4,4',4''-tris[phenyl(m-tolyl)amino]triphenylamine,m-MTDATA)、1,3,5-三[4-(3-甲基苯基苯胺基)苯基]苯(1,3,5-tris[4-(3-methylphenylphenylamino)phenyl]benzene,m-MTDAPB);聚苯胺/十二烷基苯磺酸或聚(3,4-乙烯二氧噻吩)/聚(4-苯乙烯磺酸酯)、聚苯胺/樟腦磺酸或聚苯胺/聚(4-苯乙烯磺酸酯)的可溶性導電聚合物;以及類似材料。As the hole injection layer material, known hole injection layer materials can also be used, and for example, phthalocyanine compounds such as copper phthalocyanine disclosed in U.S. Patent No. 4,356,429 and similar materials; or literature [Advanced Materials (Advanced Material), 6, p. 677 (1994)] star-burst amine derivatives such as tris (4-carbazolyl-9-ylphenyl) amine (tris (4-carbazolyl-9-ylphenyl) amine (tris (4-carbazolyl- 9-ylphenyl)amine, TCTA), 4,4',4''-tris[phenyl(m-tolyl)amino]triphenylamine (4,4',4''-tris[phenyl(m- tolyl)amino]triphenylamine, m-MTDATA), 1,3,5-tris[4-(3-methylphenylanilino)phenyl]benzene (1,3,5-tris[4-(3-methylphenylphenylamino )phenyl]benzene, m-MTDAPB); polyaniline/dodecylbenzenesulfonic acid or poly(3,4-ethylenedioxythiophene)/poly(4-styrenesulfonate), polyaniline/camphorsulfonic acid or polyaniline/poly(4-styrenesulfonate) soluble conductive polymers; and similar materials.

作為電洞傳輸層材料,可使用吡唑啉衍生物、芳基胺系衍生物、二苯乙烯衍生物、三苯基二胺衍生物及類似材料,且亦可使用低分子量或高分子量材料。As the hole transport layer material, pyrazoline derivatives, arylamine-based derivatives, stilbene derivatives, triphenyldiamine derivatives, and the like can be used, and low-molecular-weight or high-molecular-weight materials can also be used.

作為電子傳輸層材料,可使用噁二唑衍生物、蒽醌二甲烷及其衍生物、苯醌及其衍生物、萘醌及其衍生物、蒽醌及其衍生物、四氰基蒽醌二甲烷及其衍生物、芴酮衍生物、二苯基二氰基乙烯及其衍生物、二苯醌衍生物、8-羥基喹啉及其衍生物以及類似材料的金屬錯合物,且亦可使用高分子量材料以及低分子量材料。As materials for the electron transport layer, oxadiazole derivatives, anthraquinone dimethane and its derivatives, benzoquinone and its derivatives, naphthoquinone and its derivatives, anthraquinone and its derivatives, tetracyanoanthraquinone di Metal complexes of methane and its derivatives, fluorenone derivatives, diphenyldicyanoethylene and its derivatives, dibenzoquinone derivatives, 8-hydroxyquinoline and its derivatives and similar materials, and also Use high molecular weight materials as well as low molecular weight materials.

作為電子注入層材料,舉例而言,此項技術中通常使用LiF,但本申請案不限於此。As an electron injection layer material, for example, LiF is generally used in this art, but the present application is not limited thereto.

作為發光層材料,可使用紅色、綠色或藍色發光材料,且若有必要,則可混合並使用二或更多種發光材料。此時,二或更多種發光材料可被沈積並用作各別的源,或者可被預混合以被沈積並用作一個源。另外,作為發光層材料,可使用螢光材料,但亦可使用磷光材料。作為發光層材料,可單獨使用藉由對分別自正電極及負電極注入的電洞與電子進行組合來發光的材料,但亦可使用其中主體材料與摻雜劑材料一起參與發光的材料。As the light emitting layer material, red, green or blue light emitting materials can be used, and if necessary, two or more kinds of light emitting materials can be mixed and used. At this point, two or more luminescent materials may be deposited and used as separate sources, or may be premixed to be deposited and used as one source. In addition, as the light emitting layer material, a fluorescent material can be used, but a phosphorescent material can also be used. As the light-emitting layer material, a material that emits light by combining holes and electrons respectively injected from the positive electrode and the negative electrode may be used alone, but a material in which a host material participates in light emission together with a dopant material may also be used.

當混合並使用發光層材料的主體時,可混合並使用相同系列的主體,或者亦可混合並使用不同系列的主體。舉例而言,可選擇n型主體材料或p型主體材料中的任意二或更多種材料,並將其用作發光層的主體材料。When the hosts of the light-emitting layer materials are mixed and used, hosts of the same series may be mixed and used, or hosts of different series may be mixed and used. For example, any two or more of n-type host material or p-type host material can be selected and used as the host material of the light-emitting layer.

端視所使用的材料而定,根據本揭露的一個實施例的有機發光元件可為頂部發射型(top emission type)、背部發射型(back emission type)或雙側發射型(double side emission type)。Depending on the materials used, the organic light emitting device according to an embodiment of the present disclosure may be a top emission type, a back emission type, or a double side emission type. .

根據本揭露的一個實施例的雜環化合物可以與應用於有機發光元件的原理相似的原理起作用,甚至在包括有機太陽電池、有機光受體(organic photoreceptor)、有機電晶體及類似組件的有機電子元件中亦是如此。 [施行本發明的方式] The heterocyclic compound according to an embodiment of the present disclosure can work on a principle similar to that applied to organic light-emitting devices, even in organic solar cells, organic photoreceptors, organic transistors, and similar components. The same is true in electronic components. [Mode of Carrying Out the Invention]

在下文中,給出較佳實例以幫助理解本揭露,但提供以下實例僅是為了更容易理解本揭露,且本揭露不限於此。 製備例 製備例 1. 化合物 1-1 的製備

Figure 02_image133
1 )化合物 1-1-6 的製備 Hereinafter, preferred examples are given to help understand the present disclosure, but the following examples are provided only for easier understanding of the present disclosure, and the present disclosure is not limited thereto. < Preparation example > Preparation example 1. Preparation of compound 1-1
Figure 02_image133
1 ) Preparation of compound 1-1-6

將2,3-二氟-1,4-二碘苯(22.8克,62.3毫莫耳/升(mM))、(2-氟苯基)硼酸(7.3克,51.9毫莫耳/升)、四(三苯基膦)鈀(Pd(PPh 3) 4)(3.0克,2.6毫莫耳/升)及碳酸鉀(K 2CO 3)(14.3克,103.8毫莫耳/升)放入並溶解於1,4-二噁烷(250毫升)及水(H 2O)(50毫升)中,且然後回流了12小時。反應完成後,放入了蒸餾水及二氯甲烷(dichloromethane,DCM)並在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(column chromatography)(DCM:己烷=1:3)對反應產物進行了純化,以獲得13.9克目標化合物1-1-6(收率80%)。 2 )化合物 1-1-5 的製備 2,3-Difluoro-1,4-diiodobenzene (22.8 g, 62.3 mmol/L (mM)), (2-fluorophenyl)boronic acid (7.3 g, 51.9 mmol/L), Tetrakis(triphenylphosphine) palladium (Pd(PPh 3 ) 4 ) (3.0 g, 2.6 mmol/L) and potassium carbonate (K 2 CO 3 ) (14.3 g, 103.8 mmol/L) were put into and Dissolved in 1,4-dioxane (250 mL) and water (H 2 O) (50 mL), and then refluxed for 12 hours. After the reaction was completed, distilled water and dichloromethane (dichloromethane, DCM) were added and extracted at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) to obtain 13.9 g of target compound 1-1-6 (yield 80%). 2 ) Preparation of compound 1-1-5

將化合物1-1-6(17.3克,51.9毫莫耳/升)、(3-溴-2-氟苯基)硼酸(13.6克,62.3毫莫耳/升)、四(三苯基膦)鈀(Pd(PPh 3) 4)(3.0克,2.6毫莫耳/升)及碳酸鉀(K 2CO 3)(14.3克,103.8毫莫耳/升)放入並溶解於1,4-二噁烷(250毫升)及水(H 2O)(50毫升)中,且然後回流了12小時。反應完成後,放入了蒸餾水及二氯甲烷(DCM)並在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化,以獲得16.8克目標化合物1-1-5(收率85%)。 3 )化合物 1-1-4 的製備 Compound 1-1-6 (17.3 g, 51.9 mmol/L), (3-bromo-2-fluorophenyl) boronic acid (13.6 g, 62.3 mmol/L), tetrakis(triphenylphosphine) Palladium (Pd(PPh 3 ) 4 ) (3.0 g, 2.6 mmol/L) and potassium carbonate (K 2 CO 3 ) (14.3 g, 103.8 mmol/L) were added and dissolved in 1,4-di Oxane (250ml) and water ( H2O ) (50ml), and then refluxed for 12 hours. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extracted at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) to obtain 16.8 g of target compound 1-1-5 (yield 85%). 3 ) Preparation of compound 1-1-4

在將化合物1-1-5(16.8克,44.1毫莫耳/升)及第三丁醇鉀( t-BuOK)(29.7克,264.6毫莫耳/升)放入並溶解於六甲基磷醯胺(hexamethylphosphoramide,HMPA)(160毫升)中之後,在120℃下在微波反應器中對混合物進行了攪拌。反應完成後,放入了蒸餾水及二氯甲烷(DCM)並在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化,以獲得13.8克目標化合物1-1-4(收率93%)。 4 )化合物 1-1-3 的製備 Compound 1-1-5 (16.8 g, 44.1 mmol/L) and potassium t-butoxide ( t -BuOK) (29.7 g, 264.6 mmol/L) were put into and dissolved in hexamethylphosphorus After adding hexamethylphosphoramide (HMPA) (160 ml), the mixture was stirred at 120 °C in a microwave reactor. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extracted at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) to obtain 13.8 g of target compound 1-1-4 (yield 93%). 4 ) Preparation of compound 1-1-3

將化合物1-1-4(17.5克,51.9毫莫耳/升)、2-氯苯胺(7.9克,62.3毫莫耳/升)、乙酸鈀(II)(Pd(OAc) 2)(0.58克,2.6毫莫耳/升)、9,9-二甲基-4,5-雙(二苯基膦基)-呫噸(9,9-Dimethyl-4,5-bis(diphenylphosphino)xanthene,XantPhos)(3克,5.2毫莫耳/升)及第三丁醇鈉(t-BuONa)(10.0克,103.8毫莫耳/升)放入並溶解於1,4-二噁烷(200毫升)中,且然後回流了12小時。反應完成後,放入了蒸餾水及二氯甲烷(DCM)並在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化,以獲得15.9克目標化合物1-1-3(收率80%)。 5 )化合物 1-1-2 的製備 Compound 1-1-4 (17.5 g, 51.9 mmol/L), 2-chloroaniline (7.9 g, 62.3 mmol/L), palladium(II) acetate (Pd(OAc) 2 ) (0.58 g , 2.6 mmol/L), 9,9-Dimethyl-4,5-bis(diphenylphosphino)-xanthene (9,9-Dimethyl-4,5-bis(diphenylphosphino)xanthene, XantPhos ) (3 g, 5.2 mmol/L) and sodium tert-butoxide (t-BuONa) (10.0 g, 103.8 mmol/L) were put into and dissolved in 1,4-dioxane (200 mL) , and then refluxed for 12 hours. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extracted at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) to obtain 15.9 g of target compound 1-1-3 (yield 80%). 5 ) Preparation of compound 1-1-2

將化合物1-1-3(15.9克,41.5毫莫耳/升)、乙酸鈀(II)(Pd(OAc) 2)(0.47克,2.1毫莫耳/升)、50%的三第三丁基膦(P( t-Bu) 3)(2毫升,4.2毫莫耳/升)及1,8-二氮雜雙環[5.4.0]十一碳-7-烯(1,8-diazabicyclo[5.4.0]undec-7-ene,DBU)(9.3毫升,62.3毫莫耳/升)放入並溶解於二甲苯(400毫升)中,且然後回流了4小時。反應完成後,放入了蒸餾水及二氯甲烷(DCM)並在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化,以獲得12.5克目標化合物1-1-2(收率87%)。 6 )化合物 1-1-1 的製備 Compound 1-1-3 (15.9 g, 41.5 mmol/L), palladium (II) acetate (Pd(OAc) 2 ) (0.47 g, 2.1 mmol/L), 50% tributyl Phosphine (P( t -Bu) 3 ) (2 ml, 4.2 mmol/L) and 1,8-diazabicyclo[5.4.0]undec-7-ene (1,8-diazabicyclo[ 5.4.0] undec-7-ene, DBU) (9.3 ml, 62.3 mmol/l) was put into and dissolved in xylene (400 ml), and then refluxed for 4 hours. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extracted at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) to obtain 12.5 g of target compound 1-1-2 (yield 87%). 6 ) Preparation of compound 1-1-1

將化合物1-1-2(12.5克,36.2毫莫耳/升)及三氟甲磺酸(80.1毫升,905.0毫莫耳/升)放入並溶解於苯-d6(150毫升)中,且然後在40℃下進行了回流。反應完成後,放入了蒸餾水及二氯甲烷(DCM)並在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化,以獲得10.1克目標化合物1-1-1(收率78%)。 7 )化合物 1-1 的製備 Compound 1-1-2 (12.5 g, 36.2 mmol/L) and trifluoromethanesulfonic acid (80.1 mL, 905.0 mmol/L) were put into and dissolved in benzene-d6 (150 mL), and Reflux was then performed at 40°C. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extracted at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) to obtain 10.1 g of the target compound 1-1-1 (yield 78%). 7 ) Preparation of compound 1-1

將化合物1-1-1(10.1克,28.2毫莫耳/升)、2-氯-4,6-二苯基-1,3,5-三嗪(9.1克,33.9毫莫耳/升)、三(二亞苄基丙酮)二鈀(Pd 2(dba) 3)(1.3克,1.4毫莫耳/升)、XPhos(1.3克,2.8毫莫耳/升)及第三丁醇鈉( t-BuONa)(5.4克,56.4毫莫耳/升)放入並溶解於二甲苯(200毫升)中,且然後回流了12小時。反應完成後,放入了蒸餾水及二氯甲烷(DCM)並在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化,以獲得12.2克目標化合物1-1(收率73%)。 Compound 1-1-1 (10.1 g, 28.2 mmol/L), 2-chloro-4,6-diphenyl-1,3,5-triazine (9.1 g, 33.9 mmol/L) , tris(dibenzylideneacetone)dipalladium (Pd 2 (dba) 3 ) (1.3 g, 1.4 mmol/L), XPhos (1.3 g, 2.8 mmol/L) and sodium tert-butoxide ( t -BuONa) (5.4 g, 56.4 mmol/l) was put into and dissolved in xylene (200 ml), and then refluxed for 12 hours. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extracted at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) to obtain 12.2 g of target compound 1-1 (yield 73%).

藉由在以上製備例1中使用下表1的中間體A代替2-氯-4,6-二苯基-1,3,5-三嗪,以與以上製備例1的製備中相同的方式合成出了下表1的目標化合物。 [表1] 化合物編號 中間體 A 目標化合物 化合物編號 中間體 A 目標化合物 1-3

Figure 02_image135
Figure 02_image137
1-4
Figure 02_image139
Figure 02_image141
1-26
Figure 02_image143
Figure 02_image145
1-32
Figure 02_image147
Figure 02_image149
1-56
Figure 02_image151
Figure 02_image153
  
製備例 2 :化合物 1-61 的製備
Figure 02_image155
1 )化合物 1-61-5 的製備 By replacing 2-chloro-4,6-diphenyl-1,3,5-triazine in the above Preparation Example 1 by using Intermediate A of Table 1 below, in the same manner as in the preparation of the above Preparation Example 1 The target compounds in Table 1 below were synthesized. [Table 1] Compound number Intermediate A target compound Compound number Intermediate A target compound 1-3
Figure 02_image135
Figure 02_image137
1-4
Figure 02_image139
Figure 02_image141
1-26
Figure 02_image143
Figure 02_image145
1-32
Figure 02_image147
Figure 02_image149
1-56
Figure 02_image151
Figure 02_image153
Preparation Example 2 : Preparation of Compound 1-61
Figure 02_image155
1 ) Preparation of compound 1-61-5

將4,6-二溴代二苯並[b,d]呋喃(5.2克,15.8毫莫耳/升)、2-胺基苯硫醇(2.0克,15.8毫莫耳/升)、碘化銅(I)(CuI)(3.0克,15.8毫莫耳/升)、反-1,2-二胺基環己烷(1.9毫升,15.8毫莫耳/升)及磷酸三鉀(K 3PO 4)(3.3克,31.6毫莫耳/升)放入並溶解於1,4-二噁烷(100毫升)中,且然後回流了24小時。反應完成後,放入了蒸餾水及二氯甲烷(DCM)並在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化,以獲得5.0克目標化合物1-61-5(收率85%)。 2 )化合物 1-61-4 的製備 4,6-Dibromodibenzo[b,d]furan (5.2 g, 15.8 mmol/L), 2-aminobenzenethiol (2.0 g, 15.8 mmol/L), iodide Copper(I) (CuI) (3.0 g, 15.8 mmol/L), trans-1,2-diaminocyclohexane (1.9 mL, 15.8 mmol/L) and tripotassium phosphate (K 3 PO 4 ) (3.3 g, 31.6 mmol/l) was put into and dissolved in 1,4-dioxane (100 ml), and then refluxed for 24 hours. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extracted at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) to obtain 5.0 g of the target compound 1-61-5 (yield 85%). 2 ) Preparation of Compound 1-61-4

在將化合物1-61-5(5.2克,15.8毫莫耳/升)及亞硝酸第三丁酯( t-BuONO)(2.4克,23.7毫莫耳/升)放入並溶解於乙腈(MeCN)(100毫升)中之後,在0℃下將混合物攪拌了1小時,並在0℃下將銅(Cu)(2.0克,31.6毫莫耳/升)放入其中,且然後在80℃下攪拌了3小時。反應完成後,放入了蒸餾水及二氯甲烷(DCM)並在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化並自甲醇重結晶,以獲得2.9克目標化合物1-61-4(收率52%)。 3 )化合物 1-61 的製備 Compound 1-61-5 (5.2 g, 15.8 mmol/L) and tert-butyl nitrite ( t -BuONO) (2.4 g, 23.7 mmol/L) were dissolved in acetonitrile (MeCN ) (100 ml), the mixture was stirred at 0°C for 1 hour, and copper (Cu) (2.0 g, 31.6 mmol/L) was put into it at 0°C, and then at 80°C Stirred for 3 hours. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extracted at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) and recrystallized from methanol to obtain 2.9 g of target compound 1-61-4 (yield 52%). 3 ) Preparation of compound 1-61

藉由以與以上製備例1中化合物1-1-3、化合物1-1-2、化合物1-1-1及化合物1-1的製備中相同的方式製備化合物1-61-3、化合物1-61-2、化合物1-61-1及化合物1-61,且藉由在以上製備例2中使用下表2的中間體A代替4,6-二溴代二苯並[b,d]呋喃且使用下表2的中間體B代替2-氯-4,6-二苯基-1,3,5-三嗪,以與製備例2的製備中相同的方式合成出了下表2的目標化合物。 [表2] 化合物編號 中間體 A 中間體 B 目標化合物 1-64

Figure 02_image157
Figure 02_image139
Figure 02_image160
1-114
Figure 02_image157
Figure 02_image163
Figure 02_image165
1-241
Figure 02_image167
Figure 02_image169
Figure 02_image171
1-243
Figure 02_image167
Figure 02_image135
Figure 02_image175
1-244
Figure 02_image167
Figure 02_image139
Figure 02_image179
1-264
Figure 02_image167
Figure 02_image181
Figure 02_image183
1-265
Figure 02_image167
Figure 02_image185
Figure 02_image187
1-272
Figure 02_image167
Figure 02_image189
Figure 02_image191
1-294
Figure 02_image167
Figure 02_image163
Figure 02_image195
1-295
Figure 02_image167
Figure 02_image197
Figure 02_image199
1-296
Figure 02_image167
Figure 02_image201
Figure 02_image203
製備例 3 :化合物 1-121 的製備
Figure 02_image205
1 )化合物 1-121-4 的製備 Compound 1-61-3, Compound 1 were prepared in the same manner as in the preparation of Compound 1-1-3, Compound 1-1-2, Compound 1-1-1 and Compound 1-1 in Preparation Example 1 above. -61-2, compound 1-61-1 and compound 1-61, and by using the intermediate A of the following table 2 in the above preparation example 2 to replace 4,6-dibromodibenzo[b,d] furan and use the intermediate B of the following table 2 to replace 2-chloro-4,6-diphenyl-1,3,5-triazine, and synthesized the following table 2 in the same way as in the preparation of the preparation example 2 target compound. [Table 2] Compound number Intermediate A Intermediate B target compound 1-64
Figure 02_image157
Figure 02_image139
Figure 02_image160
1-114
Figure 02_image157
Figure 02_image163
Figure 02_image165
1-241
Figure 02_image167
Figure 02_image169
Figure 02_image171
1-243
Figure 02_image167
Figure 02_image135
Figure 02_image175
1-244
Figure 02_image167
Figure 02_image139
Figure 02_image179
1-264
Figure 02_image167
Figure 02_image181
Figure 02_image183
1-265
Figure 02_image167
Figure 02_image185
Figure 02_image187
1-272
Figure 02_image167
Figure 02_image189
Figure 02_image191
1-294
Figure 02_image167
Figure 02_image163
Figure 02_image195
1-295
Figure 02_image167
Figure 02_image197
Figure 02_image199
1-296
Figure 02_image167
Figure 02_image201
Figure 02_image203
Preparation Example 3 : Preparation of Compound 1-121
Figure 02_image205
1 ) Preparation of compound 1-121-4

在將12,12-二甲基-12H-芴酮並[1,2-b]苯並呋喃(11.8克,41.5毫莫耳/升)放入並溶解於四氫呋喃(tetrahydrofuran,THF)(260毫升)中之後,在-78℃下用氮對所述混合物進行了取代,並緩慢放入2.5莫耳/升(M)正丁基鋰(n-butyllithium,n-BuLi)(20.0毫升,49.8毫莫耳/升),並攪拌至室溫。此後,將碘(15.8克,62.3毫莫耳/升)放入其中並攪拌了1小時。反應完成後,放入了蒸餾水及二氯甲烷(DCM)並進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化,以獲得11.7克目標化合物1-121-4(收率69%)。 2 )化合物 1-121 的製備 12,12-Dimethyl-12H-fluorenone[1,2-b]benzofuran (11.8 g, 41.5 mmol/L) was added and dissolved in tetrahydrofuran (THF) (260 mL ), the mixture was substituted with nitrogen at -78°C and slowly added to 2.5 mol/L (M) n-butyllithium (n-BuLi) (20.0 ml, 49.8 ml mol/L), and stirred to room temperature. Thereafter, iodine (15.8 g, 62.3 mmol/L) was put thereinto and stirred for 1 hour. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extracted. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) to obtain 11.7 g of target compound 1-121-4 (yield 69%). 2 ) Preparation of compound 1-121

藉由以與以上製備例1中化合物1-1-3、化合物1-1-2、化合物1-1-1及化合物1-1的製備中相同的方式製備化合物1-121-3、化合物1-121-2、化合物1-121-1及化合物1-121,且藉由在以上製備例3中使用下表3的中間體A代替12,12-二甲基-12H-芴酮並[1,2-b]苯並呋喃且使用下表3的中間體B代替2-氯-4,6-二苯基-1,3,5-三嗪,以與製備例3的製備中相同的方式合成出了下表3的目標化合物。 [表3] 化合物編號 中間體 A 中間體 B 目標化合物 1-123

Figure 02_image207
Figure 02_image135
Figure 02_image210
1-156
Figure 02_image207
Figure 02_image213
Figure 02_image215
1-175
Figure 02_image207
Figure 02_image218
Figure 02_image220
1-301
Figure 02_image222
Figure 02_image224
Figure 02_image226
1-304
Figure 02_image222
Figure 02_image139
Figure 02_image229
1-356
Figure 02_image222
Figure 02_image232
Figure 02_image234
製備例 4 :化合物 1-181 的製備
Figure 02_image236
1 )化合物 1-181-3 的製備 Compound 1-121-3, Compound 1 were prepared in the same manner as in the preparation of Compound 1-1-3, Compound 1-1-2, Compound 1-1-1 and Compound 1-1 in Preparation Example 1 above. -121-2, compound 1-121-1 and compound 1-121, and by using the intermediate A of the following table 3 in the above preparation example 3 to replace 12,12-dimethyl-12H-fluorenone[1 , 2-b] benzofuran and use intermediate B of the following table 3 instead of 2-chloro-4,6-diphenyl-1,3,5-triazine in the same manner as in the preparation of Preparation Example 3 The target compounds in Table 3 below were synthesized. [table 3] Compound number Intermediate A Intermediate B target compound 1-123
Figure 02_image207
Figure 02_image135
Figure 02_image210
1-156
Figure 02_image207
Figure 02_image213
Figure 02_image215
1-175
Figure 02_image207
Figure 02_image218
Figure 02_image220
1-301
Figure 02_image222
Figure 02_image224
Figure 02_image226
1-304
Figure 02_image222
Figure 02_image139
Figure 02_image229
1-356
Figure 02_image222
Figure 02_image232
Figure 02_image234
Preparation Example 4 : Preparation of Compound 1-181
Figure 02_image236
1 ) Preparation of Compound 1-181-3

將化合物1-181-4(8.2克,28.2毫莫耳/升)、2-氯苯胺(4.3克,33.9毫莫耳/升)及第三丁醇鉀( t-BuOK)(6.3克,56.4毫莫耳/升)放入並溶解於二甲基亞碸(dimethyl sulfoxide,DMSO)(200毫升)中,且然後進行了回流。反應完成後,放入了蒸餾水及二氯甲烷(DCM)且在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化,以獲得8.2克目標化合物1-181-3(收率73%)。 2 )化合物 1-181 的製備 Compound 1-181-4 (8.2 g, 28.2 mmol/L), 2-chloroaniline (4.3 g, 33.9 mmol/L) and potassium tert-butoxide ( t -BuOK) (6.3 g, 56.4 mmol/L) was put into and dissolved in dimethyl sulfoxide (DMSO) (200 ml), and then refluxed. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extraction was performed at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) to obtain 8.2 g of target compound 1-181-3 (yield 73%). 2 ) Preparation of compound 1-181

藉由以與以上製備例2中化合物1-61-5、化合物1-61-4、化合物1-61-2、化合物1-61-1及化合物1-61的製備中相同的方式製備化合物1-181-5、化合物1-181-4、化合物1-181-2、化合物1-181-1及化合物1-181,且藉由在以上製備例4中使用下表4的中間體A代替2-氯-4,6-二苯基-1,3,5-三嗪,以與製備例4的製備中相同的方式合成出了下表4的目標化合物。 [表4] 化合物編號 中間體 A 目標化合物 化合物編號 中間體 A 目標化合物 1-183

Figure 02_image135
Figure 02_image239
1-184
Figure 02_image241
Figure 02_image243
1-238
Figure 02_image245
Figure 02_image247
  
製備例 5 :化合物 1-361 的製備
Figure 02_image249
1 )化合物 1-361-3 的製備 Compound 1 was prepared in the same manner as in the preparation of Compound 1-61-5, Compound 1-61-4, Compound 1-61-2, Compound 1-61-1 and Compound 1-61 in Preparation 2 above -181-5, compound 1-181-4, compound 1-181-2, compound 1-181-1 and compound 1-181, and by using intermediate A of the following table 4 in the above preparation example 4 to replace 2 - Chloro-4,6-diphenyl-1,3,5-triazine, the target compound in the following Table 4 was synthesized in the same manner as in the preparation of Preparation Example 4. [Table 4] Compound number Intermediate A target compound Compound number Intermediate A target compound 1-183
Figure 02_image135
Figure 02_image239
1-184
Figure 02_image241
Figure 02_image243
1-238
Figure 02_image245
Figure 02_image247
Preparation Example 5 : Preparation of Compound 1-361
Figure 02_image249
1 ) Preparation of compound 1-361-3

將4-溴-3-氯二苯並[b,d]呋喃(14.6克,51.9毫莫耳/升)、二苯並[b,d]呋喃-4-胺(11.4克,62.3毫莫耳/升)、乙酸鈀(II)(Pd(OAc) 2)(0.58克,2.6毫莫耳/升)、XantPhos(3克,5.2毫莫耳/升)及第三丁醇鈉( t-BuONa)(10.0克,103.8毫莫耳/升)放入並溶解於1,4-二噁烷(200毫升)中,且然後回流了12小時。反應完成後,放入了蒸餾水及二氯甲烷(DCM)且在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化,以獲得16.5克目標化合物1-361-3(收率83%)。 2 )化合物 1-361 的製備 4-Bromo-3-chlorodibenzo[b,d]furan (14.6 g, 51.9 mmol/L), dibenzo[b,d]furan-4-amine (11.4 g, 62.3 mmol /L), palladium(II) acetate (Pd(OAc) 2 ) (0.58 g, 2.6 mmol/L), XantPhos (3 g, 5.2 mmol/L) and sodium tert-butoxide ( t -BuONa ) (10.0 g, 103.8 mmol/L) was put into and dissolved in 1,4-dioxane (200 ml), and then refluxed for 12 hours. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extraction was performed at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) to obtain 16.5 g of the target compound 1-361-3 (yield 83%). 2 ) Preparation of compound 1-361

藉由以與以上製備例1中化合物1-1-2、化合物1-1-1及化合物1-1的製備中相同的方式製備化合物1-361-2、化合物1-361-1及化合物1-361,且藉由在以上製備例5中使用下表5的中間體A代替4-溴-3-氯二苯並[b,d]呋喃、使用下表5的中間體B代替二苯並[b,d]呋喃-4-胺且使用下表5的中間體C代替2-氯-4,6-二苯基-1,3,5-三嗪,以與製備例5的製備中相同的方式合成出了下表5的目標化合物。 [表5] 化合物編號 中間體 A 中間體 B 中間體 C 目標化合物 1-372

Figure 02_image251
Figure 02_image253
Figure 02_image255
Figure 02_image257
1-379
Figure 02_image251
Figure 02_image253
Figure 02_image245
Figure 02_image262
1-381
Figure 02_image251
Figure 02_image265
Figure 02_image224
Figure 02_image268
1-383
Figure 02_image251
Figure 02_image265
Figure 02_image139
Figure 02_image271
1-398
Figure 02_image251
Figure 02_image265
Figure 02_image275
Figure 02_image277
1-401
Figure 02_image251
Figure 02_image279
Figure 02_image224
Figure 02_image281
1-408
Figure 02_image251
Figure 02_image279
Figure 02_image283
Figure 02_image285
1-416
Figure 02_image251
Figure 02_image279
Figure 02_image288
Figure 02_image290
1-421
Figure 02_image292
Figure 02_image265
Figure 02_image224
Figure 02_image295
1-423
Figure 02_image292
Figure 02_image265
Figure 02_image139
Figure 02_image299
1-436
Figure 02_image292
Figure 02_image265
Figure 02_image301
Figure 02_image303
1-441
Figure 02_image292
Figure 02_image279
Figure 02_image224
Figure 02_image306
1-442
Figure 02_image292
Figure 02_image279
Figure 02_image309
Figure 02_image311
1-455
Figure 02_image292
Figure 02_image279
Figure 02_image314
Figure 02_image316
1-461
Figure 02_image279
Figure 02_image224
Figure 02_image322
1-477
Figure 02_image279
Figure 02_image324
Figure 02_image326
製備例 6 :化合物 2-3 的製備
Figure 02_image328
1 )化合物 2-3 的製備 Compound 1-361-2, Compound 1-361-1 and Compound 1 were prepared in the same manner as in the preparation of Compound 1-1-2, Compound 1-1-1 and Compound 1-1 in Preparation Example 1 above -361, and by replacing 4-bromo-3-chlorodibenzo[b,d]furan with Intermediate A in Table 5 below and using Intermediate B in Table 5 below in Preparation 5 above to replace dibenzo [b,d] Furan-4-amine and use the intermediate C of the following table 5 instead of 2-chloro-4,6-diphenyl-1,3,5-triazine, to be the same as in the preparation of Preparation Example 5 The target compound of following table 5 has been synthesized by the method. [table 5] Compound number Intermediate A Intermediate B Intermediate C target compound 1-372
Figure 02_image251
Figure 02_image253
Figure 02_image255
Figure 02_image257
1-379
Figure 02_image251
Figure 02_image253
Figure 02_image245
Figure 02_image262
1-381
Figure 02_image251
Figure 02_image265
Figure 02_image224
Figure 02_image268
1-383
Figure 02_image251
Figure 02_image265
Figure 02_image139
Figure 02_image271
1-398
Figure 02_image251
Figure 02_image265
Figure 02_image275
Figure 02_image277
1-401
Figure 02_image251
Figure 02_image279
Figure 02_image224
Figure 02_image281
1-408
Figure 02_image251
Figure 02_image279
Figure 02_image283
Figure 02_image285
1-416
Figure 02_image251
Figure 02_image279
Figure 02_image288
Figure 02_image290
1-421
Figure 02_image292
Figure 02_image265
Figure 02_image224
Figure 02_image295
1-423
Figure 02_image292
Figure 02_image265
Figure 02_image139
Figure 02_image299
1-436
Figure 02_image292
Figure 02_image265
Figure 02_image301
Figure 02_image303
1-441
Figure 02_image292
Figure 02_image279
Figure 02_image224
Figure 02_image306
1-442
Figure 02_image292
Figure 02_image279
Figure 02_image309
Figure 02_image311
1-455
Figure 02_image292
Figure 02_image279
Figure 02_image314
Figure 02_image316
1-461
Figure 02_image279
Figure 02_image224
Figure 02_image322
1-477
Figure 02_image279
Figure 02_image324
Figure 02_image326
Preparation Example 6 : Preparation of Compound 2-3
Figure 02_image328
1 ) Preparation of compound 2-3

將3-溴-1,1'-聯苯(3.7克,15.8毫莫耳/升)、9-苯基-9H,9'H-3,3'-雙咔唑(6.5克,15.8毫莫耳/升)、碘化銅(I)(CuI)(3.0克,15.8毫莫耳/升)、反-1,2-二胺基環己烷(1.9毫升,15.8毫莫耳/升)及磷酸三鉀(K 3PO 4)(3.3克,31.6毫莫耳/升)放入並溶解於1,4-二噁烷(100毫升)中,且然後回流了24小時。反應完成後,放入了蒸餾水及二氯甲烷(DCM)且在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化並自甲醇重結晶,以獲得7.5克目標化合物2-3(收率85%)。 3-Bromo-1,1'-biphenyl (3.7 g, 15.8 mmol/L), 9-phenyl-9H,9'H-3,3'-biscarbazole (6.5 g, 15.8 mmol mol/L), copper(I) iodide (CuI) (3.0 g, 15.8 mmol/L), trans-1,2-diaminocyclohexane (1.9 mL, 15.8 mmol/L) and Tripotassium phosphate (K 3 PO 4 ) (3.3 g, 31.6 mmol/l) was put into and dissolved in 1,4-dioxane (100 ml), and then refluxed for 24 hours. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extraction was performed at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) and recrystallized from methanol to obtain 7.5 g of target compound 2-3 (yield 85%).

藉由在以上製備例6中使用下表6的中間體A代替3-溴-1,1'-聯苯且使用下表6的中間體B代替9-苯基-9H,9'-H-3,3'-雙咔唑,以與製備例6的製備中相同的方式合成出了下表6的目標化合物。 [表6] 化合物編號 中間體 A 中間體 B 目標化合物 2-4

Figure 02_image330
Figure 02_image332
Figure 02_image334
2-7
Figure 02_image336
Figure 02_image332
Figure 02_image339
2-9
Figure 02_image341
Figure 02_image332
Figure 02_image344
2-31
Figure 02_image346
Figure 02_image348
Figure 02_image350
2-32
Figure 02_image330
Figure 02_image348
Figure 02_image354
2-42
Figure 02_image330
Figure 02_image357
Figure 02_image359
製備例 7 :化合物 2-73 的製備
Figure 02_image361
1 )化合物 2-73-2 的製備 By using intermediate A in Table 6 below in place of 3-bromo-1,1'-biphenyl and intermediate B in Table 6 below in place of 9-phenyl-9H,9'-H- in Preparation 6 above 3,3'-Biscarbazole, the target compound in the following Table 6 was synthesized in the same manner as in the preparation of Preparation Example 6. [Table 6] Compound number Intermediate A Intermediate B target compound 2-4
Figure 02_image330
Figure 02_image332
Figure 02_image334
2-7
Figure 02_image336
Figure 02_image332
Figure 02_image339
2-9
Figure 02_image341
Figure 02_image332
Figure 02_image344
2-31
Figure 02_image346
Figure 02_image348
Figure 02_image350
2-32
Figure 02_image330
Figure 02_image348
Figure 02_image354
2-42
Figure 02_image330
Figure 02_image357
Figure 02_image359
Preparation Example 7 : Preparation of Compound 2-73
Figure 02_image361
1 ) Preparation of compound 2-73-2

將2-溴代二苯並[b,d]噻吩(4.2克,15.8毫莫耳/升)、9-苯基-9H,9'H-3,3'-雙咔唑(6.5克,15.8毫莫耳/升)、碘化銅(I)(CUI)(3.0克,15.8毫莫耳/升)、反-1,2-二胺基環己烷(1.9毫升,15.8毫莫耳/升)及磷酸三鉀(K 3PO 4)(3.3克,31.6毫莫耳/升)放入並溶解於1,4-二噁烷(100毫升)中,且然後回流了24小時。反應完成後,放入了蒸餾水及二氯甲烷(DCM)且在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化並自甲醇重結晶,以獲得7.9克目標化合物2-73-2(收率85%)。 2 )化合物 2-73-1 的製備 2-Bromodibenzo[b,d]thiophene (4.2 g, 15.8 mmol/L), 9-phenyl-9H,9'H-3,3'-biscarbazole (6.5 g, 15.8 mmol/L), copper(I) iodide (CUI) (3.0 g, 15.8 mmol/L), trans-1,2-diaminocyclohexane (1.9 mL, 15.8 mmol/L ) and tripotassium phosphate (K 3 PO 4 ) (3.3 g, 31.6 mmol/l) were put into and dissolved in 1,4-dioxane (100 ml), and then refluxed for 24 hours. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extraction was performed at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) and recrystallized from methanol to obtain 7.9 g of the target compound 2-73-2 (yield 85%). 2 ) Preparation of Compound 2-73-1

將化合物2-73-2(8.4克,14.3毫莫耳)放入並溶解於四氫呋喃(THF)(100毫升)中後,在-78℃下用氮對混合物進行了取代,且緩慢放入2.5莫耳/升正丁基鋰(n-BuLi)(7.4毫升,18.6毫莫耳)並在室溫下攪拌了1小時。將硼酸三甲酯(B(OMe) 3)(4.8毫升,42.9毫莫耳)緩慢放入反應混合物中,並在室溫下攪拌了2小時。反應完成後,放入了蒸餾水及二氯甲烷(DCM)且在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:MeOH=100:3)對反應產物進行了純化並自DCM重結晶,以獲得3.9克目標化合物2-73-1(收率70%)。 3 )化合物 2-73 的製備 Compound 2-73-2 (8.4 g, 14.3 mmol) was dissolved in tetrahydrofuran (THF) (100 ml), and the mixture was substituted with nitrogen at -78°C, and slowly placed in 2.5 mol/L n-butyllithium (n-BuLi) (7.4 ml, 18.6 mmol) and stirred at room temperature for 1 hour. Trimethyl borate (B(OMe) 3 ) (4.8 mL, 42.9 mmol) was slowly added to the reaction mixture and stirred at room temperature for 2 hours. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extraction was performed at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:MeOH=100:3) and recrystallized from DCM to obtain 3.9 g of the target compound 2-73-1 (yield 70%). 3 ) Preparation of compound 2-73

將化合物2-73-1(6.7克,10.5毫莫耳/升)、碘苯(2.1克,10.5毫莫耳/升)、四(三苯基膦)鈀(Pd(PPh 3) 4)(606毫克,0.52毫莫耳/升)及碳酸鉀(K 2CO 3)(2.9克,21.0毫莫耳/升)放入並溶解於甲苯(100毫升)、乙醇(EtOH)(20毫升)及水(H 2O)(20毫升)中,且然後回流了12小時。反應完成後,放入了蒸餾水及二氯甲烷(DCM)且在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化並自甲醇重結晶,以獲得4.9克目標化合物2-73(收率70%)。 製備例 8 :化合物 3-2 的製備

Figure 02_image363
1 )化合物 3-2-1 的製備 Compound 2-73-1 (6.7 g, 10.5 mmol/L), iodobenzene (2.1 g, 10.5 mmol/L), tetrakis(triphenylphosphine) palladium (Pd(PPh 3 ) 4 ) ( 606 mg, 0.52 mmol/L) and potassium carbonate (K 2 CO 3 ) (2.9 g, 21.0 mmol/L) were put into and dissolved in toluene (100 ml), ethanol (EtOH) (20 ml) and water (H 2 O) (20 ml), and then refluxed for 12 hours. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extraction was performed at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) and recrystallized from methanol to obtain 4.9 g of target compound 2-73 (yield 70%). Preparation Example 8 : Preparation of Compound 3-2
Figure 02_image363
1 ) Preparation of compound 3-2-1

將9H,9'H-3,3'-雙咔唑(10克,30.0毫莫耳/升)、4-溴-1,1'-聯苯-2,2',3,3',4',5,5',6,6'-D 9[A](7.26克,30毫莫耳/升)、碘化銅(I)(CuI)(0.57克,3.0毫莫耳/升)、反-1,2-二胺基環己烷(0.34克,3.0毫莫耳/升)及磷酸三鉀(K 3PO 4)(12.7克,60.0毫莫耳/升)放入並溶解於1,4-二噁烷(100毫升)中,且然後在125℃下回流了8小時。反應完成後,放入了蒸餾水及二氯甲烷(DCM)且在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化並自甲醇重結晶,以獲得13.9克目標化合物3-2-1(收率94%)。 2 )化合物 3-2 的製備 9H,9'H-3,3'-biscarbazole (10 g, 30.0 mmol/L), 4-bromo-1,1'-biphenyl-2,2',3,3',4 ',5,5',6,6'-D 9 [A] (7.26 g, 30 mmol/L), copper(I) iodide (CuI) (0.57 g, 3.0 mmol/L), Trans-1,2-diaminocyclohexane (0.34 g, 3.0 mmol/L) and tripotassium phosphate (K 3 PO 4 ) (12.7 g, 60.0 mmol/L) were put into and dissolved in 1 , 4-dioxane (100 ml), and then refluxed at 125°C for 8 hours. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extraction was performed at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) and recrystallized from methanol to obtain 13.9 g of target compound 3-2-1 (yield 94%). 2 ) Preparation of Compound 3-2

化合物3-2-1(13.9克,28.0毫莫耳/升)、4-溴-1,1'-聯苯-2,2',3,3',4',5,5',6,6'-D 9[A'](6.8克,28.0毫莫耳/升)、碘化銅(I)(CuI)(0.53克,2.8毫莫耳/升)、反-1,2-二胺基環己烷(0.32克,2.8毫莫耳/升)及磷酸三鉀(K 3PO 4)(11.9克,56.0毫莫耳/升)放入並溶解於1,4-二噁烷(140毫升)中,且然後在125℃下回流了8小時。反應完成後,放入了蒸餾水及二氯甲烷(DCM)且在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化並自甲醇重結晶,以獲得16.1克目標化合物3-2(收率88%)。 Compound 3-2-1 (13.9 g, 28.0 mmol/L), 4-bromo-1,1'-biphenyl-2,2',3,3',4',5,5',6, 6'-D 9 [A'] (6.8 g, 28.0 mmol/L), copper(I) iodide (CuI) (0.53 g, 2.8 mmol/L), trans-1,2-diamine Cyclohexane (0.32 g, 2.8 mmol/L) and tripotassium phosphate (K 3 PO 4 ) (11.9 g, 56.0 mmol/L) were put into and dissolved in 1,4-dioxane (140 ml), and then refluxed at 125 °C for 8 h. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extraction was performed at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) and recrystallized from methanol to obtain 16.1 g of target compound 3-2 (yield 88%).

當化合物A與化合物A'相同時,藉由放入2當量以上製備例8中的化合物A,可直接合成出目標化合物。亦即,當化合物A與化合物A'相同時,可省略化合物3-2-1的製備。When compound A is the same as compound A', the target compound can be directly synthesized by adding more than 2 equivalents of compound A in Preparation Example 8. That is, when Compound A is the same as Compound A', the preparation of Compound 3-2-1 can be omitted.

藉由使用下表7的中間體A代替在上述製備例8中的4-溴-1,1'-聯苯-2,2',3,3',4',5,5',6,6'-D 9[A],且使用下表7的中間體A'代替在上述製備例8中的4-溴-1,1'-聯苯-2,2',3,3',4',5,5',6,6'-D 9[A'],以與製備例8的製備中相同的方式合成出了下表7的目標化合物。 [表7] 化合物編號 中間體 A 中間體 A' 目標化合物 3-3

Figure 02_image365
Figure 02_image367
Figure 02_image369
3-5
Figure 02_image367
Figure 02_image372
Figure 02_image374
3-6
Figure 02_image367
Figure 02_image376
Figure 02_image378
3-8
Figure 02_image365
Figure 02_image365
Figure 02_image381
3-19
Figure 02_image376
Figure 02_image376
Figure 02_image384
3-22
Figure 02_image386
Figure 02_image386
Figure 02_image389
製備例 9 :化合物 3-26 的製備
Figure 02_image391
1 )化合物 3-26-2 的製備 By using intermediate A of Table 7 below in place of 4-bromo-1,1'-biphenyl-2,2',3,3',4',5,5',6 in Preparation 8 above, 6'-D 9 [A], and use intermediate A' of Table 7 below instead of 4-bromo-1,1'-biphenyl-2,2',3,3',4 in Preparation 8 above ',5,5',6,6'-D 9 [A'], the target compound in the following Table 7 was synthesized in the same manner as in the preparation of Preparation Example 8. [Table 7] Compound number Intermediate A Intermediate A' target compound 3-3
Figure 02_image365
Figure 02_image367
Figure 02_image369
3-5
Figure 02_image367
Figure 02_image372
Figure 02_image374
3-6
Figure 02_image367
Figure 02_image376
Figure 02_image378
3-8
Figure 02_image365
Figure 02_image365
Figure 02_image381
3-19
Figure 02_image376
Figure 02_image376
Figure 02_image384
3-22
Figure 02_image386
Figure 02_image386
Figure 02_image389
Preparation Example 9 : Preparation of Compound 3-26
Figure 02_image391
1 ) Preparation of compound 3-26-2

將9H,9'H-3,3'-雙咔唑(12.0克,36.2毫莫耳/升)及三氟甲磺酸(CF 3CO 3H)(80.1毫升,905.0毫莫耳/升)放入並溶解於苯-d6(100毫升)中,且然後在40℃下進行了回流。反應完成後,放入了蒸餾水及二氯甲烷(DCM)且在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化,以獲得8.9克目標化合物3-26-2(收率71%)。 2 )化合物 3-26-1 的製備 9H,9'H-3,3'-biscarbazole (12.0 g, 36.2 mmol/L) and trifluoromethanesulfonic acid (CF 3 CO 3 H) (80.1 mL, 905.0 mmol/L) Put and dissolved in benzene-d6 (100 ml), and then refluxed at 40°C. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extraction was performed at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) to obtain 8.9 g of the target compound 3-26-2 (yield 71%). 2 ) Preparation of compound 3-26-1

將化合物3-26-2(5.5克,15.8毫莫耳/升)、4-溴-1,1'-聯苯[B](3.7克,15.8毫莫耳/升)、碘化銅(I)(CuI)(3.0克,15.8毫莫耳/升)、反-1,2-二胺基環己烷(1.9毫升,15.8毫莫耳/升)及磷酸三鉀(K 3PO 4)(3.3克,31.6毫莫耳/升)放入並溶解於1,4-二噁烷(100毫升)中,且然後回流了24小時。反應完成後,放入了蒸餾水及二氯甲烷(DCM)且在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化並自甲醇重結晶,以獲得6.5克目標化合物3-26-1(收率83%)。 3 )化合物 3-26 的製備 Compound 3-26-2 (5.5 g, 15.8 mmol/L), 4-bromo-1,1'-biphenyl [B] (3.7 g, 15.8 mmol/L), copper iodide (I )(CuI) (3.0 g, 15.8 mmol/L), trans-1,2-diaminocyclohexane (1.9 mL, 15.8 mmol/L) and tripotassium phosphate (K 3 PO 4 ) ( 3.3 g, 31.6 mmol/L) was put into and dissolved in 1,4-dioxane (100 mL), and then refluxed for 24 hours. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extraction was performed at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) and recrystallized from methanol to obtain 6.5 g of the target compound 3-26-1 (yield 83%). 3 ) Preparation of compound 3-26

將化合物3-26-1(14.0克,28.0毫莫耳/升)、4-溴-1,1'-聯苯[B'](6.8克,28.0毫莫耳/升)、碘化銅(I)(CuI)(0.53克,2.8毫莫耳/升)、反-1,2-二胺基環己烷(0.32克,2.8毫莫耳/升)及磷酸三鉀(K 3PO 4)(11.9克,56.0毫莫耳/升)放入並溶解於1,4-二噁烷(140毫升)中,且然後在125℃下回流了8小時。反應完成後,放入了蒸餾水及二氯甲烷(DCM)且在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化並自甲醇重結晶,以獲得15.8克目標化合物3-26(收率87%)。 Compound 3-26-1 (14.0 g, 28.0 mmol/L), 4-bromo-1,1'-biphenyl [B'] (6.8 g, 28.0 mmol/L), copper iodide ( I) (CuI) (0.53 g, 2.8 mmol/L), trans-1,2-diaminocyclohexane (0.32 g, 2.8 mmol/L) and tripotassium phosphate (K 3 PO 4 ) (11.9 g, 56.0 mmol/l) was put into and dissolved in 1,4-dioxane (140 ml), and then refluxed at 125°C for 8 hours. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extraction was performed at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) and recrystallized from methanol to obtain 15.8 g of target compound 3-26 (yield 87%).

當化合物B與化合物B'相同時,藉由放入2當量以上製備例9中的化合物B,可直接合成出目標化合物。亦即,當化合物B與化合物B'相同時,可省略以上化合物3-26-1的製備。When compound B is the same as compound B', the target compound can be directly synthesized by adding more than 2 equivalents of compound B in Preparation Example 9. That is, when compound B is the same as compound B', the preparation of the above compound 3-26-1 can be omitted.

藉由在以上製備例9中使用下表8的中間體B代替4-溴-1,1'-聯苯[B]且使用下表8的中間體B'代替4-溴-1,1'-聯苯[B'],以與製備例9的製備中相同的方式合成出了下表8的目標化合物。 [表8] 化合物編號 中間體 B 中間體 B' 目標化合物 3-26

Figure 02_image393
Figure 02_image393
Figure 02_image396
3-27
Figure 02_image398
Figure 02_image400
Figure 02_image402
3-29
Figure 02_image404
Figure 02_image400
Figure 02_image407
3-32
Figure 02_image409
Figure 02_image409
Figure 02_image412
3-33
Figure 02_image393
Figure 02_image409
Figure 02_image416
3-36
Figure 02_image418
Figure 02_image409
Figure 02_image421
3-39
Figure 02_image418
Figure 02_image393
Figure 02_image425
3-44
Figure 02_image427
Figure 02_image393
Figure 02_image430
製備例 10 :化合物 3-50 的製備
Figure 02_image432
1 )化合物 3-50-1 的製備 By using intermediate B of Table 8 below in place of 4-bromo-1,1'-biphenyl [B] and intermediate B' of Table 8 below in place of 4-bromo-1,1' in Preparation 9 above - Biphenyl [B'], the target compound in Table 8 below was synthesized in the same manner as in the preparation of Preparation Example 9. [Table 8] Compound number Intermediate B Intermediate B' target compound 3-26
Figure 02_image393
Figure 02_image393
Figure 02_image396
3-27
Figure 02_image398
Figure 02_image400
Figure 02_image402
3-29
Figure 02_image404
Figure 02_image400
Figure 02_image407
3-32
Figure 02_image409
Figure 02_image409
Figure 02_image412
3-33
Figure 02_image393
Figure 02_image409
Figure 02_image416
3-36
Figure 02_image418
Figure 02_image409
Figure 02_image421
3-39
Figure 02_image418
Figure 02_image393
Figure 02_image425
3-44
Figure 02_image427
Figure 02_image393
Figure 02_image430
Preparation Example 10 : Preparation of Compound 3-50
Figure 02_image432
1 ) Preparation of compound 3-50-1

將9-([1,1'-聯苯基]-4-基)-9H,9'H-3,3'-雙咔唑(13.6克,28.0毫莫耳/升)、4-溴-1,1'-聯苯(6.8克,28.0毫莫耳/升)、碘化銅(I)(CuI)(0.53克,2.8毫莫耳/升)、反-1,2-二胺基環己烷(0.32克,2.8毫莫耳/升)及磷酸三鉀(K 3PO 4)(11.9克,56.0毫莫耳/升)放入並溶解於1,4-二噁烷(140毫升)中,且在125℃下回流了8小時。反應完成後,放入了蒸餾水及二氯甲烷(DCM)且在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化並自甲醇重結晶,以獲得15.9克目標化合物3-50-1(收率89%)。 2 )化合物 3-50 的製備 9-([1,1'-biphenyl]-4-yl)-9H,9'H-3,3'-biscarbazole (13.6 g, 28.0 mmol/L), 4-bromo- 1,1'-biphenyl (6.8 g, 28.0 mmol/L), copper(I) iodide (CuI) (0.53 g, 2.8 mmol/L), trans-1,2-diaminocyclo Hexane (0.32 g, 2.8 mmol/L) and tripotassium phosphate (K 3 PO 4 ) (11.9 g, 56.0 mmol/L) were put into and dissolved in 1,4-dioxane (140 mL) and reflux at 125°C for 8 hours. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extraction was performed at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) and recrystallized from methanol to obtain 15.9 g of the target compound 3-50-1 (yield 89%). 2 ) Preparation of compound 3-50

將化合物3-50-1(23.0克,36.2毫莫耳/升)及三氟甲磺酸(CF 3CO 3H)(80.1毫升,905.0毫莫耳/升)放入並溶解於苯-d6(100毫升)中,且然後在40℃下進行了回流。反應完成後,放入了蒸餾水及二氯甲烷(DCM)且在室溫下進行了萃取。此後,用硫酸鎂(MgSO 4)自有機層移除了水分,且然後使用旋轉蒸發器移除了溶劑。藉由管柱層析法(DCM:己烷=1:3)對反應產物進行了純化,以獲得16.9克目標化合物3-50(收率70%)。 Compound 3-50-1 (23.0 g, 36.2 mmol/L) and trifluoromethanesulfonic acid (CF 3 CO 3 H) (80.1 mL, 905.0 mmol/L) were put into and dissolved in benzene-d6 (100 ml), and then refluxed at 40 °C. After the reaction was completed, distilled water and dichloromethane (DCM) were added and extraction was performed at room temperature. Thereafter, moisture was removed from the organic layer with magnesium sulfate (MgSO 4 ), and then the solvent was removed using a rotary evaporator. The reaction product was purified by column chromatography (DCM:hexane=1:3) to obtain 16.9 g of target compound 3-50 (yield 70%).

藉由在以上製備例10中使用下表9的中間體C代替9-([1,1'-聯苯基]-4-基)-9H,9'H-3,3'-雙咔唑且使用下表9的中間體C'代替4-溴-1,1'-聯苯,以與製備例10的製備中相同的方式合成出了下表9的目標化合物。 [表9] 化合物編號 中間體C 中間體C' 目標化合物 3-50

Figure 02_image434
Figure 02_image393
Figure 02_image437
3-51
Figure 02_image439
Figure 02_image441
Figure 02_image443
3-53
Figure 02_image439
Figure 02_image404
Figure 02_image446
3-56
Figure 02_image448
Figure 02_image409
Figure 02_image450
3-57
Figure 02_image448
Figure 02_image393
Figure 02_image454
3-58
Figure 02_image448
Figure 02_image456
Figure 02_image458
3-60
Figure 02_image448
Figure 02_image460
Figure 02_image462
3-62
Figure 02_image434
Figure 02_image404
Figure 02_image465
3-63
Figure 02_image434
Figure 02_image460
Figure 02_image468
3-67
Figure 02_image470
Figure 02_image460
Figure 02_image473
3-68
Figure 02_image434
Figure 02_image476
Figure 02_image478
By replacing 9-([1,1'-biphenyl]-4-yl)-9H,9'H-3,3'-biscarbazole in the above Preparation 10 by using Intermediate C of Table 9 below And using the intermediate C' in Table 9 below instead of 4-bromo-1,1'-biphenyl, the target compound in Table 9 below was synthesized in the same manner as in Preparation Example 10. [Table 9] Compound number Intermediate C Intermediate C' target compound 3-50
Figure 02_image434
Figure 02_image393
Figure 02_image437
3-51
Figure 02_image439
Figure 02_image441
Figure 02_image443
3-53
Figure 02_image439
Figure 02_image404
Figure 02_image446
3-56
Figure 02_image448
Figure 02_image409
Figure 02_image450
3-57
Figure 02_image448
Figure 02_image393
Figure 02_image454
3-58
Figure 02_image448
Figure 02_image456
Figure 02_image458
3-60
Figure 02_image448
Figure 02_image460
Figure 02_image462
3-62
Figure 02_image434
Figure 02_image404
Figure 02_image465
3-63
Figure 02_image434
Figure 02_image460
Figure 02_image468
3-67
Figure 02_image470
Figure 02_image460
Figure 02_image473
3-68
Figure 02_image434
Figure 02_image476
Figure 02_image478

除了以上製備例1至製備例10及表1至表9中闡述的化合物以外的其餘化合物亦是以與上述製備例中相同的方式製備,且合成結果示出於以下表10及表11中。下表10是 1H核磁共振(nuclear magnetic resonance,NMR)(CDCl 3,200Mz)的量測值,且下表11是場脫附質譜(field desorption mass spectrometry,FD-MS)的量測值。 [表10] 化合物編號 1 H NMR CDCl 3 200 Mz 1-1 δ= 8.36 (4H, d), 7.50 (6H, m) 1-3 δ= 8.38~8.36 (3H, m), 7.94 (1H, s), 7.75~7.73 (3H, m), 7.61 (1H, d), 7.50~7.41(6H, m) 1-4 δ= 8.36 (2H, d), 7.96 (2H, d), 7.75 (2H, m), 7.50~7.41(6H, m), 7.25(2H, d) 1-26 δ= 7.96 (4H, d), 7.75 (4H, m), 7.49~7.41(6H, m), 7.25(4H, d) 1-32 δ= 8.36 (2H, d), 8.03~7.98 (2H, m), 7.82~7.76 (2H, m), 7.54~7.50(4H, m), 7.39~7.31 (2H, m) 1-56 δ = 100%氘含量,無峰值 1-61 δ= 8.36 (4H, d), 7.50 (6H, m) 1-64 δ= 8.36 (2H, d), 7.96 (2H, d), 7.75 (2H, m), 7.50~7.41(6H, m), 7.25(2H, d) 1-114 δ = 100%氘含量,無峰值 1-121 δ= 8.36 (4H, d), 7.50 (6H, m), 1.69 (6H, s) 1-123 δ= 8.38~8.36 (3H, m), 7.94 (1H, s), 7.75~7.73 (3H, m), 7.61 (1H, d), 7.50~7.41(6H, m), 1.69 (6H, s) 1-156 δ= 8.45 (1H, d), 8.38 (2H, d), 8.24~8.20 (2H, m), 7.94 (1H, d), 7.56~7.49 (5H, m), 1.69 (6H, s) 1-175 δ = 100%氘含量,無峰值 1-181 δ= 8.36 (4H, d), 7.50 (6H, m) 1-183 δ= 8.38~8.36 (3H, m), 7.94 (1H, s), 7.75~7.73 (3H, m), 7.61 (1H, d), 7.50~7.41(6H, m) 1-184 δ= 8.36 (2H, d), 7.96 (2H, d), 7.75 (2H, m), 7.50~7.41(6H, m), 7.25(2H, d) 1-238 δ = 100%氘含量,無峰值 1-241 δ= 8.36 (4H, d), 7.50 (6H, m) 1-243 δ= 8.38~8.36 (3H, m), 7.94 (1H, s), 7.75~7.73 (3H, m), 7.61 (1H, d), 7.50~7.41(6H, m) 1-244 δ= 8.36 (2H, d), 7.96 (2H, d), 7.75 (2H, m), 7.50~7.41(6H, m), 7.25(2H, d) 1-264 δ= 8.38 (2H, d), 7.94 (2H, s), 7.75~7.73 (6H, m), 7.61 (2H, d), 7.49~7.41(6H, m) 1-265 δ= 8.38 (1H, d), 7.96~7.94 (3H, m), 7.75~7.73 (5H, m), 7.61 (1H, d), 7.49~7.41(6H, m), 7.25 (2H, d) 1-272 δ= 8.36 (2H, d), 8.03~7.98 (2H, m), 7.82~7.76 (2H, m), 7.54~7.50(4H, m), 7.39~7.31 (2H, m) 1-294 δ = 100%氘含量,無峰值 1-295 δ = 100%氘含量,無峰值 1-296 δ = 100%氘含量,無峰值 1-301 δ= 8.36 (4H, d), 7.50 (6H, m), 1.69 (6H, s) 1-304 δ= 8.36 (2H, d), 7.96 (2H, d), 7.75 (2H, m), 7.50~7.41(6H, m), 7.25(2H, d) 1-356 δ = 100%氘含量,無峰值 1-361 δ= 8.36 (4H, d), 7.50 (6H, m) 1-372 δ= 8.36 (2H, d), 8.03~7.98 (2H, m), 7.82~7.76 (2H, m), 7.54~7.50(4H, m), 7.39~7.31 (2H, m) 1-379 δ = 100%氘含量,無峰值 1-381 δ= 8.36 (4H, d), 7.50 (6H, m) 1-383 δ= 8.36 (2H, d), 7.96 (2H, d), 7.75 (2H, m), 7.50~7.41(6H, m), 7.25(2H, d) 1-398 δ = 100%氘含量,無峰值 1-401 δ= 8.36 (4H, d), 7.50 (6H, m), 1.69 (6H, s) 1-408 δ= 9.27 (1H, s), 8.79 (1H, d), 8.36~8.30 (5H, m), 8.15 (1H, d), 7.70~7.64 (4H, m), 7.52~7.50 (4H, m), 1.69 (6H, s) 1-416 δ = 100%氘含量,無峰值 1-421 δ= 8.36 (4H, d), 7.50 (6H, m) 1-423 δ= 8.36 (2H, d), 7.96 (2H, d), 7.75 (2H, m), 7.50~7.41(6H, m), 7.25(2H, d) 1-436 δ = 100%氘含量,無峰值 1-441 δ= 8.36 (4H, d), 7.50 (6H, m), 1.69 (6H, s) 1-442 δ= 8.38~8.36 (3H, m), 7.94 (1H, s), 7.75~7.73 (3H, m), 7.61 (1H, d), 7.50~7.41(6H, m), 1.69 (6H, s) 1-455 δ = 100%氘含量,無峰值 1-461 δ= 8.36 (4H, d), 7.50 (6H, m), 1.69 (12H, s) 1-477 δ= 8.38~8.36 (3H, m), 7.94 (1H, s), 7.75~7.73 (3H, m), 7.61 (1H, d), 7.50~7.41(6H, m), 1.69 (12H, s) 2-42 δ= 8.55 (1H, d), 8.30 (1H, d), 8.19~8.13 (2H, m), 7.99~7.89 (12H, m), 7.77~7.75 (5H, m), 7.50~7.35 (8H, m), 7.20~7.16 (2H, m) 3-2 δ= 8.55 (1H, d), 8.30 (1H, d), 8.19~8.13 (2H, m), 7.99~7.89 (4H, m), 7.77 (1H, d), 7.58~7.50 (2H, m), 7.35 (1H, m), 7.20~7.16 (2H, m) 3-26 δ= 7.92 (4H, d), 7.91 (4H, d), 7.75 (2H, d), 7.49~7.41 (6H, m) 3-50 δ = 100%氘含量,無峰值 [表11] 化合物 FD-MS 化合物 FD-MS 1-1 化學式:C 39H 10D 12N 4O 2精確質量:590.250 分子量:590.704 1-3 化學式:C 45H 14D 12N 4O 2精確質量:666.281 分子量:666.802 1-4 化學式:C 45H 14D 12N 4O 2精確質量:666.281 分子量:666.802 1-26 化學式:C 51H 18D 12N 4O 2精確質量:742.312 分子量:742.900 1-32 化學式:C 45H 12D 12N 4O 3精確質量:680.260 分子量:680.785 1-56 化學式:C 51D 30N 4O 2精確質量:760.425 分子量:761.010 1-61 化學式:C 39H 10D 12N 4OS 精確質量:606.227 分子量:606.765 1-64 化學式:C 45H 14D 12N 4OS 精確質量:682.258 分子量:682.863 1-114 化學式:C 45D 26N 4OS 精確質量:696.346 分子量:696.949 1-121 化學式:C 42H 16D 12N 4O 精確質量:616.302 分子量:616.786 1-123 化學式:C 48H 20D 12N 4O 精確質量:692.333 分子量:692.884 1-156 化學式:C 48H 18D 12N 4OS 精確質量:722.289 分子量:722.928 1-175 化學式:C 54H 6D 30N 4O 精確質量:786.477 分子量:787.092 1-181 化學式:C 39H 10D 12N 4OS 精確質量:606.227 分子量:606.765 1-183 化學式:C 45H 14D 12N 4OS 精確質量:682.258 分子量:682.863 1-184 化學式:C 45H 14D 12N 4OS 精確質量:682.258 分子量:682.863 1-238 化學式:C 45D 24N 4O 2S 精確質量:708.313 分子量:708.919 1-241 化學式:C 39H 10D 12N 4S 2精確質量:622.204 分子量:622.826 1-243 化學式:C 45H 14D 12N 4S 2精確質量:698.235 分子量:698.924 1-244 化學式:C 45H 14D 12N 4S 2精確質量:698.235 分子量:698.924 1-264 化學式:C 51H 18D 12N 4S 2精確質量:774.267 分子量:775.022 1-265 化學式:C 51H 18D 12N 4S 2精確質量:774.267 分子量:775.022 1-272 化學式:C 45H 12D 12N 4OS 2精確質量:712.214 分子量:712.907 1-294 化學式:C 45D 26N 4S 2精確質量:712.323 分子量:713.010 1-295 化學式:C 51D 30N 4S 2精確質量:792.379 分子量:793.132 1-296 化學式:C 51D 30N 4S 2精確質量:792.379 分子量:793.132 1-301 化學式:C 42H 16D 12N 4S 精確質量:632.279 分子量:632.847 1-304 化學式:C 48H 20D 12N 4S 精確質量:708.310 分子量:708.945 1-356 化學式:C 54H 6D 30N 4S 精確質量:802.454 分子量:803.153 1-361 化學式:C 39H 10D 12N 4O 2精確質量:590.250 分子量:590.704 1-372 化學式:C 45H 12D 12N 4O 3精確質量:680.260 分子量:680.785 1-379 化學式:C 45D 24N 4O 3精確質量:692.335 分子量:692.858 1-381 化學式:C 39H 10D 12N 4OS 精確質量:606.227 分子量:606.765 1-383 化學式:C 45H 14D 12N 4OS 精確質量:682.258 分子量:682.863 1-398 化學式:C 51D 28N 4OS 精確質量:772.374 分子量:773.043 1-401 化學式:C 42H 16D 12N 4O精確質量:616.302 分子量:616.786 1-408 化學式:C 54H 22D 12N 4O 精確質量:766.349 分子量:766.966 1-416 化學式:C 48H 6D 26N 4O 精確質量:706.421 分子量:706.970 1-421 化學式:C 39H 10D 12N 4S 2精確質量:622.204 分子量:622.826 1-423 化學式:C 45H 14D 12N 4S 2精確質量:698.235 分子量:698.924 1-436 化學式:C 45D 26N 4S 2精確質量:712.323 分子量:713.010 1-441 化學式:C 42H 16D 12N 4S 精確質量:632.279 分子量:632.847 1-442 化學式:C 48H 20D 12N 4S 精確質量:708.310 分子量:708.945 1-455 化學式:C 48H 6D 26N 4S 精確質量:722.398 分子量:723.031 1-461 化學式:C 45H 22D 12N 4精確質量:642.354 分子量:642.868 1-477 化學式:C 57H 12D 30N 4精確質量:812.529 分子量:813.174 2-42 化學式:C 48H 32N 2精確質量:636.257 分子量:636.798 3-2 化學式:C 48H 14D 18N 2精確質量:654.370 分子量:654.908 3-26 化學式:C 48H 18D 14N 2精確質量:650.344 分子量:650.883 3-50 化學式:C 48D 32N 2精確質量:668.457 分子量:668.993 實驗例 實驗例 1> 1 )有機發光元件的製造 Compounds other than those described in the above Preparation Examples 1 to 10 and Tables 1 to 9 were also prepared in the same manner as in the above Preparation Examples, and the synthesis results are shown in Table 10 and Table 11 below. Table 10 below is the measured value of 1 H nuclear magnetic resonance (nuclear magnetic resonance, NMR) (CDCl 3 , 200Mz), and Table 11 below is the measured value of field desorption mass spectrometry (FD-MS). [Table 10] Compound number 1 H NMR ( CDCl 3 , 200 Mz ) 1-1 δ= 8.36 (4H, d), 7.50 (6H, m) 1-3 δ= 8.38~8.36 (3H, m), 7.94 (1H, s), 7.75~7.73 (3H, m), 7.61 (1H, d), 7.50~7.41(6H, m) 1-4 δ= 8.36 (2H, d), 7.96 (2H, d), 7.75 (2H, m), 7.50~7.41(6H, m), 7.25(2H, d) 1-26 δ= 7.96 (4H, d), 7.75 (4H, m), 7.49~7.41(6H, m), 7.25(4H, d) 1-32 δ= 8.36 (2H, d), 8.03~7.98 (2H, m), 7.82~7.76 (2H, m), 7.54~7.50(4H, m), 7.39~7.31 (2H, m) 1-56 δ = 100% deuterium content, no peaks 1-61 δ= 8.36 (4H, d), 7.50 (6H, m) 1-64 δ= 8.36 (2H, d), 7.96 (2H, d), 7.75 (2H, m), 7.50~7.41(6H, m), 7.25(2H, d) 1-114 δ = 100% deuterium content, no peaks 1-121 δ= 8.36 (4H, d), 7.50 (6H, m), 1.69 (6H, s) 1-123 δ= 8.38~8.36 (3H, m), 7.94 (1H, s), 7.75~7.73 (3H, m), 7.61 (1H, d), 7.50~7.41(6H, m), 1.69 (6H, s) 1-156 δ= 8.45 (1H, d), 8.38 (2H, d), 8.24~8.20 (2H, m), 7.94 (1H, d), 7.56~7.49 (5H, m), 1.69 (6H, s) 1-175 δ = 100% deuterium content, no peaks 1-181 δ= 8.36 (4H, d), 7.50 (6H, m) 1-183 δ= 8.38~8.36 (3H, m), 7.94 (1H, s), 7.75~7.73 (3H, m), 7.61 (1H, d), 7.50~7.41(6H, m) 1-184 δ= 8.36 (2H, d), 7.96 (2H, d), 7.75 (2H, m), 7.50~7.41(6H, m), 7.25(2H, d) 1-238 δ = 100% deuterium content, no peaks 1-241 δ= 8.36 (4H, d), 7.50 (6H, m) 1-243 δ= 8.38~8.36 (3H, m), 7.94 (1H, s), 7.75~7.73 (3H, m), 7.61 (1H, d), 7.50~7.41(6H, m) 1-244 δ= 8.36 (2H, d), 7.96 (2H, d), 7.75 (2H, m), 7.50~7.41(6H, m), 7.25(2H, d) 1-264 δ= 8.38 (2H, d), 7.94 (2H, s), 7.75~7.73 (6H, m), 7.61 (2H, d), 7.49~7.41(6H, m) 1-265 δ= 8.38 (1H, d), 7.96~7.94 (3H, m), 7.75~7.73 (5H, m), 7.61 (1H, d), 7.49~7.41(6H, m), 7.25 (2H, d) 1-272 δ= 8.36 (2H, d), 8.03~7.98 (2H, m), 7.82~7.76 (2H, m), 7.54~7.50(4H, m), 7.39~7.31 (2H, m) 1-294 δ = 100% deuterium content, no peaks 1-295 δ = 100% deuterium content, no peaks 1-296 δ = 100% deuterium content, no peaks 1-301 δ= 8.36 (4H, d), 7.50 (6H, m), 1.69 (6H, s) 1-304 δ= 8.36 (2H, d), 7.96 (2H, d), 7.75 (2H, m), 7.50~7.41(6H, m), 7.25(2H, d) 1-356 δ = 100% deuterium content, no peaks 1-361 δ= 8.36 (4H, d), 7.50 (6H, m) 1-372 δ= 8.36 (2H, d), 8.03~7.98 (2H, m), 7.82~7.76 (2H, m), 7.54~7.50(4H, m), 7.39~7.31 (2H, m) 1-379 δ = 100% deuterium content, no peaks 1-381 δ= 8.36 (4H, d), 7.50 (6H, m) 1-383 δ= 8.36 (2H, d), 7.96 (2H, d), 7.75 (2H, m), 7.50~7.41(6H, m), 7.25(2H, d) 1-398 δ = 100% deuterium content, no peaks 1-401 δ= 8.36 (4H, d), 7.50 (6H, m), 1.69 (6H, s) 1-408 δ= 9.27 (1H, s), 8.79 (1H, d), 8.36~8.30 (5H, m), 8.15 (1H, d), 7.70~7.64 (4H, m), 7.52~7.50 (4H, m), 1.69 (6H, s) 1-416 δ = 100% deuterium content, no peaks 1-421 δ= 8.36 (4H, d), 7.50 (6H, m) 1-423 δ= 8.36 (2H, d), 7.96 (2H, d), 7.75 (2H, m), 7.50~7.41(6H, m), 7.25(2H, d) 1-436 δ = 100% deuterium content, no peaks 1-441 δ= 8.36 (4H, d), 7.50 (6H, m), 1.69 (6H, s) 1-442 δ= 8.38~8.36 (3H, m), 7.94 (1H, s), 7.75~7.73 (3H, m), 7.61 (1H, d), 7.50~7.41(6H, m), 1.69 (6H, s) 1-455 δ = 100% deuterium content, no peaks 1-461 δ= 8.36 (4H, d), 7.50 (6H, m), 1.69 (12H, s) 1-477 δ= 8.38~8.36 (3H, m), 7.94 (1H, s), 7.75~7.73 (3H, m), 7.61 (1H, d), 7.50~7.41(6H, m), 1.69 (12H, s) 2-42 δ= 8.55 (1H, d), 8.30 (1H, d), 8.19~8.13 (2H, m), 7.99~7.89 (12H, m), 7.77~7.75 (5H, m), 7.50~7.35 (8H, m ), 7.20~7.16 (2H, m) 3-2 δ= 8.55 (1H, d), 8.30 (1H, d), 8.19~8.13 (2H, m), 7.99~7.89 (4H, m), 7.77 (1H, d), 7.58~7.50 (2H, m), 7.35 (1H, m), 7.20~7.16 (2H, m) 3-26 δ= 7.92 (4H, d), 7.91 (4H, d), 7.75 (2H, d), 7.49~7.41 (6H, m) 3-50 δ = 100% deuterium content, no peaks [Table 11] compound FD-MS compound FD-MS 1-1 Chemical formula: C 39 H 10 D 12 N 4 O 2 Exact mass: 590.250 Molecular weight: 590.704 1-3 Chemical formula: C 45 H 14 D 12 N 4 O 2 Exact mass: 666.281 Molecular weight: 666.802 1-4 Chemical formula: C 45 H 14 D 12 N 4 O 2 Exact mass: 666.281 Molecular weight: 666.802 1-26 Chemical formula: C 51 H 18 D 12 N 4 O 2 Exact mass: 742.312 Molecular weight: 742.900 1-32 Chemical formula: C 45 H 12 D 12 N 4 O 3 Exact mass: 680.260 Molecular weight: 680.785 1-56 Chemical formula: C 51 D 30 N 4 O 2 Exact mass: 760.425 Molecular weight: 761.010 1-61 Chemical formula: C 39 H 10 D 12 N 4 OS Exact mass: 606.227 Molecular weight: 606.765 1-64 Chemical formula: C 45 H 14 D 12 N 4 OS Exact mass: 682.258 Molecular weight: 682.863 1-114 Chemical formula: C 45 D 26 N 4 OS Exact mass: 696.346 Molecular weight: 696.949 1-121 Chemical formula: C 42 H 16 D 12 N 4 O Exact mass: 616.302 Molecular weight: 616.786 1-123 Chemical formula: C 48 H 20 D 12 N 4 O Exact mass: 692.333 Molecular weight: 692.884 1-156 Chemical formula: C 48 H 18 D 12 N 4 OS Exact mass: 722.289 Molecular weight: 722.928 1-175 Chemical formula: C 54 H 6 D 30 N 4 O Exact mass: 786.477 Molecular weight: 787.092 1-181 Chemical formula: C 39 H 10 D 12 N 4 OS Exact mass: 606.227 Molecular weight: 606.765 1-183 Chemical formula: C 45 H 14 D 12 N 4 OS Exact mass: 682.258 Molecular weight: 682.863 1-184 Chemical formula: C 45 H 14 D 12 N 4 OS Exact mass: 682.258 Molecular weight: 682.863 1-238 Chemical formula: C 45 D 24 N 4 O 2 S Exact mass: 708.313 Molecular weight: 708.919 1-241 Chemical formula: C 39 H 10 D 12 N 4 S 2 Exact mass: 622.204 Molecular weight: 622.826 1-243 Chemical formula: C 45 H 14 D 12 N 4 S 2 Exact mass: 698.235 Molecular weight: 698.924 1-244 Chemical formula: C 45 H 14 D 12 N 4 S 2 Exact mass: 698.235 Molecular weight: 698.924 1-264 Chemical formula: C 51 H 18 D 12 N 4 S 2 Exact mass: 774.267 Molecular weight: 775.022 1-265 Chemical formula: C 51 H 18 D 12 N 4 S 2 Exact mass: 774.267 Molecular weight: 775.022 1-272 Chemical formula: C 45 H 12 D 12 N 4 OS 2 Exact mass: 712.214 Molecular weight: 712.907 1-294 Chemical formula: C 45 D 26 N 4 S 2 Exact mass: 712.323 Molecular weight: 713.010 1-295 Chemical formula: C 51 D 30 N 4 S 2 Exact mass: 792.379 Molecular weight: 793.132 1-296 Chemical formula: C 51 D 30 N 4 S 2 Exact mass: 792.379 Molecular weight: 793.132 1-301 Chemical formula: C 42 H 16 D 12 N 4 S Exact mass: 632.279 Molecular weight: 632.847 1-304 Chemical formula: C 48 H 20 D 12 N 4 S Exact mass: 708.310 Molecular weight: 708.945 1-356 Chemical formula: C 54 H 6 D 30 N 4 S Exact mass: 802.454 Molecular weight: 803.153 1-361 Chemical formula: C 39 H 10 D 12 N 4 O 2 Exact mass: 590.250 Molecular weight: 590.704 1-372 Chemical formula: C 45 H 12 D 12 N 4 O 3 Exact mass: 680.260 Molecular weight: 680.785 1-379 Chemical formula: C 45 D 24 N 4 O 3 Exact mass: 692.335 Molecular weight: 692.858 1-381 Chemical formula: C 39 H 10 D 12 N 4 OS Exact mass: 606.227 Molecular weight: 606.765 1-383 Chemical formula: C 45 H 14 D 12 N 4 OS Exact mass: 682.258 Molecular weight: 682.863 1-398 Chemical formula: C 51 D 28 N 4 OS Exact mass: 772.374 Molecular weight: 773.043 1-401 Chemical formula: C 42 H 16 D 12 N 4O Exact mass: 616.302 Molecular weight: 616.786 1-408 Chemical formula: C 54 H 22 D 12 N 4 O Exact mass: 766.349 Molecular weight: 766.966 1-416 Chemical formula: C 48 H 6 D 26 N 4 O Exact mass: 706.421 Molecular weight: 706.970 1-421 Chemical formula: C 39 H 10 D 12 N 4 S 2 Exact mass: 622.204 Molecular weight: 622.826 1-423 Chemical formula: C 45 H 14 D 12 N 4 S 2 Exact mass: 698.235 Molecular weight: 698.924 1-436 Chemical formula: C 45 D 26 N 4 S 2 Exact mass: 712.323 Molecular weight: 713.010 1-441 Chemical formula: C 42 H 16 D 12 N 4 S Exact mass: 632.279 Molecular weight: 632.847 1-442 Chemical formula: C 48 H 20 D 12 N 4 S Exact mass: 708.310 Molecular weight: 708.945 1-455 Chemical formula: C 48 H 6 D 26 N 4 S Exact mass: 722.398 Molecular weight: 723.031 1-461 Chemical formula: C 45 H 22 D 12 N 4 Exact mass: 642.354 Molecular weight: 642.868 1-477 Chemical formula: C 57 H 12 D 30 N 4 Exact mass: 812.529 Molecular weight: 813.174 2-42 Chemical formula: C 48 H 32 N 2 Exact mass: 636.257 Molecular weight: 636.798 3-2 Chemical formula: C 48 H 14 D 18 N 2 Exact mass: 654.370 Molecular weight: 654.908 3-26 Chemical formula: C 48 H 18 D 14 N 2 Exact mass: 650.344 Molecular weight: 650.883 3-50 Chemical formula: C 48 D 32 N 2 Exact mass: 668.457 Molecular weight: 668.993 < Experimental example > < Experimental example 1> ( 1 ) Production of organic light-emitting element

用蒸餾水超音波對上面塗佈有厚度為1,500埃的氧化銦錫(ITO)薄膜的玻璃基板進行了清潔。在用蒸餾水清潔完成之後,用溶劑(例如丙酮、甲醇及異丙醇)對基板進行了超音波清潔,且進行了乾燥,且然後在紫外線(ultraviolet,UV)清潔器中使用UV進行了5分鐘的紫外線臭氧(ultraviolet ozone,UVO)處置。此後,將基板轉移至電漿清潔器(PT),且然後,為了在真空狀態下提高ITO的功函數以及移除殘留膜,對基板進行了電漿處置,以使得基板被轉移至熱沈積設備以進行有機沈積。A glass substrate coated with a 1,500 angstrom thick film of indium tin oxide (ITO) was ultrasonically cleaned with distilled water. After cleaning with distilled water, the substrates were ultrasonically cleaned with solvents such as acetone, methanol, and isopropanol, dried, and then treated with UV in an ultraviolet (UV) cleaner for 5 minutes Ultraviolet ozone (UVO) treatment. Thereafter, the substrate was transferred to a plasma cleaner (PT), and then, in order to improve the work function of ITO and remove the residual film in a vacuum state, the substrate was subjected to plasma treatment so that the substrate was transferred to a thermal deposition equipment for organic deposition.

在透明ITO電極(正電極)上,沈積了4,4',4''-三[2-萘基(苯基)胺基]三苯基胺(4,4',4''-tris[2-naphthyl(phenyl)amino]triphenylamine,2-TNATA)來作為電洞注入層(其為共用層),且沈積了N,N'-二(1-萘基)-N,N'-二苯基-(1,1'-聯苯基)-4,4'-二胺(N,N'-di(1-naphthyl)-N,N'-diphenyl-(1,1'-biphenyl)-4,4'-diamine,NPB)來作為電洞傳輸層。

Figure 02_image480
On the transparent ITO electrode (positive electrode), 4,4',4''-tris[2-naphthyl(phenyl)amino]triphenylamine (4,4',4''-tris[ 2-naphthyl(phenyl)amino]triphenylamine, 2-TNATA) as the hole injection layer (which is a common layer), and deposited N,N'-bis(1-naphthyl)-N,N'-diphenyl Base-(1,1'-biphenyl)-4,4'-diamine (N,N'-di(1-naphthyl)-N,N'-diphenyl-(1,1'-biphenyl)-4 ,4'-diamine, NPB) as the hole transport layer.
Figure 02_image480

在以此方式形成電洞注入層及電洞傳輸層之後,如下所述在其上熱真空沈積了發光層。所述發光層是藉由將下表10中闡述的化合物沈積至為400埃的厚度來作為主體並利用Ir(ppy) 3作為綠色磷光摻雜劑以所述發光層的沈積厚度的7重量%的量在所述主體上摻雜Ir(ppy) 3而沈積。 After forming the hole injection layer and the hole transport layer in this way, a light emitting layer was thermally vacuum deposited thereon as described below. The light-emitting layer was host by depositing the compounds set forth in Table 10 below to a thickness of 400 angstroms and utilized Ir(ppy ) as a green phosphorescent dopant at 7% by weight of the deposited thickness of the light-emitting layer An amount of doped Ir(ppy) 3 is deposited on the host.

此後,將浴銅靈(bathocuproine,BCP)作為電洞阻擋層沈積至為60埃的厚度,且在其上將三(8-羥基喹啉)鋁(Alq 3)作為電子傳輸層沈積至為200埃的厚度。

Figure 02_image482
Thereafter, bathocuproine (BCP) was deposited as a hole blocking layer to a thickness of 60 angstroms, and tris(8-hydroxyquinoline) aluminum (Alq 3 ) was deposited thereon as an electron transport layer to a thickness of 200 angstroms. Angstrom thickness.
Figure 02_image482

最後,在電子傳輸層上將氟化鋰(LiF)沈積至為10埃的厚度以形成電子注入層且然後在所述電子注入層上將鋁(Al)負電極沈積至為1,200埃的厚度以形成負電極,以使得製造出了有機發光元件。Finally, lithium fluoride (LiF) was deposited to a thickness of 10 angstroms on the electron transport layer to form an electron injection layer and then an aluminum (Al) negative electrode was deposited to a thickness of 1,200 angstroms on the electron injection layer to A negative electrode was formed so that an organic light emitting element was manufactured.

同時,對於每種材料使製造有機發光元件所需的所有有機化合物分別在10 -8托至10 -6托下經歷真空昇華及純化,並用於製造所述有機發光元件。 2 )有機發光元件的驅動電壓及發光效率 Meanwhile, all organic compounds required for manufacturing an organic light emitting element were subjected to vacuum sublimation and purification at 10 −8 Torr to 10 −6 Torr for each material, respectively, and used to manufacture the organic light emitting element. ( 2 ) Driving voltage and luminous efficiency of organic light-emitting devices

利用邁克科學公司(McScience Inc.)的M7000量測了如上所述製造的有機發光元件的電致發光(electroluminescence,EL)性質,且藉由由邁克科學公司製造的壽命量測系統(M6000)使用量測結果量測了參考亮度為6,000坎德拉/平方米(cd/m 2)時的T 90值。量測根據本揭露製造的有機發光元件的驅動電壓、發光效率、顏色(EL顏色)及壽命的結果如表12中所示。 [表12]    發光層化合物 驅動電壓 (伏) 發光效率 (坎德拉 / 面積) 顏色 EL 顏色 壽命 T 90 實例 1 1-1 4.54 73.7 綠色 331 實例 2 1-3 4.53 74.9 綠色 338 實例 3 1-4 4.53 73.5 綠色 347 實例 4 1-26 4.56 73.2 綠色 352 實例 5 1-32 4.50 75.5 綠色 340 實例 6 1-56 4.86 82.1 綠色 440 實例 7 1-61 4.63 73.5 綠色 368 實例 8 1-64 4.65 73.6 綠色 370 實例 9 1-114 4.81 82.1 綠色 471 實例 10 1-121 4.62 73.1 綠色 363 實例 11 1-123 4.57 77.3 綠色 368 實例 12 1-156 4.69 74.4 綠色 366 實例 13 1-175 4.97 86.2 綠色 455 實例 14 1-181 4.35 75.8 綠色 390 實例 15 1-183 4.59 76.7 綠色 394 實例 16 1-184 4.70 76.3 綠色 402 實例 17 1-238 4.90 85.1 綠色 509 實例 18 1-241 4.38 75.7 綠色 431 實例 19 1-243 4.25 76.6 綠色 424 實例 20 1-244 4.63 73.3 綠色 441 實例 21 1-264 4.33 75.7 綠色 427 實例 22 1-265 4.41 74.5 綠色 435 實例 23 1-272 4.53 74.1 綠色 439 實例 24 1-294 4.94 82.1 綠色 550 實例 25 1-295 4.77 84.6 綠色 532 實例 26 1-296 4.99 80.1 綠色 588 實例 27 1-301 4.40 75.9 綠色 405 實例 28 1-304 4.53 74.6 綠色 415 實例 29 1-356 4.79 83.3 綠色 519 實例 30 1-361 4.33 74.0 綠色 260 實例 31 1-372 4.20 73.5 綠色 266 實例 32 1-379 4.51 82.3 綠色 353 實例 33 1-381 4.45 74.7 綠色 291 實例 34 1-383 4.35 75.1 綠色 297 實例 35 1-398 4.62 83.0 綠色 888 實例 36 1-401 4.55 72.8 綠色 272 實例 37 1-408 4.53 74.9 綠色 277 實例 38 1-416 4.84 83.1 綠色 353 實例 39 1-421 4.50 74.9 綠色 320 實例 40 1-423 4.51 73.9 綠色 326 實例 41 1-436 4.81 82.0 綠色 416 實例 42 1-441 4.45 74.7 綠色 303 實例 43 1-442 4.47 74.4 綠色 311 實例 44 1-455 4.69 83.8 綠色 423 實例 45 1-461 4.56 73.2 綠色 282 實例 46 1-477 4.77 83.5 綠色 395 實例 47 1-481 4.65 73.9 綠色 382 實例 48 1-484 4.32 82.7 綠色 486 實例 49 1-485 4.55 78.2 綠色 374 實例 50 1-488 4.91 87.1 綠色 481 實例 51 1-489 4.58 77.6 綠色 382 實例 52 1-492 4.91 86.8 綠色 489 比較例 1 Ref. 1 5.57 64.8 綠色 160 比較例 2 Ref. 2 5.83 61.2 綠色 170 比較例 3 Ref. 3 5.65 63.7 綠色 164 比較例 4 Ref. 4 5.66 61.0 綠色 188 比較例 5 Ref. 5 5.81 64.3 綠色 198 比較例 6 Ref. 6 5.62 62.5 綠色 193 比較例 7 Ref. 7 5.62 64.3 綠色 130 比較例 8 Ref. 8 5.41 65.5 綠色 149 比較例 9 Ref. 9 5.62 64.6 綠色 138 比較例 10 Ref. 10 5.62 65.1 綠色 157 比較例 11 Ref. 11 5.33 64.2 綠色 153 比較例 12 Ref. 12 5.52 64.4 綠色 142 比較例 13 Ref. 13 5.63 62.5 綠色 183 比較例 14 Ref. 14 5.82 61.2 綠色 181 比較例 15 Ref. 15 5.55 63.5 綠色 176 比較例 16 Ref. 16 5.63 62.1 綠色 185 The electroluminescence (EL) properties of the organic light-emitting element manufactured as described above were measured using M7000 of McScience Inc., and were used by a lifetime measurement system (M6000) manufactured by McScience Inc. Measurement Results The T 90 value was measured at a reference luminance of 6,000 candela/square meter (cd/m 2 ). Table 12 shows the results of measuring the driving voltage, luminous efficiency, color (EL color) and lifetime of the organic light emitting device manufactured according to the present disclosure. [Table 12] Light-emitting layer compound Driving Voltage (Volts) Luminous efficiency (cd / area) Color EL color Lifetime ( T 90 ) Example 1 1-1 4.54 73.7 green 331 Example 2 1-3 4.53 74.9 green 338 Example 3 1-4 4.53 73.5 green 347 Example 4 1-26 4.56 73.2 green 352 Example 5 1-32 4.50 75.5 green 340 Example 6 1-56 4.86 82.1 green 440 Example 7 1-61 4.63 73.5 green 368 Example 8 1-64 4.65 73.6 green 370 Example 9 1-114 4.81 82.1 green 471 Example 10 1-121 4.62 73.1 green 363 Example 11 1-123 4.57 77.3 green 368 Example 12 1-156 4.69 74.4 green 366 Example 13 1-175 4.97 86.2 green 455 Example 14 1-181 4.35 75.8 green 390 Example 15 1-183 4.59 76.7 green 394 Example 16 1-184 4.70 76.3 green 402 Example 17 1-238 4.90 85.1 green 509 Example 18 1-241 4.38 75.7 green 431 Example 19 1-243 4.25 76.6 green 424 Example 20 1-244 4.63 73.3 green 441 Example 21 1-264 4.33 75.7 green 427 Example 22 1-265 4.41 74.5 green 435 Example 23 1-272 4.53 74.1 green 439 Example 24 1-294 4.94 82.1 green 550 Example 25 1-295 4.77 84.6 green 532 Example 26 1-296 4.99 80.1 green 588 Example 27 1-301 4.40 75.9 green 405 Example 28 1-304 4.53 74.6 green 415 Example 29 1-356 4.79 83.3 green 519 Example 30 1-361 4.33 74.0 green 260 Example 31 1-372 4.20 73.5 green 266 Example 32 1-379 4.51 82.3 green 353 Example 33 1-381 4.45 74.7 green 291 Example 34 1-383 4.35 75.1 green 297 Example 35 1-398 4.62 83.0 green 888 Example 36 1-401 4.55 72.8 green 272 Example 37 1-408 4.53 74.9 green 277 Example 38 1-416 4.84 83.1 green 353 Example 39 1-421 4.50 74.9 green 320 Example 40 1-423 4.51 73.9 green 326 Example 41 1-436 4.81 82.0 green 416 Example 42 1-441 4.45 74.7 green 303 Example 43 1-442 4.47 74.4 green 311 Example 44 1-455 4.69 83.8 green 423 Example 45 1-461 4.56 73.2 green 282 Example 46 1-477 4.77 83.5 green 395 Example 47 1-481 4.65 73.9 green 382 Example 48 1-484 4.32 82.7 green 486 Example 49 1-485 4.55 78.2 green 374 Example 50 1-488 4.91 87.1 green 481 Example 51 1-489 4.58 77.6 green 382 Example 52 1-492 4.91 86.8 green 489 Comparative example 1 Ref. 1 5.57 64.8 green 160 Comparative example 2 Ref. 2 5.83 61.2 green 170 Comparative example 3 Ref. 3 5.65 63.7 green 164 Comparative example 4 Ref. 4 5.66 61.0 green 188 Comparative Example 5 Ref. 5 5.81 64.3 green 198 Comparative Example 6 Ref. 6 5.62 62.5 green 193 Comparative Example 7 Ref. 7 5.62 64.3 green 130 Comparative Example 8 Ref. 8 5.41 65.5 green 149 Comparative Example 9 Ref. 9 5.62 64.6 green 138 Comparative Example 10 Ref. 10 5.62 65.1 green 157 Comparative Example 11 Ref. 11 5.33 64.2 green 153 Comparative Example 12 Ref. 12 5.52 64.4 green 142 Comparative Example 13 Ref. 13 5.63 62.5 green 183 Comparative Example 14 Ref. 14 5.82 61.2 green 181 Comparative Example 15 Ref. 15 5.55 63.5 green 176 Comparative Example 16 Ref. 16 5.63 62.1 green 185

在表12中,比較例1至比較例16的化合物與以下化合物Ref. 1至Ref. 16相同。

Figure 02_image484
Figure 02_image486
Figure 02_image488
Figure 02_image490
Ref. 1 Ref. 2 Ref. 3 Ref. 4
Figure 02_image492
Figure 02_image494
Figure 02_image496
Figure 02_image498
Ref. 5 Ref. 6 Ref. 7 Ref. 8
Figure 02_image500
Figure 02_image502
Figure 02_image504
Figure 02_image506
Ref. 9 Ref. 10 Ref.11 Ref. 12
Figure 02_image508
Figure 02_image510
Figure 02_image512
Figure 02_image514
Ref. 13 Ref. 14 Ref.15 Ref. 16 In Table 12, the compounds of Comparative Example 1 to Comparative Example 16 are the same as the following compounds Ref. 1 to Ref. 16.
Figure 02_image484
Figure 02_image486
Figure 02_image488
Figure 02_image490
Ref. 1 Ref. 2 Ref. 3 Ref. 4
Figure 02_image492
Figure 02_image494
Figure 02_image496
Figure 02_image498
Ref. 5 Ref. 6 Ref. 7 Ref. 8
Figure 02_image500
Figure 02_image502
Figure 02_image504
Figure 02_image506
Ref. 9 Ref. 10 Ref.11 Ref. 12
Figure 02_image508
Figure 02_image510
Figure 02_image512
Figure 02_image514
Ref. 13 Ref. 14 Ref.15 Ref. 16

自上表12的結果可確認,相較於比較例1至比較例16的有機發光元件而言,在使用根據本揭露的雜環化合物作為發光層材料的有機發光元件中,驅動電壓低,且發光效率及壽命顯著提高。From the results of Table 12 above, it can be confirmed that, compared with the organic light-emitting elements of Comparative Example 1 to Comparative Example 16, in the organic light-emitting element using the heterocyclic compound according to the present disclosure as the light-emitting layer material, the driving voltage is low, and The luminous efficiency and life are significantly improved.

根據本揭露的雜環化合物是經氘取代的化合物,且比較例1至比較例16的化合物是經氫取代的化合物。經氘(其原子質量為氫的原子質量的兩倍)取代的化合物由於較經氫取代的化合物更低的零點能(zero point energy)及振動能(vibration energy)而在基態(ground state)下具有更低的能量,且由分子間振動引起的碰撞減少,且因此薄膜可以非晶態(amorphous state)製成,藉此使得能夠提高有機發光元件的壽命。The heterocyclic compound according to the present disclosure is a deuterium-substituted compound, and the compounds of Comparative Example 1 to Comparative Example 16 are hydrogen-substituted compounds. Compounds substituted with deuterium (whose atomic mass is twice that of hydrogen) are in the ground state due to lower zero point energy and vibration energy than hydrogen-substituted compounds. It has lower energy, and collisions caused by intermolecular vibrations are reduced, and thus the thin film can be made in an amorphous state, thereby enabling to improve the lifetime of the organic light emitting element.

經氘取代的化合物具有低基態能,以使得化合物的穩定性提高,且C-D鍵的解離能(dissociation energy)高,以使得分子的穩定性提高,藉此使得能夠提高有機發光元件的壽命。The deuterium-substituted compound has low ground state energy to improve the stability of the compound, and high dissociation energy of the C-D bond to improve the stability of the molecule, thereby enabling to increase the lifetime of the organic light-emitting device.

具體而言,可證實,相較於比較例化合物Ref. 1至比較例化合物Ref. 16而言,根據本揭露的經氘取代的雜環化合物1-1至雜環化合物1-492由於分子穩定性及非晶性(amorphousness)而具有提高的驅動電壓及壽命。由於經氘取代的雜環化合物的低振動能,能量損失被最小化,且有利於能量轉移至摻雜劑,以使得可提高有機發光元件的發光效率。Specifically, it can be confirmed that, compared with Comparative Example Compound Ref. 1 to Comparative Example Compound Ref. Sex and amorphousness (amorphousness) have improved driving voltage and lifetime. Due to the low vibrational energy of the deuterium-substituted heterocyclic compound, energy loss is minimized and energy transfer to the dopant is facilitated, so that the luminous efficiency of the organic light emitting device can be improved.

一般而言,當咔唑中產生自由基陽離子時,咔唑的3-位被活化而形成二聚體(dimer),藉此抑制元件的效率及壽命。Generally, when free radical cations are generated in carbazole, the 3-position of carbazole is activated to form a dimer, thereby inhibiting the efficiency and lifetime of the device.

另一方面,當在經氘取代的縮合咔唑中產生自由基陽離子時,氘使自由基陽離子穩定化以提高有機發光元件的壽命。On the other hand, when radical cations are generated in the deuterium-substituted condensed carbazole, deuterium stabilizes the radical cations to improve the lifetime of the organic light emitting element.

具體而言,證實了藉由有效地使自由基陽離子穩定化(由於氘在縮合咔唑中進行取代),根據本揭露的經氘取代的雜環化合物1-1至雜環化合物1-492有效地提高了有機發光元件的壽命,而比較例化合物Ref. 1至比較例化合物Ref. 16由於經氫取代而對自由基陽離子的穩定化並無貢獻。因此,可證實使用其中縮合咔唑經氘取代的化合物1-1至化合物1-492作為發光層的材料的有機發光元件具有提高的壽命。Specifically, it was demonstrated that deuterium-substituted heterocycles 1-1 to 1-492 according to the present disclosure are effective by effectively stabilizing radical cations due to deuterium substitution in condensed carbazoles. The life of the organic light-emitting device is greatly improved, and the comparative example compound Ref. 1 to the comparative example compound Ref. 16 do not contribute to the stabilization of free radical cations due to hydrogen substitution. Accordingly, it was confirmed that organic light-emitting elements using Compound 1-1 to Compound 1-492 in which the condensed carbazole was substituted with deuterium as the material of the light-emitting layer had improved lifetime.

此外,根據本揭露的經氘取代的雜環化合物1-294可藉由降低化合物的振動能從而減少能量損失來提高有機發光元件的發光效率,且可藉由降低基態下的能量來提高有機發光元件的壽命。In addition, the deuterium-substituted heterocyclic compound 1-294 according to the present disclosure can improve the luminous efficiency of organic light-emitting devices by reducing the vibrational energy of the compound to reduce energy loss, and can improve organic light emission by reducing the energy in the ground state component life.

此外,其中僅縮合咔唑經氘取代的化合物1-241相較於化合物1-294而言增加了分子間相互作用,藉此減小了分子間距並提高了遷移率(mobility),藉此使得能夠提高有機發光元件的驅動電壓。 實驗例 2> 1 )有機發光元件的製造 In addition, compound 1-241, in which only the condensed carbazole is deuterium-substituted, increases intermolecular interactions compared to compound 1-294, thereby reducing the molecular distance and increasing mobility, thereby enabling The driving voltage of the organic light emitting element can be increased. < Experimental example 2> ( 1 ) Manufacture of organic light-emitting device

用蒸餾水超音波對上面塗佈有厚度為1,500埃的氧化銦錫(ITO)薄膜的玻璃基板進行了清潔。在用蒸餾水清潔完成之後,用溶劑(例如丙酮、甲醇及異丙醇)對基板進行了超音波清潔,且進行了乾燥,且然後在紫外線(UV)清潔器中使用UV進行了5分鐘的紫外線臭氧(UVO)處置。此後,將基板轉移至電漿清潔器(PT),且然後,為了在真空狀態下提高ITO的功函數以及移除殘留膜,對基板進行了電漿處置,以使得基板被轉移至熱沈積設備以進行有機沈積。A glass substrate coated with a 1,500 Å thick film of indium tin oxide (ITO) was cleaned ultrasonically with distilled water. After cleaning with distilled water, the substrates were ultrasonically cleaned with solvents such as acetone, methanol, and isopropanol, dried, and then exposed to UV light for 5 minutes in an ultraviolet (UV) cleaner Ozone (UVO) disposal. Thereafter, the substrate was transferred to a plasma cleaner (PT), and then, in order to improve the work function of ITO and remove the residual film in a vacuum state, the substrate was subjected to plasma treatment so that the substrate was transferred to a thermal deposition equipment for organic deposition.

在透明ITO電極(正電極)上,沈積了4,4',4''-三[2-萘基(苯基)胺基]三苯基胺(2-TNATA)來作為電洞注入層(其為共用層),且沈積了N,N'-二(1-萘基)-N,N'-二苯基-(1,1'-聯苯基)-4,4'-二胺(NPB)來作為電洞傳輸層。

Figure 02_image516
On the transparent ITO electrode (positive electrode), 4,4',4''-tris[2-naphthyl(phenyl)amino]triphenylamine (2-TNATA) was deposited as a hole injection layer ( which is a common layer), and N,N'-bis(1-naphthyl)-N,N'-diphenyl-(1,1'-biphenyl)-4,4'-diamine was deposited ( NPB) as the hole transport layer.
Figure 02_image516

在以此方式形成電洞注入層及電洞傳輸層之後,如下所述在其上熱真空沈積了發光層。所述發光層是藉由以下方式而沈積:將下表11中示出的化合物中的一者(N型)與由以上化學式2表示的化合物中的一者(P型)預混合且然後自一個源將預混物作為主體沈積至為400埃的厚度,並使用Ir(ppy) 3作為綠色磷光摻雜劑以所述發光層的沈積厚度的7重量%的量在所述主體上摻雜Ir(ppy) 3After forming the hole injection layer and the hole transport layer in this way, a light emitting layer was thermally vacuum deposited thereon as described below. The light-emitting layer was deposited by premixing one of the compounds (N type) shown in Table 11 below with one of the compounds represented by the above Chemical Formula 2 (P type) and then auto- One source deposited a premix as a host to a thickness of 400 Angstroms and doped on the host in an amount of 7% by weight of the deposited thickness of the emissive layer using Ir(ppy) as a green phosphorescent dopant Ir(ppy) 3 .

此後,將浴銅靈(BCP)作為電洞阻擋層沈積至為60埃的厚度,且在其上將三(8-羥基喹啉)鋁(Alq 3)作為電子傳輸層沈積至為200埃的厚度。

Figure 02_image518
Thereafter, bathocuproine (BCP) was deposited to a thickness of 60 Å as a hole blocking layer, and tris(8-quinolinolato)aluminum (Alq 3 ) was deposited thereon as an electron transport layer to a thickness of 200 Å. thickness.
Figure 02_image518

最後,在電子傳輸層上將氟化鋰(LiF)沈積至為10埃的厚度以形成電子注入層且然後在所述電子注入層上將鋁(Al)負電極沈積至為1,200埃的厚度以形成負電極,以使得製造出了有機發光元件。Finally, lithium fluoride (LiF) was deposited to a thickness of 10 angstroms on the electron transport layer to form an electron injection layer and then an aluminum (Al) negative electrode was deposited to a thickness of 1,200 angstroms on the electron injection layer to A negative electrode was formed so that an organic light emitting element was manufactured.

同時,對於每種材料使製造有機發光元件所需的所有有機化合物分別在10 -8托至10 -6托下經歷真空昇華及純化,並用於製造所述有機發光元件。 2 )有機發光元件的驅動電壓及發光效率 Meanwhile, all organic compounds required for manufacturing an organic light emitting element were subjected to vacuum sublimation and purification at 10 −8 Torr to 10 −6 Torr for each material, respectively, and used to manufacture the organic light emitting element. ( 2 ) Driving voltage and luminous efficiency of organic light-emitting elements

利用邁克科學公司的M7000量測了如上所述製造的有機發光元件的電致發光(EL)性質,且藉由由邁克科學公司製造的壽命量測系統(M6000)使用量測結果量測了當參考亮度為6,000坎德拉/平方米時的T 90值。量測根據本揭露製造的有機發光元件的驅動電壓、發光效率、顏色(EL顏色)及壽命的結果如表13中所示。 [表13]    發光層化合物 比率 驅動電壓 (伏) 發光效率 (坎德拉 / 面積) 顏色 EL 顏色 壽命 T 90 實例 53 1-1 : 2-42 1 : 8 4.53 53.7 綠色 415 實例 54 1-1 : 2-42 1 : 5 4.49 56.1 綠色 524 實例 55 1-1 : 2-42 1 : 2 4.32 82.3 綠色 666 實例 56 1-1 : 2-42 1 : 1 4.38 70.1 綠色 612 實例 57 1-1 : 2-42 2 : 1 4.29 69.4 綠色 589 實例 58 1-1 : 2-42 5 : 1 4.22 68.1 綠色 520 實例 59 1-1 : 2-42 8 : 1 4.21 67.4 綠色 437 實例 60 1-181 : 3-2 1 : 2 4.25 82.7 綠色 651 實例 61 1-181 : 3-2 1 : 1 4.43 80.1 綠色 612 實例 62 1-181 : 3-2 2 : 1 4.48 78.5 綠色 588 實例 63 1-241 : 3-26 1 : 2 4.29 81.4 綠色 715 實例 64 1-241 : 3-26 1 : 1 4.46 79.8 綠色 662 實例 65 1-241 : 3-26 2 : 1 4.49 78.4 綠色 629 實例 66 1-294 : 3-50 1 : 2 4.70 94.5 綠色 742 實例 67 1-294 : 3-50 1 : 1 4.83 92.8 綠色 722 實例 68 1-294 : 3-50 2 : 1 4.95 90.1 綠色 699 比較例 17 Ref.5 : 3-2 1 : 2 5.60 71.5 綠色 302 比較例 18 Ref.5 : 3-2 1 : 1 5.73 69.8 綠色 292 比較例 19 Ref.5 : 3-2 2 : 1 5.95 67.4 綠色 247 The electroluminescence (EL) properties of the organic light-emitting element manufactured as described above were measured using M7000 of Micro Scientific Corporation, and the measurement results were used to measure when Reference T 90 value at 6,000 cd/m². Table 13 shows the results of measuring the driving voltage, luminous efficiency, color (EL color) and lifetime of the organic light emitting device manufactured according to the present disclosure. [Table 13] Light-emitting layer compound ratio Driving Voltage (Volts) Luminous efficiency (cd / area) Color EL color Lifetime ( T 90 ) Example 53 1-1 : 2-42 1 : 8 4.53 53.7 green 415 Example 54 1-1 : 2-42 1 : 5 4.49 56.1 green 524 Example 55 1-1 : 2-42 1 : 2 4.32 82.3 green 666 Example 56 1-1 : 2-42 1 : 1 4.38 70.1 green 612 Example 57 1-1 : 2-42 twenty one 4.29 69.4 green 589 Example 58 1-1 : 2-42 5:1 4.22 68.1 green 520 Example 59 1-1 : 2-42 8 : 1 4.21 67.4 green 437 Example 60 1-181 : 3-2 1 : 2 4.25 82.7 green 651 Example 61 1-181 : 3-2 1 : 1 4.43 80.1 green 612 Example 62 1-181 : 3-2 twenty one 4.48 78.5 green 588 Example 63 1-241 : 3-26 1 : 2 4.29 81.4 green 715 Example 64 1-241 : 3-26 1 : 1 4.46 79.8 green 662 Example 65 1-241 : 3-26 twenty one 4.49 78.4 green 629 Example 66 1-294 : 3-50 1 : 2 4.70 94.5 green 742 Example 67 1-294 : 3-50 1 : 1 4.83 92.8 green 722 Example 68 1-294 : 3-50 twenty one 4.95 90.1 green 699 Comparative Example 17 Ref.5 : 3-2 1 : 2 5.60 71.5 green 302 Comparative Example 18 Ref.5 : 3-2 1 : 1 5.73 69.8 green 292 Comparative Example 19 Ref.5 : 3-2 twenty one 5.95 67.4 green 247

在表13的結果中,當混合所述兩種化合物並藉由使用由以上化學式1表示的化合物(其為根據本揭露的雜環化合物)作為N型主體且使用根據本揭露的由以上化學式2表示的化合物作為P型主體來進行沈積時,可證實提高了有機發光元件的發光效率及壽命。據此,當混合並沈積所述兩種化合物時,預期可能會發生激發錯合體現象。In the results of Table 13, when the two compounds were mixed and by using the compound represented by the above Chemical Formula 1, which is the heterocyclic compound according to the present disclosure, as the N-type host and using the compound represented by the above Chemical Formula 2 according to the present disclosure When the indicated compounds are deposited as P-type hosts, it can be confirmed that the luminous efficiency and lifetime of the organic light-emitting device are improved. Accordingly, when the two compounds are mixed and deposited, it is expected that an excited complex phenomenon may occur.

激發錯合體現象為藉由兩個分子之間的電子交換而發射具有為施體(p-主體)HOMO能階及受體(n-主體)LUMO能階的大小的能量的現象。當兩個分子之間發生激發錯合體現象時,會發生反向系統間交叉(RISC),且因此,螢光的內部量子效率可提高至100%。當具有良好電洞傳輸能力的施體(p-主體)及具有良好電子傳輸能力的受體(n-主體)被用作發光層的主體時,由於電洞被注入至p-主體中且電子被注入至n-主體中,因此有機發光元件的驅動電壓可降低,藉此有助於提高有機發光元件的壽命。The exciplex phenomenon is a phenomenon in which energy having the magnitude of a donor (p-host) HOMO level and an acceptor (n-host) LUMO level is emitted by electron exchange between two molecules. Reverse intersystem crossing (RISC) occurs when excited complexes occur between two molecules, and as a result, the internal quantum efficiency of fluorescence can be increased up to 100%. When a donor (p-host) with good hole transport capability and an acceptor (n-host) with good electron transport capability are used as the host of the light-emitting layer, since holes are injected into the p-host and electrons It is injected into the n-body, so the driving voltage of the organic light-emitting element can be reduced, thereby helping to improve the lifetime of the organic light-emitting element.

在由化學式2表示的化合物的情形中,其是經氫取代或者部分地或整體地經氘取代的化合物。經氘(其原子質量為氫的原子質量的兩倍)取代的化合物由於較經氫取代的化合物更低的零點能及振動能而在基態下具有更低的能量,且由分子間振動引起的碰撞減少,且因此薄膜可以非晶態製成,藉此使得能夠提高有機發光元件的壽命。In the case of the compound represented by Chemical Formula 2, it is a compound substituted with hydrogen or partially or entirely substituted with deuterium. Compounds substituted with deuterium (whose atomic mass is twice that of hydrogen) have lower energy in the ground state due to lower zero-point and vibrational energies than hydrogen-substituted compounds, and vibrations caused by intermolecular vibrations Collisions are reduced, and thus the thin film can be made in an amorphous state, thereby making it possible to increase the lifetime of the organic light emitting element.

經氘取代的化合物具有低基態能,以使得化合物的穩定性提高,且C-D鍵的解離能高,以使得分子的穩定性提高,藉此使得能夠提高有機發光元件的壽命。The deuterium-substituted compound has low ground state energy to improve the stability of the compound, and high dissociation energy of the C-D bond to improve the stability of the molecule, thereby enabling to increase the lifetime of the organic light-emitting device.

在本揭露中,當由以上化學式2表示的化合物用作施體且由以上化學式1表示的化合物用作受體以使得所述化合物用作發光層的主體時,可證實有機發光元件表現出極佳的性質。In the present disclosure, when the compound represented by the above Chemical Formula 2 is used as a donor and the compound represented by the above Chemical Formula 1 is used as an acceptor so that the compound is used as a host of the light emitting layer, it can be confirmed that the organic light emitting element exhibits extremely good nature.

100:基板 200:正電極 300:有機材料層 301:電洞注入層 302:電洞傳輸層 303:發光層 304:電洞阻擋層 305:電子傳輸層 306:電子注入層 400:負電極 100: Substrate 200: positive electrode 300: organic material layer 301: Hole injection layer 302: Hole transport layer 303: luminous layer 304: Hole blocking layer 305: electron transport layer 306: Electron injection layer 400: negative electrode

圖1至圖3是分別示意性地示出根據本揭露一個實施例的有機發光元件的堆疊式結構的圖。1 to 3 are diagrams schematically illustrating a stacked structure of an organic light emitting device according to an embodiment of the present disclosure.

100:基板 100: Substrate

200:正電極 200: positive electrode

300:有機材料層 300: organic material layer

400:負電極 400: negative electrode

Claims (18)

一種由以下化學式1表示的雜環化合物: [化學式1]
Figure 03_image520
其中, R1至R12彼此相同或不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C60烷基;經取代或未經取代的C2至C60烯基;經取代或未經取代的C2至C60炔基;經取代或未經取代的C1至C60烷氧基;經取代或未經取代的C3至C60環烷基;經取代或未經取代的C2至C60雜環烷基;經取代或未經取代的C6至C60芳基;以及經取代或未經取代的C2至C60雜芳基,且R1至R12中的至少一者為氘, X1、X2及X3彼此相同或不同,且各自獨立地為NAr1、O、S或CR13R14,且X1、X2及X3中的至少一者為NAr1, Ar1是由以下化學式1-1表示的基團, [化學式1-1]
Figure 03_image522
其中, L1與L2彼此相同或不同,且各自獨立地為單鍵;經取代或未經取代的C6至C60伸芳基;或者經取代或未經取代的C2至C60伸雜芳基, Ar2與Ar3彼此相同或不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C60烷基;經取代或未經取代的C2至C60烯基;經取代或未經取代的C2至C60炔基;經取代或未經取代的C1至C60烷氧基;經取代或未經取代的C3至C60環烷基;經取代或未經取代的C2至C60雜環烷基;經取代或未經取代的C6至C60芳基;以及經取代或未經取代的C2至C60雜芳基, a與b彼此相同或不同,且各自獨立地為0至3的整數,且 R13與R14彼此相同或不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C60烷基;經取代或未經取代的C2至C60烯基;經取代或未經取代的C2至C60炔基;經取代或未經取代的C1至C60烷氧基;經取代或未經取代的C3至C60環烷基;經取代或未經取代的C2至C60雜環烷基;經取代或未經取代的C6至C60芳基;以及經取代或未經取代的C2至C60雜芳基。
A heterocyclic compound represented by the following Chemical Formula 1: [Chemical Formula 1]
Figure 03_image520
Wherein, R1 to R12 are the same or different from each other, and are each independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C60 alkyl; substituted or unsubstituted C2 to C60 alkenyl; substituted or unsubstituted C2 to C60 alkynyl; substituted or unsubstituted C1 to C60 alkoxy; substituted or unsubstituted C3 to C60 cycloalkyl; substituted or unsubstituted C2 to C60 heterocycloalkyl; substituted or unsubstituted C6 to C60 aryl; and substituted or unsubstituted C2 to C60 heteroaryl, and at least one of R1 to R12 For deuterium, X1, X2 and X3 are the same or different from each other, and each independently is NAr1, O, S or CR13R14, and at least one of X1, X2 and X3 is NAr1, and Ar1 is represented by the following chemical formula 1-1 group, [chemical formula 1-1]
Figure 03_image522
Wherein, L1 and L2 are the same or different from each other, and each independently is a single bond; substituted or unsubstituted C6 to C60 aryl; or substituted or unsubstituted C2 to C60 heteroaryl, Ar2 and Ar3 are the same or different from each other, and are each independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C60 alkyl; substituted or unsubstituted C2 to C60 Alkenyl; substituted or unsubstituted C2 to C60 alkynyl; substituted or unsubstituted C1 to C60 alkoxy; substituted or unsubstituted C3 to C60 cycloalkyl; substituted or unsubstituted A C2 to C60 heterocycloalkyl group; a substituted or unsubstituted C6 to C60 aryl group; and a substituted or unsubstituted C2 to C60 heteroaryl group, a and b are the same or different from each other, and are each independently An integer of 0 to 3, and R13 and R14 are the same or different from each other, and are each independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C60 alkyl; Substituted or unsubstituted C2 to C60 alkenyl; substituted or unsubstituted C2 to C60 alkynyl; substituted or unsubstituted C1 to C60 alkoxy; substituted or unsubstituted C3 to C60 ring alkyl; substituted or unsubstituted C2 to C60 heterocycloalkyl; substituted or unsubstituted C6 to C60 aryl; and substituted or unsubstituted C2 to C60 heteroaryl.
如請求項1所述的雜環化合物,其中所述由以上化學式1表示的雜環化合物是以下化學式1-a至化學式1-f中的任一者: [化學式1-a]
Figure 03_image524
[化學式1-b]
Figure 03_image526
[化學式1-c]
Figure 03_image528
[化學式1-d]
Figure 03_image530
[化學式1-e]
Figure 03_image532
[化學式1-f]
Figure 03_image534
其中, X3是O、S或CR13R14,且 R1至R14及Ar1如以上化學式1及化學式1-1中所定義。
The heterocyclic compound as claimed in item 1, wherein the heterocyclic compound represented by the above chemical formula 1 is any one of the following chemical formula 1-a to chemical formula 1-f: [chemical formula 1-a]
Figure 03_image524
[chemical formula 1-b]
Figure 03_image526
[chemical formula 1-c]
Figure 03_image528
[chemical formula 1-d]
Figure 03_image530
[chemical formula 1-e]
Figure 03_image532
[chemical formula 1-f]
Figure 03_image534
Wherein, X3 is O, S or CR13R14, and R1 to R14 and Ar1 are as defined in the above chemical formula 1 and chemical formula 1-1.
如請求項1所述的雜環化合物,其中R1至R12是氘。The heterocyclic compound as claimed in claim 1, wherein R1 to R12 are deuterium. 如請求項1所述的雜環化合物,其中以氫原子與氘原子的總數計,所述由以上化學式1表示的雜環化合物中的R1至R12的氘含量為1%至100%。The heterocyclic compound according to claim 1, wherein the deuterium content of R1 to R12 in the heterocyclic compound represented by the above chemical formula 1 is 1% to 100% based on the total number of hydrogen atoms and deuterium atoms. 如請求項1所述的雜環化合物,其中以上化學式1-1中的Ar2及Ar3是經氘取代的C6至C30芳基或者經氘取代的C2至C30雜芳基,且在此情形中,以氫原子與氘原子的總數計,氘含量為1%至100%。The heterocyclic compound as described in claim 1, wherein Ar2 and Ar3 in the above chemical formula 1-1 are deuterium-substituted C6 to C30 aryl or deuterium-substituted C2 to C30 heteroaryl, and in this case, Based on the total number of hydrogen atoms and deuterium atoms, the deuterium content is 1% to 100%. 如請求項1所述的雜環化合物,其中所述由以上化學式1表示的雜環化合物不包含氘作為取代基,或者以氫原子與氘原子的總數計,氘含量為1%至100%。The heterocyclic compound according to claim 1, wherein the heterocyclic compound represented by the above chemical formula 1 does not contain deuterium as a substituent, or the deuterium content is 1% to 100% based on the total number of hydrogen atoms and deuterium atoms. 如請求項6所述的雜環化合物,其中以氫原子與氘原子的所述總數計,在所述由以上化學式1表示的雜環化合物中,所述氘含量為20%至100%。The heterocyclic compound according to claim 6, wherein the deuterium content in the heterocyclic compound represented by the above chemical formula 1 is 20% to 100% based on the total number of hydrogen atoms and deuterium atoms. 如請求項1所述的雜環化合物,其中所述由以上化學式1表示的雜環化合物為選自由以下化合物組成的群組的任一者:
Figure 03_image536
Figure 03_image538
Figure 03_image540
Figure 03_image542
Figure 03_image544
Figure 03_image546
Figure 03_image548
Figure 03_image550
Figure 03_image552
Figure 03_image554
Figure 03_image556
Figure 03_image558
Figure 03_image560
Figure 03_image562
Figure 03_image564
Figure 03_image566
Figure 03_image568
Figure 03_image570
Figure 03_image572
Figure 03_image574
Figure 03_image576
Figure 03_image578
Figure 03_image580
Figure 03_image582
Figure 03_image584
The heterocyclic compound as claimed in item 1, wherein the heterocyclic compound represented by the above chemical formula 1 is any one selected from the group consisting of the following compounds:
Figure 03_image536
Figure 03_image538
Figure 03_image540
Figure 03_image542
Figure 03_image544
Figure 03_image546
Figure 03_image548
Figure 03_image550
Figure 03_image552
Figure 03_image554
Figure 03_image556
Figure 03_image558
Figure 03_image560
Figure 03_image562
Figure 03_image564
Figure 03_image566
Figure 03_image568
Figure 03_image570
Figure 03_image572
Figure 03_image574
Figure 03_image576
Figure 03_image578
Figure 03_image580
Figure 03_image582
Figure 03_image584
.
一種有機發光元件,包括: 第一電極; 第二電極,被設置成面對所述第一電極;以及 一或多個有機材料層,設置於所述第一電極與所述第二電極之間, 其中所述有機材料層包含如請求項1至請求項8中任一項所述的雜環化合物。 An organic light emitting element, comprising: first electrode; a second electrode disposed facing said first electrode; and one or more layers of organic material disposed between the first electrode and the second electrode, Wherein the organic material layer comprises the heterocyclic compound as described in any one of Claim 1 to Claim 8. 如請求項9所述的有機發光元件,其中所述有機發光元件包括選自由發光層、電洞注入層、電洞傳輸層、電子注入層、電子傳輸層、電子阻擋層及電洞阻擋層組成的群組的一或多個層,且所述一或多個層包含所述雜環化合物。The organic light-emitting element as claimed in item 9, wherein the organic light-emitting element comprises a light-emitting layer, a hole injection layer, a hole transport layer, an electron injection layer, an electron transport layer, an electron blocking layer, and a hole blocking layer. One or more layers of the group, and the one or more layers comprise the heterocyclic compound. 如請求項9所述的有機發光元件,其中所述有機材料層包括發光層,且所述發光層包含所述雜環化合物。The organic light-emitting device according to claim 9, wherein the organic material layer includes a light-emitting layer, and the light-emitting layer includes the heterocyclic compound. 如請求項9所述的有機發光元件,其中所述有機材料層包括發光層,所述發光層包含主體材料,且所述主體材料包含所述雜環化合物。The organic light-emitting device according to claim 9, wherein the organic material layer includes a light-emitting layer, the light-emitting layer includes a host material, and the host material includes the heterocyclic compound. 如請求項9所述的有機發光元件,其中所述有機材料層更包含由以下化學式2表示的雜環化合物: [化學式2]
Figure 03_image586
其中, R21至R34彼此相同或不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C60烷基;經取代或未經取代的C2至C60烯基;經取代或未經取代的C2至C60炔基;經取代或未經取代的C1至C60烷氧基;經取代或未經取代的C3至C60環烷基;經取代或未經取代的C2至C60雜環烷基;經取代或未經取代的C6至C60芳基;以及經取代或未經取代的C2至C60雜芳基, L3與L4彼此相同或不同,且各自獨立地為單鍵;經取代或未經取代的C6至C60伸芳基;或者經取代或未經取代的C2至C60伸雜芳基, Ar11與Ar12彼此相同或不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C60烷基;經取代或未經取代的C2至C60烯基;經取代或未經取代的C2至C60炔基;經取代或未經取代的C1至C60烷氧基;經取代或未經取代的C3至C60環烷基;經取代或未經取代的C2至C60雜環烷基;經取代或未經取代的C6至C60芳基;經取代或未經取代的C2至C60雜芳基;-P(=O)R101R102;以及–SiR101R102R103,且R101、R102及R103彼此相同或不同,且各自獨立地為經取代或未經取代的C1至C60烷基;經取代或未經取代的C6至C60芳基;或者經取代或未經取代的C2至C60雜芳基,且 m與n彼此相同或不同,且各自獨立地為0至3的整數。
The organic light-emitting element as claimed in item 9, wherein the organic material layer further comprises a heterocyclic compound represented by the following chemical formula 2: [chemical formula 2]
Figure 03_image586
Wherein, R21 to R34 are the same or different from each other, and are each independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C60 alkyl; substituted or unsubstituted C2 to C60 alkenyl; substituted or unsubstituted C2 to C60 alkynyl; substituted or unsubstituted C1 to C60 alkoxy; substituted or unsubstituted C3 to C60 cycloalkyl; substituted or unsubstituted C2 to C60 heterocycloalkyl; substituted or unsubstituted C6 to C60 aryl; and substituted or unsubstituted C2 to C60 heteroaryl, L3 and L4 are the same or different from each other, and Each independently is a single bond; substituted or unsubstituted C6 to C60 aryl; or substituted or unsubstituted C2 to C60 heteroaryl, Ar11 and Ar12 are the same or different from each other, and each independently selected The group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C60 alkyl; substituted or unsubstituted C2 to C60 alkenyl; substituted or unsubstituted C2 to C60 alkynyl; substituted or unsubstituted C1 to C60 alkoxy; substituted or unsubstituted C3 to C60 cycloalkyl; substituted or unsubstituted C2 to C60 heterocycloalkyl; substituted or unsubstituted C6 to C60 aryl; substituted or unsubstituted C2 to C60 heteroaryl; -P(=O)R101R102; and -SiR101R102R103, and R101, R102 and R103 are the same or different from each other, and each independently substituted or unsubstituted C1 to C60 alkyl; substituted or unsubstituted C6 to C60 aryl; or substituted or unsubstituted C2 to C60 heteroaryl, and m and n are the same as each other or different, each independently being an integer of 0 to 3.
如請求項13所述的有機發光元件,其中所述由以上化學式2表示的雜環化合物不包含氘作為取代基,或者以氫原子與氘原子的總數計,氘含量為1%至100%。The organic light-emitting device according to claim 13, wherein the heterocyclic compound represented by the above chemical formula 2 does not contain deuterium as a substituent, or the deuterium content is 1% to 100% based on the total number of hydrogen atoms and deuterium atoms. 如請求項13所述的有機發光元件,其中所述由以上化學式2表示的雜環化合物為選自由以下化合物組成的群組的任一者:
Figure 03_image588
Figure 03_image590
Figure 03_image592
Figure 03_image594
Figure 03_image596
Figure 03_image598
Figure 03_image600
Figure 03_image602
The organic light-emitting element as claimed in item 13, wherein the heterocyclic compound represented by the above chemical formula 2 is any one selected from the group consisting of the following compounds:
Figure 03_image588
Figure 03_image590
Figure 03_image592
Figure 03_image594
Figure 03_image596
Figure 03_image598
Figure 03_image600
Figure 03_image602
.
如請求項13所述的有機發光元件,其中所述由以上化學式1表示的雜環化合物及所述由以上化學式2表示的雜環化合物中的至少一者不包含氘作為取代基,或者以氫原子與氘原子的總數計,氘含量為1%至100%。The organic light-emitting element according to claim 13, wherein at least one of the heterocyclic compound represented by the above chemical formula 1 and the heterocyclic compound represented by the above chemical formula 2 does not contain deuterium as a substituent, or is replaced by hydrogen The deuterium content ranges from 1% to 100% based on the total number of atoms and deuterium atoms. 一種有機發光元件的有機材料層之組成物,包含如請求項1至請求項8中任一項所述的由化學式1表示的雜環化合物及由以下化學式2表示的雜環化合物: [化學式2]
Figure 03_image604
其中, R21至R34彼此相同或不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C60烷基;經取代或未經取代的C2至C60烯基;經取代或未經取代的C2至C60炔基;經取代或未經取代的C1至C60烷氧基;經取代或未經取代的C3至C60環烷基;經取代或未經取代的C2至C60雜環烷基;經取代或未經取代的C6至C60芳基;以及經取代或未經取代的C2至C60雜芳基, L1與L2彼此相同或不同,且各自獨立地為單鍵;經取代或未經取代的C6至C60伸芳基;或者經取代或未經取代的C2至C60伸雜芳基, Ar11與Ar12彼此相同或不同,且各自獨立地選自由以下組成的群組:氫;氘;鹵素;氰基;經取代或未經取代的C1至C60烷基;經取代或未經取代的C2至C60烯基;經取代或未經取代的C2至C60炔基;經取代或未經取代的C1至C60烷氧基;經取代或未經取代的C3至C60環烷基;經取代或未經取代的C2至C60雜環烷基;經取代或未經取代的C6至C60芳基;經取代或未經取代的C2至C60雜芳基;-P(=O)R101R102;以及–SiR101R102R103,且R101、R102及R103彼此相同或不同,且各自獨立地為經取代或未經取代的C1至C60烷基;經取代或未經取代的C6至C60芳基;或者經取代或未經取代的C2至C60雜芳基,且 m與n彼此相同或不同,且各自獨立地為0至3的整數。
A composition of an organic material layer of an organic light-emitting element, comprising a heterocyclic compound represented by Chemical Formula 1 and a heterocyclic compound represented by the following Chemical Formula 2 as described in any one of Claim 1 to Claim 8: [Chemical Formula 2 ]
Figure 03_image604
Wherein, R21 to R34 are the same or different from each other, and are each independently selected from the group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C60 alkyl; substituted or unsubstituted C2 to C60 alkenyl; substituted or unsubstituted C2 to C60 alkynyl; substituted or unsubstituted C1 to C60 alkoxy; substituted or unsubstituted C3 to C60 cycloalkyl; substituted or unsubstituted C2 to C60 heterocycloalkyl; substituted or unsubstituted C6 to C60 aryl; and substituted or unsubstituted C2 to C60 heteroaryl, L1 and L2 are the same or different from each other, and Each independently is a single bond; substituted or unsubstituted C6 to C60 aryl; or substituted or unsubstituted C2 to C60 heteroaryl, Ar11 and Ar12 are the same or different from each other, and each independently selected The group consisting of hydrogen; deuterium; halogen; cyano; substituted or unsubstituted C1 to C60 alkyl; substituted or unsubstituted C2 to C60 alkenyl; substituted or unsubstituted C2 to C60 alkynyl; substituted or unsubstituted C1 to C60 alkoxy; substituted or unsubstituted C3 to C60 cycloalkyl; substituted or unsubstituted C2 to C60 heterocycloalkyl; substituted or unsubstituted C6 to C60 aryl; substituted or unsubstituted C2 to C60 heteroaryl; -P(=O)R101R102; and -SiR101R102R103, and R101, R102 and R103 are the same or different from each other, and each independently substituted or unsubstituted C1 to C60 alkyl; substituted or unsubstituted C6 to C60 aryl; or substituted or unsubstituted C2 to C60 heteroaryl, and m and n are the same as each other or different, each independently being an integer of 0 to 3.
如請求項17所述的組成物,其中所述由以上化學式1表示的雜環化合物與所述由以上化學式2表示的雜環化合物具有為1:10至10:1的重量比。The composition according to claim 17, wherein the heterocyclic compound represented by the above Chemical Formula 1 and the heterocyclic compound represented by the above Chemical Formula 2 have a weight ratio of 1:10 to 10:1.
TW111134757A 2021-09-14 2022-09-14 Heterocyclic compound, organic light emitting device comprising same, and composition for organic material layer of organic light emitting device TW202323498A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020210122791A KR20230039445A (en) 2021-09-14 2021-09-14 Heterocyclic compound, organic light emitting device comprising the same and composition for organic layer of organic light emitting device
KR10-2021-0122791 2021-09-14

Publications (1)

Publication Number Publication Date
TW202323498A true TW202323498A (en) 2023-06-16

Family

ID=85603296

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111134757A TW202323498A (en) 2021-09-14 2022-09-14 Heterocyclic compound, organic light emitting device comprising same, and composition for organic material layer of organic light emitting device

Country Status (3)

Country Link
KR (1) KR20230039445A (en)
TW (1) TW202323498A (en)
WO (1) WO2023043300A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356429A (en) 1980-07-17 1982-10-26 Eastman Kodak Company Organic electroluminescent cell
KR20160028737A (en) * 2014-09-04 2016-03-14 에스에프씨 주식회사 An organoelectro luminescent compounds and organoelectro luminescent device using the same
JPWO2017038728A1 (en) * 2015-08-28 2018-06-14 出光興産株式会社 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE
CN106397398A (en) * 2016-08-31 2017-02-15 北京绿人科技有限责任公司 Organic compound and application thereof to organic electroluminescent devices
CN111269243A (en) * 2018-12-05 2020-06-12 北京鼎材科技有限公司 Organic electroluminescent compound and application thereof
KR20200076817A (en) * 2018-12-19 2020-06-30 삼성디스플레이 주식회사 Organic light-emitting device and display including the same

Also Published As

Publication number Publication date
WO2023043300A1 (en) 2023-03-23
KR20230039445A (en) 2023-03-21

Similar Documents

Publication Publication Date Title
EP4190779A1 (en) Heterocyclic compound, organic light-emitting device comprising same, and composition for organic layer of organic light-emitting device
JP2024041960A (en) Heterocyclic compound, organic light emitting device containing the same, and composition for organic layer
JP2022101491A (en) Heterocyclic compound, organic light emitting device comprising the same, method for manufacturing the same, and composition for organic material layer
JP2023540006A (en) Composition for organic light emitting device and organic layer formation
JP2022519980A (en) Heterocyclic compound, organic light emitting device containing the same, method for producing the same, and composition for an organic layer.
EP4160708A1 (en) Organic light-emitting device, manufacturing method therefor, and composition for organic material layer of organic light-emitting device
JP2023508832A (en) Heterocyclic compound, organic light-emitting device containing the same, composition for organic layer of organic light-emitting device, and method for manufacturing organic light-emitting device
JP2023539075A (en) Heterocyclic compound, organic light-emitting device containing the same, and composition for organic layer of organic light-emitting device
CN112204022A (en) Heterocyclic compound, organic light-emitting element including the same, composition of organic material layer for organic light-emitting element, and method for manufacturing organic light-emitting element
JP2023029297A (en) Heterocyclic compound, organic light emitting device comprising the same, composition for organic layer of organic light emitting device
TW202317583A (en) Heterocyclic compound, organic light emitting device, and composition for organic material layer of organic light emitting device
KR102110833B1 (en) Heterocyclic compound and organic light emitting device comprising the same
TW202219243A (en) Heterocyclic compound, organic light emitting device comprising same and composition for organic layer of organic light emitting device
TW202146401A (en) Heterocyclic compound, organic light emitting device comprising same, manufacturing method of same and composition for organic layer of organic light emitting device
CN112020502A (en) Heterocyclic compound, organic light-emitting element including the same, method for producing the same, and composition for organic layer of organic light-emitting element
TW202302811A (en) Heterocyclic compound, organic light emitting device including same and composition for organic material layer
TW202231839A (en) Heterocyclic compound, organic light emitting device comprising the same, manufacturing method of the same and composition for organic layer of organic light emitting device
CN114096535A (en) Heterocyclic compound, organic light-emitting element comprising same, composition for organic layer of organic light-emitting element, and method for producing organic light-emitting element
TW202323498A (en) Heterocyclic compound, organic light emitting device comprising same, and composition for organic material layer of organic light emitting device
TWI838619B (en) Heterocyclic compound and organic light emitting device comprising the same
TW202319510A (en) Heterocyclic compound, organic light emitting device comprising the same, and composition
TW202302601A (en) Heterocyclic compound, organic light emitting device comprising the same and method for manufacturing the same
TW202319509A (en) Heterocyclic compound, organic light emitting device comprising the same and composition for organic material layer
TW202302536A (en) Heterocyclic compound and organic light emitting device comprising the same
JP2023554619A (en) Heterocyclic compound, organic light emitting device containing the same, method for producing the same, and composition for organic layer